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Economically, bovine respiratory disease (BRD) is the most important disease 
affecting feedlot cattle (Martin et al., 1989; Edwards, 1996).  Annual economic losses
due to death, decreased feed efficiency, and medicine costs associated with BRD are 
estimated at $800-900 million (Chirase and Greene, 2001).  Bovine respiratory disease
accounts for approximately 75% of feedlot morbidity and from 50 to 80% of mortality 
(Edwards, 1996; Chirase and Greene, 2001).  Although the medical costs attributable to 
the treatment of BRD are substantial (Martin et al., 1982; Perino, 1992), the economic 
impact of BRD on animal performance, carcass merit, and meat quality are likely even 
more devastating. McNeill et al. (1996) reported that “healthy” steers had gre ter daily 
gains and 12% more U.S. Choice carcasses than cattle identified as “sick” at ome point 
during the finishing period.  Gardner et al. (1999) showed that steers with lung lesions 
plus active lymph nodes had $73.78 less net return, of which 21% was due to medicine 
costs and 79% due to lower carcass weight (8.4% less) and lower quality grade (24.7% 
more U.S. Standards).  This negative impact on carcass traits 200 d after receiving th  
cattle illustrates the importance of preventing BRD.   
With demand for higher quality products and an increase in value-based marketing, beef  
producers are becoming more in-tune to health management practices that have the 
potential to increase profitability and beef product quality.  Effects of BRD illustrate the 
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importance of pre-weaning health management to producers because of the associated 
economic risk (Speer et al., 2001).  If feedlots were able to purchase calves that are more 
likely to remain healthy during the feeding period, their profits would increase through 
reduced costs and higher revenues.  Previous studies have indicated that calves 
preconditioned prior to being placed in the feedlot remain healthier and perform better 
(Step et al., 2008); however, few studies have documented the value of preconditioning 
programs to the feedlot operator, cow-calf producer, or the public in general. 
One of the greatest challenges with implementing programs and managemet 
strategies to prevent BRD is our lack of understanding of the multi-factorial etiology and 
predisposing factors involved with the disease (Duff and Galyean, 2007).  Despite the 
availability of new generation vaccines and antimicrobials, mortality ssociated with 
BRD has increased in the last decade (Babcock et al., 2006).  Booker et al. (2008) 
reported a wide variety of bacterial and viral pathogens in animals that succumbed to 
BRD.  Thus, a better understanding of the impact that stress and viral and bacterial 
pathogens alone or in combination have on animal health and growth is essential to 
improving production efficiency, meat quality, and food safety in beef cattle.  In non-
ruminant species, recent research has implicated the fat cell as an interface between 
energy status of the animal and immune function, which may regulate muscle fiber 
growth through a variety of signals which influence fatty acid oxidation, glucose uptake, 
and insulin sensitivity (Jacobi et al., 2006).  Intramuscular fat cells are strat gically 
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positioned to act as immunological sensors to regulate direct and indirect responses of 
muscle cells to inflammatory signals.  During an infectious process, immune cells release 
soluble proteins (i.e., “inflammatory signals”) called cytokines (Bannerman, 2008).  
Cytokines have been demonstrated to redirect nutrient utilization from growth t support 
of an immune response (Humphrey and Klasing, 2004).  Therefore, an acute phase 
response has the potential to have long-term effects on animal growth and development; 
however; little information is available in the bovine.  
Objectives  
Basic information regarding the underlying mechanisms of how stress associated 
with current cattle marketing strategies and BRD influence growth and developm nt of 
beef cattle are largely lacking.  Information in this regard is critical o improving 
livestock productivity and end product quality.  The overall goal of the work presented 
herein was to identify biological links that exist between the BRD complex and decreas d 
animal performance and carcass quality.  Our objectives were to evaluate the effects of 
BRD challenge models on immune response, cattle performance, carcass characteristics, 
visceral organ mass, apparent nutrient digestibility, nutrient retention, and net flux of 
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Pathogens involved in Bovine Respiratory Disease (BRD) 
 Bovine viral diarrhea virus (BVDV) and its relationship with BRD.  The 
presence of animals persistently infected (PI) with BVDV in feedlot pens has been 
associated with increased BRD morbidity and mortality during the finishing period 
(Loneragan et al., 2005). Bovine viral diarrhea viruses involved in BRD can cause 
clinical infections on their own (Potgieter et al., 1984), but have also been reported to 
make cattle more susceptible to secondary bacterial infections that are common 
inhabitants of the respiratory tract of healthy animals (Barbour et al., 1997).  Therefore, 
increasing our understanding of the impact of BVDV and it’s interaction with BRD on 
animal health is important. 
Gånheim et al. (2003; 2005) evaluated the effects of BVDV and M. haemolytica 
challenge on immune response of calves. In their study calves ranged from 9 to 18 wk of 
age and the virus of interest was directly inoculated into the nostril.  Clinical signs were 
more severe in animals challenged with both BVDV and M. haemolytica followed by the 
BVDV only group.  Calves receiving only the bacterial challenge had very mild clinical 
signs.  Rectal temperature and serum concentrations of serum amyloid A, fibrinogen, and 
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haptoglobin were increased in all experimental treatments.  In addition, BVDV 
inoculation induced a significant decrease in total white blood cell counts and absolute 
counts of neutrophils and lymphocytes, whereas M. haemolytica inoculation increased 
total white blood cell counts and neutrophils, while decreasing the lymphocyte count. 
Fulton et al. (2006a) suggested that in order to study the pathogenesis and efficacy of 
vaccines the use of a challenge model that simulates natural disease exposure would be 
beneficial.  Niskanen and Lindberg et al. (2003) demonstrated that the route of 
transmission of BVDV from a PI calf could occur by direct contact, ambient ar, or by 
sharing the feed-bunk.  Therefore, it appears a potential model to study the effects of 
BRD on animal growth and health could include exposure of naïve animals to animals PI 
with BVDV. 
Mannheimia haemolytica and its relationship in BRD.  Despite the development 
of new vaccines and antibiotics, Mannheimia haemolytica has been reported to be the 
most common pathogen isolated in animal’s succumbing from BRD (Booker et al., 
2008). The difficulty of implementing prevention strategies against this bacteria has been 
associated with its high virulence due to different pathogenic factors that it possesse , 
including outer membrane proteins (Pandher et al., 1999) and leukotoxin (Rice et al., 
2007).  Leukotoxin is secreted during the logarithmic growth phase of M. haemolytica 
(Czuprynski et al., 2004) and is considered to be one of components of M. haemolytica 
with detrimental effects on health of the host animal.  Previous challenge studi s with M. 
haemolytica have shown that iron-regulated outer membrane protein and leukotoxin are 
produced in vivo by M. haemolytica during pathogenesis associated with this bacteria 
(Confer et al. 1995). Therefore, increased serum antibody concentration against these 
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proteins in non-vaccinated and sero-negative animals is associated with clinical or 
subclinical disease.  
Effects of BRD on white blood cell counts 
When correlated with a clinical evaluation, leukograms can provide informative 
and low cost evaluation of disease processes (Cole et al., 1997). Gånheim et al. (2005) 
and Corrigan et al. (2007) reported that an intratracheal M. haemolytica challenge can 
produce an acute immune response during the first 24 h after the challenge.  In those 
studies, the long-term effects of M. haemolytica challenge were not addressed due to the 
relatively short duration of the experiments (138 h, Corrigan et al., 2007; and 23 d, 
Gånheim et al., 2003).  However, their experiments have provided valuable information 
in respect to the cellular immune response and describing physiological events which 
occur during the acute phase response to BRD.  In both studies, animals challenged with 
M. haemolytica developed an increased concentration of circulating neutrophils, which 
have been recognized as the first line of defense of the immune system during bacterial 
infection. The type of cells of the immune system that respond to an immune challenge 
depends on the type of antigen involved.  In general, viruses require the cellular 
machinery of the host animal to replicate (Janeway et al., 2005), and it has been reported 
that BVDV increased affinity for lymphocytes in order to replicate.  Therefore, one might 
speculate that an infection with BVDV would cause a decrease in circulating 
lymphocytes (Lambot et al., 1998).  Potgieter et al. (1995) reported lymphocyte depletion 
and decreased capacity for phagocytosis in calves infected with BVDV.  Corrigan et al. 
(2007) performed an intratracheal M. haemolytica challenge in a group of “market age” 
heifers of unknown history and reported a decrease in lymphocyte counts during the 138 
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h post inoculation with M. haemolytica.  In addition, Gånheim et al. (2005) reported 
decreased lymphocyte counts when animals were challenged with M. haemolytica alone.  
It is evident that BVDV or bacterial challenges can elicit an immune response, and that 
responses could be attributed to the type of challenge utilized.  However, limited 
information has evaluated the effects a natural exposure to BVDV by contact with a PI-
BVDV animal alone or in combination with a bacterial challenge on cellular, humoral 
and performance of beef steers.   
Cytokines as immune modulators during a BRD event 
Cytokines are soluble proteins synthesized by a variety of cells and tissues in th  
body and are involved in a wide variety of biological processes (Bannerman, 2008) 
influencing energy (Jacobi et al., 2006) and protein (Webel et al., 1997) metabolism.  
Increased cytokine concentrations are thought to result in repartitioning of energy and 
amino acids away from adipose and skeletal muscle growth by providing substrates for 
higher priority immunological functions (Jacobi et al., 2006; Waggoner et al., 2008).  
Although previous experiments have reported the concentration of cytokines in beef 
cattle (Reuter et al., 2008; Waggoner et al., 2008), these studies were conducted using 
intravenous infusion of lipopolysaccharide (LPS).  Varied concentrations and length of 
infusion of LPS can result in different responses from the immune system (Webel et al., 
1997). Gouwy et al. (2005) reported that the primary mechanism of action of cytokines is 
by up or down-regulation of genes involved in specific intracellular transduction 
pathways.  A greater understanding of cytokine response to the most common pathogens 
could provide valuable information of the implications of these proteins for decreasing 
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performance and carcass characteristics in animals that suffer from BRD during the 
growing and finishing period (Larson, 2005).  
Interferon gamma (IFNγ).  Interferon gamma has been reported as the link 
between the innate and adaptive immune systems and is critical for an adequate r sponse 
to intracellular pathogens (Bannerman, 2008).  Schroder et al. (2004) suggested that the 
main source of IFNγ is lymphocytes.  Ellis and Baeman (2004) and Schroder et al. (2004) 
have reported that the effect of IFNγ results from macrophages and neutrophils enhancing 
phagocytosis of extracellular pathogens (bacteria) and inducing a respiratory burst and 
nitric oxide production which has microbiocidal effects.  Tatsufumi et al. (2007) 
concluded that increased concentration of IFNγ is a strong indicator of a cellular immune 
response. 
Interleukin-1 (IL-1).  Dinarello (1998) described IL-1 as one of the most potent 
endogenous inducers of fever and the induction of this cytokine has been associated with 
viral, bacterial, fungal and parasitic infections.  In addition, Pruitt et al. (1995) reported 
that IL-1 is one of the principal inducers of acute phase protein synthesis.  Although IL-1 
is expressed as both IL-1α and IL-1β, Bannerman (2008) differentiated the proteins as 
either intracellular (IL-1α) or secreted by the cells (extracellular; IL-1β).  Godson et al. 
(1995) administered different doses of recombinant IL-1β to beef calves and reported that 
the effect of IL-1β on rectal temperature was dose dependant.  Only animals dosed with 
333 and 1,000 ng/kg of IL-1β had a mean rectal temperature greater than 40.0oC 
compared with animals dosed with 10, 33 and 100 ng/kg.  Maximum rectal temperature 
was observed at 6 h for all treatments and returned to baseline by 24 h post IL-1β 
injection.  In addition, the acute phase protein haptoglobin concentration was increased 
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above 0.50 mg/mL in animals receiving 1,000 ng/kg of recombinant IL-1β starting at 24 
h post injection, and haptoglobin concentration remained elevated for 72 h.  Serum 
concentrations of IL-1β were not reported (Godson et al., 1995).  These results suggest 
that the pyrogenic and acute phase induction of IL-1β is dose dependant.   
Interleukin-4 (IL-4).  Limited information exists regarding the role of IL-4 in 
beef cattle.  Elkenov et al. (2005) and Carroll and Forsberg (2007) described IL-4 as an 
anti-inflammatory cytokine which inhibits the production of pro-inflammatory cytokines 
(IL-1β, IL-6 and TNFα).  Reuter et al. (2008) reported decreased concentrations of IL-4 
in animals fed a 30% concentrate diet compared with animals fed 70% concentrate when 
challenged with LPS and provided an antimicrobial injection.  Reuter et al. (2008) 
observed higher concentrations of IFNγ, TNFα and IL-6 and concluded that the increased 
concentrations of these pro-inflammatory cytokines could be associated with the 
decreased concentrations of IL-4.  An additional mechanism of action of IL-4 in the 
immune response has been described by Salak-Johnson and McGlone (2007), who 
proposed that the main effect of IL-4 is to disrupt T-helper cell 1 and 2 (TH1 and TH2) 
homeostasis.  Bot et al. (2004) reported that when IL-4 is over expressed it can have 
detrimental effects on the immune system by decreasing the recruitment, expansion or 
activity of TH1 cells, resulting in a strong TH2 bias.  The resulting increase of TH2 
relative to TH1 might interfere with viral clearance by the host and suppress the innate 
immune response predisposing the host to secondary infections (Salak-Johnosn and 
McGlone, 2007).  Therefore, increased IL-4 may decrease viral clearance and predispose 
animals to secondary infections resulting in increased morbidity and mortality when 
feedlot cattle are exposed to BVDV. 
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Tumor necrosis factor-α (TNFα).  TNFα is a proinflammatory cytokine produced 
by different immune cells and presents a wide variety of activities (Ordas et al., 2006). 
Sordillo and Peel (1992) reported increased concentrations of TNFα in milk and serum of 
cows suffering from mastitis, and the increased concentration of TNFα was associated 
with the severity of the clinical manifestation of the disease. In addition, when dogs and 
cats were infused with recombinant human TNFα, a similar endotoxic response was 
observed (Tracey et al., 1986).  Interestingly, recombinant anti-TNF monoclonal 
antibodies prevented the induction of septic shock during acute bacteremia in baboons 
(Tracey et al., 1987).  Therefore, increasing concentrations of TNFα might be associated 
with severity of disease and decreased growth rates (Levine et al., 2005). 
Implications of BRD on antibody production 
One factor which can influence antibody production to a pathogen is antigen load 
(Katare et al., 2005).  In addition, higher antibody production to BVDV has been reported 
as an indicator of better protection induced by vaccines (Kelling et al., 2007).  Zhang et 
al. (1997) suggested that exposure of healthy animals to a virus that produces an 
immunosuppression might not only predispose animals to secondary infections, but could 
also have a detrimental effect on antibody production to other pathogens (i.e., vaccines), 
which could subsequently have a negative effect on animal health and performance. 
Rectal Temperature and its relationship with BRD 
During a BRD event, animals exhibit distinct behavioral patterns caused in part 
by changes in body temperature (Johnson et al., 1998; Johnson, 2002).  Confer et al. 
(2008) reported an increased rectal temperature in animals challenged with M. 
haemolytica when compared with control animals.  Similarly, Corrigan et al. (2007) 
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reported that animals that were challenged with M. haemolytica had increased rectal 
temperature (>40oC) during the time elapsed between 0 to 12 h and returned to normal by 
24 h.  Reuter et al. (2008) reported rectal temperatures above 40oC for 1 to 2 h, 3 to 6 h 
post LPS challenge depending on the dietary treatment, whereas Gilliam et al. (2008) and 
Waggoner et al. (2008) reported the highest rectal temperature to be ~39.5 and ~39.2oC at 
2 and 4 h post LPS challenge, respectively, and returned to pre-challenge temperature 6 h 
post-challenge 
Kelling et al. (2007) reported that non-vaccinated animals that were challenged 
with BVDV type 2 had higher rectal temperature from d 9 to 11 after intranasal challenge 
compared with a vaccinated group.  In addition, Gånheim et al. (2005) reported that 
animals that were challenged with non-cytopathic type 1 BVDV had a mild fever
(>39.5oC) from d 1 through 5 after viral inoculation.  These results suggest that increased 
rectal temperature can result from either direct inoculation of known amounts of BVDV 
virus into nostrils of calves or exposure of healthy calves to animals PI with BVDV. 
 Increased body temperature during a febrile process in humans and rats (Dantzer, 
2002) has been reported to increase metabolic rate by 13% for every 1oC increase in body 
temperature.  The length and amount of increased rectal temperature can have a great 
impact on nutrient requirements of sick animals due to the increased energetic cost for
this metabolic process that should be accounted for when formulating diets for animals 
suffering from BRD.   
Haptoglobin production during a BRD event 
Haptoglobin is an acute phase protein produced mainly by the liver in response to 
pro-inflammatory cytokines including TNFα, IL-1 and IL-6 secreted by bronchoalveolar 
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macrophages in response to bacterial infection (Yoo et al., 1995; Morsey et al., 1999). 
Haptoglobin has been reported to have antibacterial and anti-inflammatory functions 
during immunological stress (Wassel, 2000).  In cattle, haptoglobin has been evaluated s 
a predictor of BRD (Burciaga-Robles et al., 2009a) and correlated with the number of 
antimicrobial treatments for BRD (Carter et al., 2002; Berry et al., 2004; Step et al., 
2008).  Increased haptoglobin concentrations was associated with clinical cases of BRD 
and number of antimicrobial treatments required for animals during the disease (Carter et 
al., 2002; Berry et al., 2004).  In addition to bacterial infections, Gånheim et al. (2002) 
reported that animals that were challenged directly into the nostrils with a non-cytopathic 
type 1 BVDV had higher concentrations of haptoglobin than control animals. 
Klasing (1998a) suggested a switch in amino acid utilization from growth to 
production of acute phase proteins occurs following an immune challenge in chicks.  The 
synthesis of acute proteins by the liver in response to an immune challenge could change
the amino acid requirements as well as energy required for maintenance in support of the 
acute phase response.  In the absence of stress or infections, animals will assimilate 
nutrients into tissues according to their genetic potential and according to age and stage 
of production (Klassing et al., 1987; Elsasser, 1993).  However, during infection, there is 
an increase in protein turnover (Jepson et al., 1986) due to anorexia induced by cytokine 
production in response to the pathogen (Klassing, 1998b; Johnson, 1997), increased 
amino acid requirements for acute phase protein synthesis by the liver (Reeds and Jahoor, 
2001), and increased mobilization of protein stores from muscle either by decreased 
synthesis or increased catabolism (Ling et al, 1997) providing energy precursors for 
gluconeogenesis or amino acids for protein synthesis by the liver (Espat et al., 1994).   
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Effects of BRD on dry matter intake (DMI) 
Pro-inflammatory cytokines secreted by activated cells of the immune system 
have been reported to decrease feed intake (Johnson, 1997; Klasing, 1988).  According to 
Hutcheson and Cole (1986), when expressed as a percentage of BW, DMI may be 
decreased during the first wk after arrival to the feedlot and that depression in DMI can 
last up to 28 d post arrival. To account for potential differences that intake has on nutriet 
digestibility and metabolism, pair feeding has been suggested for use in experiments 
comparing animals challenged with a pathogen vs. control animals (Sandberg et al., 
2007).  In addition, because pathogens induce anorexia in host animals, potential effects 
of decreased intake should be accounted for in order to develop feeding strategies for 
morbid animals in production settings (Kyriazakis et al., 1998).  In fact, according to 
most recent Beef Cattle NRC (1996), when formulating diets for high-stressed calv s
entering the feedlot, the principal consideration to account for is decreased dry matter 
intake (DMI; Hutchenson and Cole, 1986).  This is due to decreased DMI in sick/stressed 
calves (0.90 ± 0.70% of BW) compared to healthy animals (1.55 ± 0.51% of BW) during 
the first week after arrival to a feedlot.  Differences in DMI can remain for two wk, and 
therefore nutrient intake during this period might be limiting to achieve adequate immune 
function and/or maximum growth potential (Chirase et al., 1991) 
Blood flow across total splanchnic tissues (TST) 
Several studies exist that have addressed changes in blood flow and net PDV flux 
of amino acids in cattle due to different dietary protein sources and feeding manage ent 
strategies (Lomax and Baird, 1983).  In growing and lactating animals, the splanchnic 
bed provides the majority of nutrients required for growth and milk synthesis, 
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respectively (Lomax and Baird. 1983).  Therefore, any change in the metabolic status of 
the animal that affects DMI or alterations in splanchnic metabolism can have a 
detrimental effect on growth and lactation in food producing animals.  In Holstein calves, 
feed deprivation decreased portal blood flow when animals were fasted for 36 h (Koeln et 
al., 1993).  In addition, Lomax and Baird (1983) reported that in lactating and non-
lactating cows, portal blood flow was lower in feed deprived animals 2 d after feed 
deprivation occurred, and continued to decrease being lowest at the end of the fasting 
period (6 d).  Hepatic blood flow decreased 2 d after feed deprivation occurred in 
lactating animals but remained unchanged in non-lactating cows (Lomax and Baird. 
1983).  Therefore, when animals are deprived of feed during transit or DMI is decreas d 
due to morbidity, changes in blood flow and net nutrient flux through splanchnic tissues 
and might be expected. 
Effect of BRD on N Balance 
Cole et al. (1986) conducted a series of experiments to evaluate N metabolism in 
calves challenged with either bovine adenovirus-3 (PI-3) or infectious bovine 
rhinotracheitis (IBR) and reported that during the first 7 d after inoculation with IBR, 
calves that developed a febrile response had lower N digestion and N balance that non-
febrile calves that were also challenged.  Recently, Gilliam et al. (2008) reported N 
balance of steers with or without supplementation of branched-chain amino acids 
following (d 2 to 7) a bacterial LPS intravenous challenge.  In their study, there was 
lower N retention by steers when LPS was administered, and these differences were due 
to lower N intake and increased urinary N excretion.  In addition, Waggoner et al. (2008) 
reported a decrease in DMI and fecal N output during the first 6 d after LPS challenge.  
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As a result of these changes in protein metabolism and/or turnover, animals can 
experience a negative N balance (Ling et al., 1997) reflected in decreased growth (Le 
Floc’h et al., 2004). 
Effect of BRD on short and long term performance in finishing cattle 
In previous experiments, the number of antimicrobial treatments required for 
BRD has been associated with decreased performance during the feedlot phase (Gardn r 
et al., 1999; Roeber et al., 2001).  Roeber et al. (2001) showed that calves that required 
two or more antimicrobial treatments for BRD had lower ADG during the first 56 d on 
feed than calves that did not require an antimicrobial treatment, but there was no 
difference between animals that required one antimicrobial treatment compared with 
animals that did not require an antimicrobial treatment.  This might suggest that calves
receiving a single antimicrobial treatment were misdiagnosed or that severity or number 
of times a BRD event occurs plays a role in how the disease affects overall performance 
of beef cattle.   
Hesseman (2006) concluded that the incidence of calves PI with BVDV arriving 
at the feedlot is approximately 0.3% of total cattle, and that PI and acutely infected cattle 
are the main sources of transmission of this disease to susceptible animals.  However, the 
negative effects that PI calves have on health and performance has been debated.  
O’Connor et al. (2005) reported that in a population of 5,041 calves (40 pens), the 
presence of a PI calf had no negative effects on overall health of cattle in the pens.  In 
contrast, Loneragan et al. (2005) attributed an increased risk of developing BRD to 
animals PI with BVDV present in pens of feedlot cattle.  Stevens et al. (2007) reported 
that the presence of PI calves in a pen increased morbidity (18.8 vs. 29.6%) compared 
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with non-exposed cattle.  In addition, these authors evaluated the epidemiological curve 
of BRD when a PI calf was present in a pen, and reported a twofold increase (15.3 vs. 
31.7%) in the number of animals requiring an antimicrobial treatment during the first 7 d 
on feed.  Booker et al. (2008a) evaluated the effects of the presence of a PI animal and 
also the type of BVDV involved on health and performance of non-exposed cattle.  They 
concluded that the presence of a PI BVDV type 1 animal in a pen resulted in an increased 
number of BRD treatments and mortalities compared with non-exposed pens, but a PI 
BVDV type 2 animal had no negative effects on health of finishing cattle.  Elam et l. 
(2008) reported that short-term (60 d) or long-term (215 d) exposure to calves PI with 
BVDV did not affect DMI or final BW at the end of the finishing period; however, they 
did observe a tendency for decreased ADG during the first 28 d in exposed cattle, which 
they attributed to the cost of developing immunity to the wild type strain of BVD.  It is 
important to mention that in the study conducted by Elam et al. (2008), all animals had 
been vaccinated at least twice against BVDV before entering the feedlot, and at the time 
of entry to the feedlot received a metaphylactic antimicrobial treatment reducing the 
possibility of sickness not only to BVDV, but also to M. haemolytica and other 
microorganisms associated with BRD. 
Olchowy et al. (2000) and Corrigan et al. (2007) have reported effects of M. 
haemolytica in challenge studies on animal performance; although the length of their 
experiments was relatively short (16 d and 136 h, respectively).  Olchowy et al. (2000) 
reported decreased ADG of calves challenged with M. aemolytica which did not receive 
an antimicrobial treatment.  In addition, Gånheim et al. (2003, 2005) reported the effects 
of an aerosolized challenge with BVDV with or without a subsequent M. haemolytica 
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challenge.  In these studies authors characterized the production of acute phase proteins 
(Gånheim et al., 2003) and changes in white blood cell counts (Gånheim et al., 2005) due 
to the bacterial and/or viral challenges, and the length of the experiments were only 23 d.  
To our knowledge, no long-term effects of acute M. haemolytica challenge on 
performance and carcass characteristics in cattle have been reported. 
Visceral Organ Mass 
Reports in the literature exist showing effects that anabolic implants (Hutcheson 
et al., 1997), postruminal carbohydrate load (McLeod et al., 2007), different winter 
grazing strategies (Hersom et al., 2004), protein levels (Baldwin et al., 2000), and mineral 
content of the diet (Soto-Navarro et al., 2004).  Hersom et al. (2004) observed differences 
in several components of the GIT due to different grazing strategies during the growing 
phase.  In addition, Sainz and Bentley (1997) reported differences in visceral organ mass 
attributed to the utilization of different levels of concentrate or forage in diets.  However, 
there are no previous reports that have addressed any possible changes in visceral organ 
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EXPOSURE BY PERSISTENTLY INFECTED CALVES WITH BVDV1B AND 
SUBSEQUENT INFECTION WITH MANNHEIMA HAEMOLYTICA 
DEMONSTRATING EFFECTS ON CLINICAL SIGNS AND IMMUNE 
PARAMETERS: MODEL FOR BOVINE RESPIRATORY DISEASE VIA VIRAL 
AND BACTERIAL INTERACTION  
ABSTRACT:   
Objectives - The objective of this study was to determine effects of an intratracheal 
Mannheimia haemolytica challenge following short-term exposure (72 hours) to bovine 
viral diarrhea virus type 1b (BVDV1b) persistently infected (PI) calves on serum 
antibody production, total and differential white blood cell count (WBC), cytokine 
concentrations, and blood gases in feedlot steers. 
Animals, Procedures and Experimental Design - Twenty-four steers (initial BW = 314 
± 31 kg) were randomly allocated to one of four treatments (six animals/treatment) 
arranged as a 2 × 2 factorial.  Treatments were: 1) steers not exposed to BVDV nor 
challenged with M. haemolytica (Control); 2) steers exposed to two calves PI with 
BVDV1b for 72 hours (BVD); 3) steers intratracheally challenged with M. aemolytica 
on day 0 (MH); and 4) steers with 72 hour exposure to calves PI with BVDV1b and 
intratracheally challenged with M. haemolytica on day 0 (BVD+MH).   
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Results - Changes were observed in serum antibody production, total and differential 
white blood cell count, cytokine concentrations, and blood gases consistent with an 
immune challenge in beef cattle.   
Conclusions - Our results suggest that development of a successful immune challenge 
model using exposure of naïve steers to steers PI with BVDV1b, intratracheal challenge 
with M. haemolytica, or their combination which will allow researchers to further 
characterize the detrimental effects that BRD pathogens have on food producing animals. 
Clinical Relevance - Understanding the physiological changes in morbid animals will 
lead to improved strategies for decreasing severity and economic losses associated with 
BRD. 















 Bovine viral diarrhea virus (BVDV) has been isolated alone or in combination 
with other viral and bacterial pathogens in animals diagnosed with bovine respiratory 
disease (BRD).  Cattle persistently infected (PI) with BVDV have been sugge ted to be 
the main source of transmission of this disease in feedlot settings,1 a d the presence of an 
animal PI with BVDV in a feedlot pen has been reported to increase the risk of 
antimicrobial treatment for BRD by 43% compared with non-exposed cattle.2 Because 
the economic losses associated with BRD are not just the direct cost associated with 
treatments, but also decreased performance and carcass quality,3 a better understanding of 
the physiological changes associated with BRD are needed to improve manage ent 
strategies for the prevention and treatment of the disease. 
Based on BVDV studies to determine prevalence of BVDV subtypes in cattle, the 
BVDV1b subtype is more commonly identified than BVDV1a and BVDV2a based on a 
survey of BVDV isolates from diagnostic laboratory accessions and PI cattle en ering a 
feedlot.4,5 In addition, over the last 20 years Mannheimia haemolytica serotype 1 has 
been the most common bacterial pathogen isolated in calves suffering from BRD.6 The 
objective of the present experiment was to develop a model that would allow us to study 
immune and metabolic changes associated with the acute response to BRD and the 
possible implications of this response on subsequent performance and carcass 
characteristics in feedlot cattle. The effects of exposure to steers PI with BVDV1b and 
intratracheal challenge with M. haemolytica serotype 1 on serum antibody production, 
total and differential white blood cell count (WBC), cytokine concentrations, and blood 
gas analysis in feedlot steers were determined. 
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  MATERIALS AND METHODS 
Animals   
All procedures for the present experiment were approved by the Oklahoma State 
University Institutional Animal Care and Use Committee (Protocol# AG-06-16).  A total 
of 24 Angus crossbred steers (initial body weight = 313 ± 31 kg) were housed at the 
Nutrition Physiology Research Center, Oklahoma State University, Stillwater to 
determine the effects of viral exposure and/or bacterial challenge with pathogens that 
have been associated with BRD on immune response of feedlot cattle.  All animals were 
considered clinically healthy and were seronegative to all pathogens involved in th  study 
as determined with paired serum samples collected 14 days apart prior to the start of the 
experiment.  
Treatments  
The 24 steers were randomly allocated to one of four treatments (six animals/treatment) 
arranged as a 2 × 2 factorial.  Treatments were: 1) steers not exposed to BVDV nor 
challenged with M. haemolytica (Control); 2) steers exposed to two calves PI with 
BVDV1b for 72 hours (BVD); 3) steers intratracheally challenged with M. aemolytica 
on day 0 (MH); and 4) steers with 72 hour exposure to calves PI with BVDV1b and 
intratracheally challenged with M. haemolytica on day 0 (BVD+MH).  Steers exposed to 
the calves PI with BVDV1b were transported approximately 3.2 km to the Willard Spaks 
Beef Research Center, Stillwater, OK where they were commingled in a 6 × 10.8 m pen 
with two steers previously confirmed as being PI with BVDV1b via 
immunohistochemistry and genotyping. The two PI with BVDV 1b calves were identified 
at 2575 and 3604.  The PI subtype was determined by sequencing a region of the 5’-
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UTR.5 For both the BVD and BVD+MH groups, the length of exposure to the PI calves 
was 72 hours.  After the time of BVDV exposure, calves were returned to the Nutrition 
Physiology Research Center where they remained for the remainder of the experim nt.  
Steers challenged with M. haemolytica received 10 mL of a solution containing 6 × 109
CFU of M. haemolytica serotype 1 that was reconstituted and grown prior to the 
challenge following a previously published procedure.7 Steers not challenged with M. 
haemolytica were intratracheally dosed with 10 mL of a phosphate–buffered salinea 
(PBS) as described8 with some modifications.  Briefly, steers were restrained and a 
broncheoalveolar lavage (BAL) tubeb was inserted into the ventral meatus of a nostril, 
passed on into the trachea, and advanced to the tracheal bifurcation.  At the tracheal 
bifurcation, the tube was removed approximately 2-3cm.  The challenge material was 
then delivered such that material would be allowed to enter both lung fields.  Calveswere 
observed for any adverse effects of the challenge procedure itself.  The broncheoalveolar 
lavage tube was sanitized with weak chlorhexidine diacetatec solution, rinsed with saline, 
and was re-used for animals on the same treatment only.  Challenge with M. haemolytica 
occurred on the same day for all appropriate treatment groups beginning at 0800.  To 
facilitate sample collection, steers were blocked by body weight into 2 grups of twelve, 
and the challenge procedures and sample collections for each weight block were 
staggered by a 2 week interval. 
The experiment proceeded 28 days during which the animals were kept in individual pens 
(3.7 × 3.7 m) with the exception of days 0 to 4, 7 to 11 and 14 to 18.  During those days, 
animals were placed in individual metabolic stanchions to allow for the collectin of total 
urine and feces.  During the experiment, steers were offered feed for ad libitum intake 
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with feed delivered twice daily.  The diet contained 46% dry rolled corn, 9% corn dried 
distiller’s grains, 40% alfalfa hay, 1% liquid supplement and 4% dry supplement, and 
was formulated to meet or exceed nutrient requirements.9  
Data Collection 
Rectal Temperature, Respiration Rate, and Subjective Clinical Score.  Rectal 
temperatures were recorded using a digital veterinary thermometerd and espiration rates 
were measured by counting flank movements for 1 minute with a stopwatch.10 In 
addition, all steers were monitored by trained personnel throughout the length of the 
experiment for clinical signs consistent with BRD.  The visual evaluation utilized in this 
experiment was performed using the standard protocol for our research facility.11 Briefly, 
the subjective criteria included depression (e.g., hanging head, sunken eyes, arched back 
and difficulty getting up from lying down), abnormal appetite, and respiratory signs (e.g., 
labored breathing, head and neck extended).  Based on the severity of the signs, the 
evaluator assigned a numeric score ranging from 1 to 4, where 1 was assigned for mil , 2 
for moderate, 3 for severe, and 4 for moribund (steer would not rise from recumbency or 
assistance was needed).  Rectal temperature, respiration rate, and subjective clinical score 
were recorded prior to BVDV exposure and M. haemolytica challenge and at 4, 6, 12, 18, 
24, 36, 48, 72 and 96 hours following the intratracheal bacterial challenge. 
Serum Haptoglobin. Blood samples were collected via jugular venipuncture with an 18 
gauge × 1 inch needle into an evacuated tube for serum harveste on days -3, 0 (prior to 
and 2, 4, 6, 12, 18, 24, 36, 48, 72 and 96 hours following the 0 hour challenge), 7, 17 and 
28.  Samples collected were allowed to clot for 24 h at 4oC. After the clotting time, 
chilled blood samples were centrifuged at 3,000 × g at 40oC for 20 min.  Serum was 
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harvested in 2 mL centrifuge tubes and stored at -20oC until further analyses were 
performed. Once all the serum samples were collected, a bovine haptoglobin ELISA testf 
was used to determine the haptoglobin concentration of each serum sample.  Prior to the 
analysis, serum samples were diluted 1:10,000 in Tris-buffered saline.g  Th  intra- and 
inter-assay coefficients of variation were below 5%. 
Cytokines.  Before cytokine analysis, all serum samples were diluted 1:1 in Tris-buffered 
saline.g  After samples were diluted, cytokine [interferon γ (IFNγ), interleukin 1β (IL-1β), 
interleukin 4 (IL-4), interleukin 6 (IL-6), and tumor necrosis factor α (TNFα)] 
concentrations in serum were measured in duplicate with commercially available ELISA 
kits (IFNγh, IL-1βi, IL-4j, IL-6k, and TNF-αl) with reagents provided by the manufacturer 
unless otherwise specified.  Briefly, 96 well platesm were coated overnight at room 
temperature with the appropriate bovine specific coating antibody diluted in Tris-buffered 
saline.g After the incubation, the coating solution was aspirated followed by the addition 
of 300 µL of ELISA ultra block solutionn to each well, and incubated at room 
temperature for 1 hour.  This step was followed by aspiration of the blocking solution, 
addition of 100 µL of samples or standards to wells, and incubation at room temperature 
for 1 hour.  Following sample incubation, standards and samples were aspirated and a 
three-step wash was performed using a manual plate washer.o T ree hundred microliters 
of ELISA wash bufferp were added during each wash followed by aspiration.  Following 
the initial three-step wash, the appropriate detection antibody was added to each well nd 
incubated for 1 hour at room temperature, followed by the three-step wash as describe  
before.  Following the washing step, 100 µL of horse radish peroxidase-labeled streptavid 
 40
in Tris-buffered salineg were added to each well and incubated at room temperature for 
30 min, followed by a final three-step wash. 
For the colorimetric determination of cytokines, 100 µL of 3,3’,5,5’-tetramethylbenzidine 
substrate solutionq were added to each well and incubated for 20 min at room temperature 
followed by the addition of 100 µL of stop solutionr and optical density was measured at 
450 and 550 nm using a plate reader.s Detection limits for the cytokine procedures were: 
2,000 to 31 pg/mL for IFNγ and IL-1β; 1,000 to 17 pg/mL for IL-4; 5,000 to 78 pg/mL 
for IL-6; and 8,500 to 133 pg/mL for TNFα based on maximum and minimum 
concentrations of the recombinant bovine cytokine standards, respectively.  
Concentrations of cytokines in serum samples were calculated by subtracting the 450 nm 
absorbance from the 550 nm absorbance to account for any optical imperfections in the 
plates.  Subsequently readings were subtracted from the blank and a 4-point parameter 
logistic method standard curve was developed for each plate to calculate the 
concentrations of the cytokine in each sample.  All intra-assay coefficients of variation 
were lower than 5% and inter-assay coefficient of variation below 7.5%.  
Hemogram. Blood samples were collected via jugular venipuncture with an 18 gauge × 1 
inch needle into an evacuated tube containing EDTAt on days -3 and at 0, 6, 18, 36, 96 
and 168 hours following the M. haemolytica challenge.  Samples were immediately 
submitted to a commercial laboratoryu for total and differential white blood cell count 
determination, total red blood cells, total platelets, hemoglobin, hematocrit, mean 
corpuscular volume (MCV), and mean corpuscular hemoglobin (MCH) concentration. 
Blood gas, pH, Glucose and Lactate. Blood samples were collected via jugular 
venipuncture with an 18 gauge × 1 inch needle into an evacuated tube containing lithium 
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heparinv on days -3, 0 (prior to and 2, 4, 6, 12, 18, 24, 36, 48, 72 and 96 hours following 
the 0 hour challenge), 7, 17, and 28.  These samples were immediately analyzed using a 
blood gas analyzerw. Response variables for blood gas analysis included partial pressure 
of carbon dioxide, sodium, potassium, calcium, glucose, lactate, hematocrit, bicarbonate 
ion, carbonic acid, carbon dioxide, sulfur dioxide, hemoglobin, and base excess of 
extracellular fluid.  After the analysis, samples were centrifuged at 3,500 × g at 4oC for 
30 min and 1.5 mL of plasma were harvested and stored in plastic tubes at -20oC. 
Mannheimia haemolytica.  Serum samples from days -3, 0, 4, 7, 14 and 28 were used to 
determine antibodies to whole bacterial cell and leukotoxin for a formalin killed M. 
haemolytica S1 by an ELISA test as described in previous studies.12, 13 Antibody 
responses were expressed as nanograms of immunoglobulin binding based on a set of 
IgG standards on each plate. The intra- and inter-assay coefficients of variation were 
below 5%. 
Bovine viral diarrhea virus antibodies. Serum samples from days -3, 0, 4, 7, 17 and 28 
were submitted to a commercial veterinary diagnostic laboratoryx f r BVDV serology 
using a virus neutralization test (VNT) in Madin-Darby bovine kidney cell monolayers in 
96-well microtiter plates. The viruses used as challenge viruses in the VNT were CP 
BVDV1a (Singer strain), CP BVDV1b (TGAC 8HB), and CP BVDV2a (125-C).  A 1:4 
dilution was the lowest tested, and titers of less than 1:4 were considered negative. 
Statistical Analyses 
The experiment was designed as a randomized complete block with a 2 × 2 factorial 
arrangement of treatments; animal served as the experimental unit.  Data for BVDV 
antibody titers, Mannheimia haemolytica whole cell and leukotoxin antibody titers, rectal 
 42
temperatures, haptoglobin, cytokines, hemogram, blood gas, pH, glucose and lactate were 
analyzed using repeated measures analysis of the MIXED procedure of SASy with a non-
structured covariance structure and slice output option.  The model for all variables 
included the main effects of BVD, MH, BVD × MH, and all possible interactions with 
time.  When a BVD or MH × time interaction was significant (P < 0.05), the slice output 
option was used to determine the time points at which the time effect was different ac oss 
treatments. In addition, when a BVD × MH interaction was significant (P < 0.05), Least 
squares means were separated using the pdiff statement of SAS. 
RESULTS 
 There was a BVD × time interaction (P < 0.0001) for BVDV1b antibody titers (Figure 
1a).  Antibody titers increased across time for steers exposed to steers PI with BVDV, 
and on day 28, BVDV1b antibody titers were greater (P < 0.05) for steers exposed to 
BVDV compared with steers not exposed to BVDV.  In addition, there was a MH × time 
interaction (P < 0.0001) for M. haemolytica whole cell antibodies (Figure 2a).  Antibody 
titers for M. haemolytica whole cells increased across time for steers challenged with M. 
haemolytica, and were greater (P < 0.05) on days 7, 17, and 28 following M. haemolytica 
challenge compared with steers not challenged with M. aemolytica.  Antibodies for M. 
haemolytica leukotoxin responded with a BVD × MH × time interaction (P = 0.001; 
Figure 2b).  Mannheimia haemolytica leukotoxin antibodies increased over time, and on 
days 7, 14, and 28 were greatest (P < 0.05) for MH steers, lowest for steers not 
challenged with M. haemolytica, and intermediate for BVD+MH steers.  
Rectal temperatures of steers in response to exposure to BVDV and M. haemolytica 
challenge are shown in Figures 3a and 3b, respectively. Rectal temperatures were greater 
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for steers challenged with M. haemolytica from 2 to 24 hours following the challenge 
(MH × time interaction, P < 0.0001).  In addition, there was a BVD × time interaction (P 
= 0.02).  Rectal temperature was greater (P < 0.05) for steers exposed to steers PI with 
BVDV at 36, 48, and 72 hours after BVDV exposure compared with steers not exposed 
to BVDV. 
Haptoglobin concentrations responded with a MH × time interaction (P = 0.0007; Figure 
4a).  Haptoglobin concentrations were greater (P < 0.05) for steers challenged with M.
haemolytica from 18 to 96 hours following the challenge.  There was no BVD × time 
interaction (P = 0.93) for serum haptoglobin concentrations (Figure 4b). 
 Total and differential white blood cell count data are shown in Table 1.  There was a 
BVD × MH interaction (P = 0.002) for total white blood cells. This resulted from a 
decrease in total white blood cells for steers exposed to steers PI with BVDV but not 
challenged with M. haemolytica.  Exposure to steers PI with BVDV (P < 0.0001) and not 
challenged with M. haemolytica (P = 0.003) decreased total white blood cells.  In 
addition, there was a MH × time interaction (P < 0.0001; Figure 5a) for total white blood 
cells.  Steers challenged with M. haemolytica had greater (P < 0.05) total white blood 
cells at 18 and 36 hours following M. haemolytica challenge. There was a BVD × MH 
interaction (P = 0.01) for neutrophils. Similar to total white blood cells, this resulted from 
a decrease in neutrophils (Table 1) for steers exposed to steers PI with BVDV but not 
challenged with M. haemolytica.  Neutrophils were increased (P < 0.0001) when steers 
were challenged with M. haemolytica compared to control and BVD steers.  In addition, 
neutrophils were greater (P < 0.05) for steers challenged with M. haemolytica compared 
with steers not challenged with M. haemolytica at 18, 36, and 168 hours after the M. 
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haemolytica challenge (MH × time interaction, P < 0.0001; Figure 5b). Both exposure to 
steers PI with BVDV (P = 0.002) and M. haemolytica challenge (P < 0.0001) decreased 
lymphocytes (Table 1).  Lymphocytes were lower (P < 0.05) for steers challenged with 
M. haemolytica compared with steers not challenged with M. haemolytica at 18, 36, and 
96 hours after the M. haemolytica challenge (MH × time interaction, P < 0.05; Figure 5c).  
Monocytes were not affected (P > 0.50) by exposure to BVDV or M. haemolytica (Table 
1).  However, exposure to steers PI with BVDV decreased (P = 0.03) and challenge with 
M. haemolytica increased (P = 0.01) eosinophils.  Similarly, basophils were decreased (P 
= 0.0007) by exposure to BVDV, but were increased (P = 0.001) by M. haemolytica.  
Hematocrits tended (P = 0.08) to be decreased by challenge with M. haemolytica (Table 
1), whereas hemoglobin was decreased (P < 0.0001) by M. haemolytica.  A BVD × MH 
interaction (P = 0.02) resulted from a greater decrease in hemoglobin concentration when 
steers challenged with M. haemolytica were not exposed to steers PI with BVDV than 
when steers challenged with M. haemolytica were exposed to BVDV.  Mean corpuscular 
volume and hemoglobin concentration were decreased (P < 0.05) by challenge with M. 
haemolytica.  Similar to hemoglobin, a BVD × MH interaction (P = 0.03) resulted from a 
greater decrease in mean corpuscular hemoglobin concentration when steers challenged 
with M. haemolytica were not exposed to steers PI with BVDV than when steers 
challenged with M. haemolytica were exposed to BVDV.  Concentration of platelets were 
not affected (P > 0.28) by exposure to steers PI with BVDV or challenge with M. 
haemolytica.  However, red cells were decreased (P = 0.04) by M. haemolytica. 
Cytokine data are shown in Table 2.  There was a BVD × MH interaction (P = 0.02) for 
IFNγ.  This resulted from an approximately twofold increase in IFNγ concentration for 
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BVD+MH steers compared with steers on the remaining treatments.  Exposure of te rs 
to steers PI with BVDV tended (P = 0.06) to increase IFNγ and challenge with M. 
haemolytica increased (P = 0.02) IFNγ. Interleukin-1β was increased by exposure to 
steers PI with BVDV (P = 0.04) and challenge with M. haemolytica (P = 0.0006). In 
addition, IL-4 tended (P = 0.08) to be increased by exposure to steers PI with BVDV. 
There was a BVD × MH interaction (P = 0.01) for IL-6. Interleukin-6 was greatest (P < 
0.05) for BVD steers, lowest for control steers, and intermediate for steers challenged 
with M. haemolytica.  In addition, IL-6 was increased (P = 0.04) by exposure to steers PI 
with BVDV.  Both exposure of steers to steers PI with BVDV (P = 0.0005) and challenge 
with M. haemolytica (P = 0.0009) increased serum concentrations of TNFα. In addition, 
TNFα concentration was greatest (P < 0.05) for BVD+MH steers, lowest for control 
steers, and intermediate for BVD and MH steers (BVD × MH interaction, P = 0.01). 
Clinical score, blood gas and metabolite data are shown in Table 3.  Exposure to BVDV 
or M. haemolytica did not affect (P > 0.18) blood pH, calcium, potassium, glucose, and 
sulfur dioxide concentrations, or base excess in blood.  Subjective clinical score was 
greater (P < 0.0001) in steers challenged with M. haemolytica than in steers not 
challenged with M. haemolytica.  There was a BVD × MH interaction (P = 0.01) for 
respiration rate.  Challenge with M. haemolytica decreased respiration rate when steers 
were not exposed to steers PI with BVDV and increased respiration rate when steers were 
exposed to steers PI with BVDV.  In addition, there was a BVD × MH interaction (P = 
0.005) for plasma sodium concentration.  Challenge with M. aemolytica decreased 
sodium to a greater extent when steers were not exposed to steers PI with BVDV 
compared with steers exposed to BVDV.  Plasma lactate concentration was decreased (P 
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= 0.02) when steers were exposed to steers PI with BVDV.  Base excess in extracellular 
fluid was increased (P = 0.01) by exposure to BVDV, and was decreased (P = 0.0002) by 
challenge with M. haemolytica.  There were BVD × MH interactions (P < 0.04) for 
plasma carbon dioxide, carbonic acid, and sodium bicarbonate concentrations.  Challenge 
with M. haemolytica decreased carbon dioxide, carbonic acid, and sodium bicarbonate 
concentrations to a greater extent when steers were not exposed to steers PI with BVDV 
compared with steers exposed to BVDV.  Carbon dioxide and sodium bicarbonate 
concentrations acid were decreased (P < 0.04) by exposure to steers PI with BVDV, 
whereas carbonic acid concentration was increased (P = 0.02).  Challenge with M. 
haemolytica resulted in MH × time interactions (P < 0.03) for carbon dioxide (Figure 6a), 
carbonic acid (Figure 6b), and sodium bicarbonate (Figure 6c), generally resulting from 
decreased (P < 0.05) concentrations from 4 to 48 h after the challenge.  There was a BVD 
× MH interaction (P = 0.0006) for partial pressure of carbon dioxide.  Challenge with M. 
haemolytica decreased partial pressure of carbon dioxide to a greater extent when steers 
were not exposed to steers PI with BVDV compared with steers exposed to BVDV. 
 
DISCUSSION 
Although previous research has evaluated the effects of BVDV and M. haemolytica 
challenge on immune response of calves,14,15 in those studies calves ranged from 9 to 18 
weeks of age and the virus of interest was directly inoculated into the nostril.  In order to 
better understand BVDV pathogenesis and to study efficacy of BVDV vaccines, a natur l 
exposure model has been recommended as opposed to direct virus inoculation to the 
animals.16 Therefore, in the present experiment, time exposure of healthy animals to 
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steers PI with BVDV was an attempt to simulate a commercial feedlot operati n where 
animals from different sources might be commingled and then tested for BVDV at 
arrival.  Generally, if an animal tests positive for being PI with BVDV it is removed after 
a 48-hour assay result time and potentially an additional 24 hours from receiving the 
results to removing the PI calf from the pen.  In the present experiment, increased serum 
BVDV antibody concentrations 28 days after exposure to animals PI with BVDV 
compared with non-exposed animals confirmed that animals became infected with 
BVDV without direct inoculation of the virus.  This BVDV infection in the present study 
could be either by direct contact with body fluids of a PI steer, ambient air, or by sharing 
the feedbunk.17 
Mannheimia haemolytica has been shown to have several pathogenic factors including 
outer membrane proteins18 and leukotoxin.19 In the present experiment, total antibody 
production to M. haemolytica whole cell increased across time in challenged steers 
compared with steers that received the PBS solution only (Figure 1b).  It has been 
previously reported that antigen load can influence antibody production.20 Therefore, the 
lack of a BVD × MH interaction in the present experiment might suggest that all steers 
challenged with M. haemolytica received the same amount of bacteria during the 
challenge. Leukotoxin is secreted during the logarithmic growth phase of M. 
haemolytica.21 In the present experiment, the BVD × MH × time interaction for M. 
haemolytica leukotoxin (Figure 1c) suggests that animals exposed to steers PI with 
BVDV had decreased antibody production to M. haemolytica leukotoxin. Our results are 
in agreement with a previous study22 in which animals that were challenged with bovine 
immunodeficiency virus had a decreased and delayed post-vaccinal antibody production 
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to BVDV and bovine herpes virus-1.  Higher antibody production has been reported as an 
indication of better protection induced by vaccines.23 The present and previously 
published data22,23 suggests that exposure of healthy animals to a virus that produces an 
immunosuppression might predispose animals to secondary bacterial infections due to 
decreased antibody production.  Decreased antibody production may also have a 
detrimental effect on the efficacy of vaccines, which could subsequently have a negative 
effect on animal health and performance.22 
 Morbid animals exhibit distinct behavioral patterns caused in part by changes in body 
temperature.24,25 In the present experiment, animals challenged with M. aemolytica 
developed an acute increase in rectal temperature during the first 24 hours post M. 
haemolytica challenge compared with animals that were not challenged.  Rectal 
temperature (Figure 2a) was significant reaching a maximum of 41.5oC 6 hours after the 
challenge.  Our results are in agreement with previous results26 in which animals that 
were challenged with M. haemolytica had an increased rectal temperature compared with 
control animals.  Similarly, it was reported that animals challenged with M. haemolytica 
had increased rectal temperature (>40oC) during the time elapsed between 0 to 12 hours 
and returned to normal by 24 hours.27  In the present experiment, there was no effect of 
exposure to steers PI with BVDV on rectal temperature during the first 24 hours
following the intratracheal challenge.  However, from 36 to 72 hours animals that had 
been exposed to steers PI with BVDV had a higher rectal temperature (Figure 2b) 
compared with animals that were not exposed. The rectal temperature during this period 
ranged from 39.3 to 39.5oC for the steers exposed to BVDV.  In a previous study, a 
higher rectal temperature was reported in non-vaccinated animals challenged with BVDV 
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type 2 from days 9 to 11 after intranasal challenge compared with a vaccinated group.23  
In addition, animals challenged with non-cytopathic type 1 BVDV had a mild fever 
(>39.5oC) from days 1 to 5 after viral inoculation when compared to non-challenged 
animals.15  These results suggest that increased rectal temperature can result from ei her 
direct inoculation of known amounts of BVDV virus into nostrils of calves or from 
exposure of healthy calves to animals PI with BVDV. 
Haptoglobin is an acute phase protein produced mainly by the liver in response to pro-
inflammatory cytokines including TNFα, IL-1 and IL-6 secreted by bronchoalveolar 
macrophages in response to bacterial infection.28,29 In the present experiment, 
haptoglobin concentrations in animals that were exposed to PI steers were no diff rent 
when compared with animals that were not exposed.  In a previous study, calves that 
were challenged directly into the nostrils with a non-cytopathic type 1 BVDV had higher 
haptoglobin concentrations than control animals.14 These conflicting results could be 
attributed to differences in the challenge model used in the previous experiment14 
compared with the natural exposure model used for the present experiment.  For animals
that were challenged with M. haemolytica in the present study, the increase in 
haptoglobin concentration was acute starting at 18 hours post challenge and continued to 
be greater until returning to baseline concentrations after 96 hours of the bacterial 
inoculation.  These results are in agreement with haptoglobin concentrations in respo s  
to M. haemolytica challenge in cattle.14,27 Increased haptoglobin concentrations have been 
associated with clinical cases of BRD and number of antimicrobial treatments required 
for animals during the disease.30, 31  
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The presence of PI BVDV animals in feedlot pens has been associated with increased 
BRD morbidity and mortality during the finishing period.2 Bovine viral diarrhea viruses 
involved in BRD can cause clinical infections by themselves,32 but also have been 
reported to increase cattle’s susceptibility to secondary bacterial infections from common 
inhabitants of the respiratory tract of healthy animals.33 When correlated with a clinical 
evaluation, leukograms can provide informative evaluation of disease processes.34 In the 
present study, animals exposed to steers PI with BVDV had decreased total WBC counts 
compared with non-exposed animals.  After the M. haemolytica challenge, animals that 
had been exposed to PI steers had a decreased total WBC count at 18, 36 and 96 hours 
post challenge compared with steers that were not exposed to PI animals but were 
challenged with M. haemolytica.  In addition, steers that were challenged with M. 
haemolytica had a marked increase in neutrophil counts during the first 36 h post 
inoculation compared with animals that were not challenged. These results are in 
agreement with previous observations15, 27 and show that an intratracheal M. haemolytica 
challenge can produce an acute immune response during the first 24 hours after the 
challenge.   
Both exposure to BVDV and M. haemolytica challenge resulted in steers having 
decreased lymphocytes. These results are in contrast with a previous report27 in which 
decreased lymphocyte counts during 138 hours post inoculation with M. haemolytica 
were observed.  However, decreased lymphocyte counts have been reported when 
animals were challenged with M. haemolytica alone.15  Bovine viral diarrhea viruses have 
been reported to have high affinity to cells of the immune system35 and a transient 
decrease in the total number of lymphocytes has been reported in animals with BVDV 
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infection.36,37 This decrease in lymphocyte counts could be an explanation for the 
decreased M. haemolytica leukotoxin antibody concentrations observed in our experiment 
when animals were exposed to PI steers before the M. haemolytica challenge compared 
with animals not exposed to BVDV. Eosinophils and basophils were affected by 
exposure to steers PI with BVDV and challenge with M. haemolytica.  These results are 
in agreement with a previous study;27 however, the clinical relevance of the response is 
unknown. 
Cytokines are soluble proteins involved in a wide variety of biological processes38 
influencing energy and protein metabolism.39  Increased cytokine concentrations are 
thought to result in repartitioning of energy and amino acids away from adipose and 
skeletal muscle growth by providing substrates for higher priority immunological 
functions.39,40 The primary mechanism of action of cytokines appears to be up or down-
regulation of genes involved in specific intracellular transduction pathways.41 A greater 
understanding of cytokine response to the most common pathogens could provide 
valuable information of the implications of these proteins for decreasing performance and 
carcass characteristics in animals that suffer from BRD during the rowing and finishing 
period.42,43 Interferon gamma has been reported as the link between the innate and 
adaptive immune systems and is critical for an adequate response to intracellular 
pathogens.38 The main source of IFNγ is thought to be lymphocytes.44 In the present 
experiment, serum concentrations of IFNγ tended to increase in response to exposure to 
steers PI with BVDV, although the total number of lymphocytes decreased during the 
first 18 hours after M. haemolytica challenge.  Although unknown, the lower lymphocyte 
count might have affected the absolute concentration of IFNγ during the length of the 
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experiment.  Challenge with M. haemolytica increased serum concentrations of IFNγ in 
the present experiment.  It has been suggested that the effect of IFNγ results from 
macrophages and neutrophils enhancing phagocytosis of extracellular pathogens 
(bacteria) and inducing a respiratory burst and nitric oxide production which has 
microbiocidal effects.44,45  Therefore, the increased concentration of IFNγ in the M. 
haemolytica treatment group might have been due to the increased number of circulating 
neutrophils in response to the bacterial infection 6 hours after M. haemolytica challenge 
in the present experiment.  The greater IFNγ concentration for the BVD+MH group 
might be explained as an additive effect of increased IFNγ secretion from major cells 
affected in response to the BVDV and M. haemolytica challenge. 
Interleukin-1 is one of the most potent endogenous inducers of fever and the induction of 
this cytokine has been associated with viral, bacterial, fungal and parasitic infections.46 In 
addition, IL-1 has been reported as one of the principal inducers of acute phase protein 
synthesis.47 Although IL-1 is expressed as both IL-1α and IL-1β, they have been 
differentiated  as either intracellular (IL-1α) or secreted by the cells (extracellular; IL-
1β).38  Therefore, IL-1β was measured in the present experiment.  In the present 
experiment, steers that were exposed to PI calves for 72 hours had increased 
concentrations of serum IL-1β compared with non-exposed animals.  However, in 
contrast to previous reports,46, 47 the increased concentration of serum IL-1β  in BVD 
steers was not associated with rectal temperatures greater than 40.0oC or greater 
concentrations of haptoglobin.46,47  These conflicting results could be explained by 
different concentrations of circulating IL-1β. Recombinant IL-1β administered to beef 
calves suggested that the effect of IL-1β on rectal temperature was dose dependant.48 
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Only animals dosed with 333 and 1,000 ng/kg of IL-1β had a mean rectal temperature 
greater than 40.0oC compared with animals dosed with 10, 33 and 100 ng/kg.  Maximum 
rectal temperature was observed at 6 hours for all treatments and returned to baseline by 
24 hours post IL-1β injection.  In addition, haptoglobin concentration was increased 
above 0.50 mg/mL in animals receiving 1,000 ng/kg of recombinant IL-1β starting at 24 
hours post injection, and haptoglobin concentration remained elevated for 72 hours. 
Serum concentrations of IL-1β were not reported in that study.48 Results suggest that the 
pyrogenic and acute phase induction of IL-1β is dose dependant.  In the present 
experiment, although animals experiencing infection with BVDV due to exposure to PI 
calves had increased rectal temperature when compared with non-exposed animals, the 
increase in IL-1β may not have been enough to result in an increase in rectal temperature 
above 40.0oC or to stimulate hepatocytes to increase haptoglobin synthesis.  Challenge 
with M. haemolytica increased IL-1β, haptoglobin, and rectal temperature in the present 
experiment.  Interestingly, the tendency for an interaction between BVD and MH may 
indicate the possibility of an additive effect in the intensity of the immune response when 
both pathogens were utilized in the challenge. 
Limited information exists regarding the role of IL-4 in beef cattle.49 This cytokine has 
been described as an anti-inflammatory cytokine which inhibits the production of pro-
inflammatory cytokines (IL-1β, IL-6 and TNFα).50,51 In a recent report,43 decreased 
concentrations of IL-4 were detected in animals fed a 30% concentrate diet compared 
with animals fed 70% concentrate when challenged with LPS and provided an 
antimicrobial injection.  The same study43 observed higher concentrations of IFNγ, TNFα 
and IL-6 and concluded that the increased concentrations of these pro-inflammatory 
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cytokines could be associated with the decreased concentrations of IL-4.  In the present
experiment, serum concentrations of IL-4 tended to be increased along with pro-
inflammatory cytokines in steers exposed to BVDV compared with control steers, which 
is in contrast to previous reports. It has also been suggested that when IL-4 is over 
expressed it can have detrimental effects on the immune system by decreasing the 
recruitment, expansion or activity of TH1 cells, resulting in a strong TH2 bias.52  This 
increased TH2 relative to TH1 might interfere with viral clearance by the host and 
suppress the innate immune response predisposing the host to secondary infections.52 
Therefore, increased IL-4 may decrease viral clearance and predispose animals to 
secondary infections resulting in increased morbidity and mortality when feedlot cattle 
are exposed to BVDV.  
In pre- and post-partum dairy cows, an increase in IL-6 has been associated with an
increase in the TH2 population.53 Steers exposed to BVDV or challenged with M. 
haemolytica in the present experiment had greater IL-6 concentrations than control 
animals, although the greatest IL-6 concentration occurred for animals exposed to BVDV 
but not challenged with M. haemolytica. Our data is in agreement with results showing 
increased concentrations of IL-6 when steers were challenged with LPS starting at 2 
hours post LPS infusion and returning to baseline within the first 24 hours of the LPS 
challenge.43 Interleukin-6 has been reported to induce fever and stimulate hepatocytes to 
synthesize acute phase proteins.54,55 In the present experiment, haptoglobin 
concentrations were increased for steers challenged with M. haemolytica, but not for 
steers exposed to BVDV.  Therefore, additional mechanisms that induce fever and 
synthesis of acute phase proteins likely exist. For example, it has been reported that the 
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injection of IL-6 in IL-6 knockout mice had no or a very mild pyrogenic effect compared 
with injecting the same mice with IL-1β suggesting that other neuromodulators (e.g., 
prostaglandin E2) are involved in modulating fever.56  
Increased concentrations of TNFα in milk and serum of cows suffering from mastitis has 
been reported, and the increased concentration of TNFα was associated with the severity 
of the clinical manifestation of the disease.57 In the present experiment, TNFα 
concentrations in serum were greatest in animals exposed to BVDV and challenged with 
M. haemolytica, although subjective clinical scores did not respond with the same 
interaction and were higher in steers challenged with M. aemolytica regardless of 
exposure to BVDV.  During LPS challenge, septic shock has been associated with 
endotoxemia40 which has resulted in death of challenged animals.43 In addition, when 
dogs and cats were infused with recombinant human TNFα, a similar endotoxic response 
was observed; however, recombinant anti-TNF monoclonal antibodies prevented the 
induction of septic shock during acute bacteremia in baboons.58 I creased concentrations 
of TNFα might partially explain the increased mortality in calves with multiple BRD 
pathogens isolated from lungs.59 In addition, due to the systemic effects of TNFα60 
detrimental effects on meat quality could be observed with increased severity of BRD.  
Decreasing the number or severity of pro-inflammatory cytokine responses might be 
helpful for decreasing economic losses associated with decreased carcassquality in 
feedlot cattle treated for BRD.3 
In contrast to a previous report where increased plasma lactate concentrations were 
correlated with BRD morbidity,61 plasma lactate was decreased in animals that were 
exposed to steers PI with BVDV in the present experiment.  In the earlier study,61 no 
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changes in plasma lactate in animals receiving one treatment for BRD were reported, but 
increased plasma lactate was measured in animals suffering from BRD 24 hours prior to 
death.  The rationale for these results was an increased anaerobic metabolism by ani als 
during a BRD event due to decreased lung capacity, and the decreased O2/CO2 exchange 
changing the metabolism of glucose at the muscle level toward lactate production as the 
end product of glycolysis in the absence of O2.  In addition, M. haemolytica challenge 
was reported to decrease plasma lactate for 72 hours post M. haemolytica challenge,27 
whereas in the present study, M. haemolytica challenge had no effect on plasma lactate 
concentrations.  To our knowledge, there are no previous studies in the literature that 
provide greater insight into the possible effects of BVDV or M. haemolytica on plasma 
lactate concentrations in feeder calves.  However, it was reported that anim ls that 
received at least one antimicrobial treatment against BRD during a 36-day 
preconditioning program had lower plasma lactate concentrations at arrival.62  P thogens 
involved in BRD cases were not identified and no direct comparisons with our results can 
be made.  Plasma lactate can be increased during cases of ruminal acidosis.63 B th 
ruminal acidosis and BRD have been associated with decreased or altered DMI. Due to 
similar clinical signs, ruminal acidosis should be considered in the list of differential 
diagnosis of BRD in field conditions.64 However, ruminal pH measured in calves pulled 
or pulled and treated against BRD showed no differences between experimental groups.65 
Increased respiration rate is an important thermoregulatory mechanism for preventing 
heat overload in cattle via evaporative cooling.66  In the present experiment, respiration 
rate of control steers was greatest compared with steers on the remaining treatments.  In 
cattle exposed to heat stress, the initial response was an increased respiration rate, which 
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changed to panting midway through the heat stress period followed by a deep open mouth 
respiration at a reduced rate.67 Interestingly, decreased respiration rate in our challenge 
model was present for steers on all experimental treatments that had an increased rectal 
temperature compared with control steers.  Changes in frequency and dynamics of 
respiration in exposed and/or challenged steers also corresponded with changes in blood 
gases for steers in the present experiment.  Respiratory alkalosis has been describe  as 
increased alveolar ventilation resulting in excretion of carbon dioxide at a rate exce ding 
production,68 which results in decreased partial pressure of carbon dioxide, increased 
blood pH, and decreased concentration of bicarbonate.  Cattle exposed to heat stress have 
been reported to have an increased respiration rate, decreased partial pressure of carbon 
dioxide and bicarbonate concentration, with no change in blood pH.
69  In the present 
experiment, M. haemolytica challenge decreased partial pressure of carbon dioxide and 
carbon dioxide and bicarbonate concentrations during the first 48 hours post M. 
haemolytica challenge.  The lack of an effect on blood gases due to BVDV exposure 
might be due to the lack of a direct effect of this virus on the host animal’s respiratory 
capacity and gas exchange, especially when compared to other viral or bacterial 
infections associated with BRD.  Interestingly, despite changes in blood gases there was 
no effect of our infectious challenge or heat stress69 on blood pH, reflecting the host 
animals’ capacity to maintain homeostasis.  
In conclusion, we observed changes in serum antibody production, total and differential 
white blood cell count, cytokine concentrations, and blood gases consistent with an 
immune challenge in beef cattle.  Our results suggest that we were able to successfully 
develop an immune challenge model using exposure of naïve steers to steers PI with 
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BVDV, intratracheal challenge with M. haemolytica, or their combination which will 
allow us to further characterize the detrimental effects that BRD pathogens have on food 
producing animals.  In addition, exposure to calves PI with BVDV and intratracheal 
challenge with M. haemolytica resulted in decreased antibody production to M. 
haemolytica leukotoxin and increased serum concentrations of IFNγ, IL-1β and TNFα, 
suggesting that exposure of naïve calves to PI calves increases potential for secondary 
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a. Phosphate buffered saline pH 7.4, Sigma Aldrich. 
b. Bivona Medical Technology, Gary, IN. 
c. Nolvasan, Fort Dodge Animal Health, Overland Park, KS. 
d. GLA M-500, GLA Agricultural Electronics, San Luis Obispo, CA. 
e. Clott activator, Becton Dickinson Vacutainer Systems, Franklin Lakes, NJ. 
f. Immunology Consultants Lab, Portland OR. 
g. Tris-buffered saline with Tween 20 pH 4.0, Sigma-Aldrich, St Louis, MO. 
h. Bovine IFNI gamma Screening Set, Pierce Protein Research Products, Thermo 
Scientific, Rockford, IL. 
i. Bovine IL-1 beta ELISA Set, Pierce Protein Research Products, Thermo 
Scientific, Rockford, IL. 
j. Bovine IL-4 Screening Set, Pierce Protein Research Products, Thermo Scientific, 
Rockford, IL. 
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Rockford, IL. 
l. Bovine TNF-alpha / TNFSF1A ELISA Development Kit, DuoSet, R&D Systems, 
Minneapolis, MN. 
m. Microtiter 96-well plates, Thermo Scientific, Waltham, MA. 
n. ELISA ultra block solution, AbD Serotec, Raleigh, NC. 
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Table 1. Effect of 72 h exposure to a PI BVDV calf with or without an intratracheal callenge with M. haemolytica on hemogram of 
steers 
 No BVD BVD  P-value 
Item No MH MH No MH MH SEM BVD MH BVD×MH 
Total white blood cells, 103/µL 9.86a 9.83a 7.93b 9.48a 0.60 <0.0001 0.003 0.002 
Neutrophils/µL 2,941a 3,977b 2,080c 4,045b 306 0.03 <0.0001 0.01 
Lymphocytes/µL 6,341 5,215 5,340 4,827 338 0.002 <0.0001 0.09 
Monocytes/µL 354 362 342 401 51.1 0.78 0.50 0.61 
Eosionphils/µL 139 185 119 146 14.1 0.03 0.01 0.50 
Basophils/µL 91 124 66 88 8.9 0.0007 0.001 0.53 
Hematocrit, % 30.5 28.4 29.9 29.8 0.79 0.50 0.08 0.10 
Hemoglobin, g/100 mL 11.4a 10.4c 11.1ab 10.7bc 0.12 0.55 <0.0001 0.02 
Mean corpuscular volume, fL 38.7 36.7 38.2 37.6 0.51 0.67 0.01 0.20 
Mean corpuscular hemoglobin, 
% 
14.3a 13.5b 14.3a 14.1a 0.16 0.09 0.05 0.03 
Platlets, 103/µL 487 506 517 524 33.1 0.28 0.56 0.78 
Red cells, 106/µL 7.97 7.74 7.87 7.60 0.12 0.33 0.04 0.86 
a,b,cWithin a row means with different superscripts are different (P < 0.05). 
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Table 2. Effect of 72 h exposure to a PI BVDV calf with or without an intratracheal callenge with M. haemolytica on serum cytokine 
concentrations of steers 
 No BVD BVD  P-value 
Item No MH MH No MH MH SEM BVD MH BVD×MH 
Interferon-γ, pg/mL 90a 86a 78a 181b 54.6 0.06 0.02 0.02 
Interleukin 1β, pg/mL 75 157 90 329 89.2 0.04 0.0006 0.11 
Interleukin 4, pg/mL 67 75 119 139 34.3 0.08 0.68 0.86 
Interleukin 6, pg/mL 1,442a 1,966b 2,591c 2,003b 645 0.04 0.87 0.01 
Tumor necrosis factor-α, pg/mL 367a 540b 583b 1,984c 319 0.0005 0.0009 0.01 













Table 3. Effect of 72 h exposure to a PI BVDV calf with or without an intratracheal callenge with M. haemolytica on clinical score, 
respiration rate, blood pH and gas and metabolite concentrations in steers   
 No BVD BVD  P-value 
Item No MH MH No MH MH SEM BVD MH BVD×MH 
Subjective clinical score 0.00 0.34 0.05 0.45 0.04 0.99 <0.0001 0.57 
Respirations per minute 58.0a 55.8b 54.8c 56.0b 3.50 0.16 0.02 0.01 
pH 7.46 7.44 7.44 7.44 0.02 0.59 0.70 0.46 
Calcium, mM 1.24 1.23 2.97 1.23 0.87 0.32 0.31 0.32 
Potassium, mM 4.09 4.02 4.22 4.10 0.11 0.35 0.38 0.80 
Sodium, mM 141a 139b 141a 140ab 0.70 0.002 <0.0001 0.005 
Glucose, mg/100 mL 71.1 69.9 72.3 71.2 1.11 0.18 0.25 0.93 
Lactate, mM 1.25 1.25 0.81 1.04 0.10 0.02 0.29 0.29 
Sulfur dioxide, mM 69.9 71.8 70.7 70.5 1.90 0.74 0.36 0.30 
Base excess in extracellular fluid, 
mM 
6.51 4.88 6.98 6.10 0.48 0.01 0.0002 0.25 
Carbon dioxide, mM1 32.1a 30.2b 31.8a 31.4ab 0.30 0.04 <0.0001 0.001 
Carbonic acid, mM1 28.9a 27.9b 29.0a 28.7a 0.26 0.02 0.0007 0.04 
Sodium bicarbonate, mM1 30.7a 28.9b 30.6a 30.1a 0.29 0.01 <0.0001 0.003 
Partial pressure of carbon dioxide, 
mm/Hg 
45.9a 42.1b 44.6ac 43.6c 0.41 0.77 <0.0001 0.0006 
Base excess in blood, mM 5.78 5.44 5.85 5.50 0.52 0.90 0.50 0.99 
1A BVD × MH × time interaction was detected (P < 0.05). 
a,b,cWithin a row means with different superscripts are different (P < 0.05). 
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Figures  
Figure 1. Serum concentration of bovine viral diarrhea virus 1b (BVDV1b) 
neutralization antibody titers in calves exposed during 72 hours to two steers PI with
BVDV (BVD) compared with non-exposed controls (No BVD).  There was a BVD × 
time interaction (P < 0.0001; SEM = 275).  Values plotted represent Least squares means 
± standard error of the mean, calculated for 12 animals per experimental group. a,bWithin 
day, Least squares means with different letters are different (P < 0.05). 
Figure 2. Serum concentration of M. haemolytica whole cell antibodies (Figure 
2a) and M. haemolytica leukotoxin antibodies (Figure 2b) in calves challenged 
intratracheally on d 0 with 6 × 109 CFU of M. haemolytica serotye 1 (MH) compared 
with non-challenged controls (No MH). There was a MH × time interaction (P < 0.0001; 
SEM = 0.36; Figure 2a) for M. haemolytica whole cell antibodies, and a BVD × MH × 
time interaction (P < 0.0001; SEM = 0.15; Figure 2b) for M. haemolytica leukotoxin 
antibodies.  Values plotted represent Least squares means ± standard error of the mean, 
calculated for 12 animals per experimental group for M. haemolytica whole cell 
antibodies, and 6 animals per experimental group for M. haemolytica leukotoxin 
antibodies. a,b,cWithin day, Least squares means with different letters are different (P < 
0.05). 
Figure 3. Rectal temperature of calves challenged intratracheally with 6 × 109
CFU of M. haemolytica serotye 1 (MH) compared with non-challenged controls (No MH; 
Figure 3a) or exposed during 72 hours to two steers PI with BVDV 1b (BVD) compared 
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with non-exposed controls (No BVD; Figure 3b).  There was a MH × time interaction (P 
< 0.0001; SEM = 0.11; Figure 3a) and a BVD × time interaction (P = 0.02; SEM 0.11; 
Figure 3b).  Values plotted represent Least squares means ± standard error of the mean, 
calculated for 12 animals per experimental group. a,bWithin a day, Least squares means 
with different letters are different (P < 0.05). 
Figure 4. Serum haptoglobin concentrations of calves challenged intratracheally 
with 6 × 109 CFU of M. haemolytica serotye 1 (MH) compared with non-challenged 
controls (No MH; Figure 4a) or exposed during 72 hours to two steers PI with BVDV 1b 
(BVD) compared with non-exposed controls (No BVD; Figure 4b).  There was a MH×
time interaction (P < 0.0007; SEM = 0.32; Figure 4a), and the BVD × time interaction 
was not significant (P = 0.93; SEM = 0.32; Figure 4b).  Values plotted represent Least 
squares means ± standard error of the mean, calculated for 12 animals per experimental 
group. a,bWithin a day, Least squares means with different letters are different (P < 0.05). 
Figure 5.  Total white blood cell (Figure 5a), neutrophil (Figure 5b) and 
lymphocyte (Figure 5c) counts of calves challenged intratracheally with 6 × 109 CFU of 
M. haemolytica serotye 1 (MH) compared with non-challenged controls (No MH; Figures 
5a and 5b) or exposed during 72 hours to two steers PI with BVDV (BVD) compared 
with non-exposed controls (No BVD; Figure 5c). There were MH × time interactions (P 
< 0.0001, SEM = 0.71, Figure 5a; P < 0.0001, SEM = 417, Figures 5b) and a BVD × time 
interaction (P < 0.01; SEM = 445; Figure 5c).  Values plotted represent Least squares 
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means ± standard error of the mean, calculated for 12 animals per experimental group. 
a,bWithin a day, Least squares means with different letters are different (P < 0.05). 
Figure 6. Carbon dioxide (Figure 6a), carbonic acid (Figure 6b), and sodium 
bicarbonate (Figure 6c) concentrations in whole blood of calves challenged 
intratracheally with 6 × 109 CFU of M. haemolytica serotye 1 (MH) compared with non-
challenged controls (No MH). There were MH × time interactions (P = 0.005, SEM = 
0.60, Figure 6a; P =0.03, SEM = 0.50, Figure 6b; P < 0.002; SEM = 0.60, Figure 6c).  
Values plotted represent Least squares means ± standard error of the mean, calculated for 
12 animals per experimental group. a,bWithin a day, Least squares means with different 






















































EFFECTS OF EXPOSURE TO CALVES PERSISTENTLY INFECTED WITH 
BOVINE VIRAL DIARRHEA VIRUS TYPE 1B AND MANNHEIMIA 
HAEMOLYTICA CHALLENGE ON ANIMAL PERFORMANCE, N BALANCE, 
AND VISCERAL ORGAN MASS IN BEEF STEERS 
 
ABSTRACT:  Bovine Viral Diarrhea viruses (BVDV) have been isolated alone or in 
combination with other viral and bacterial pathogens in animals diagnosed with Bovine 
Respiratory Disease (BRD), a disease causing major economic loss to the feedlot 
industry. The objective of this experiment was to determine the effects of Mannheimia 
haemolytica following short-term (72 h) exposure to BVDV persistently infected (PI) 
calves on performance, N balance and organ mass in finishing cattle.  Treatments 
included: 1) steers not challenged with BVDV or M. haemolytica (Control); 2) steers 
challenged with 72 h exposure to steers PI with BVDV (BVD); 3) steers intratracheally 
challenged with M. haemolytica on d 0 (MH); and 4) steers challenged with 72 h 
exposure to steers PI with BVDV and intratracheally with M. haemolytica on d 0 
(BVD+MH).  Six steers/treatment (initial BW = 314 ± 31 kg) were used for the 
experiment.  Steers were weighed every 28 d and were housed in metabolism crate  
during the first 5 d following the M. haemolytica challenge, the 2nd wk after the M.
haemolytica challenge, and on d 28 to 32, d 56 to 60, and 7 to 10 d prior to slaughter 
 82
to determine N balance.  At slaughter, carcass and organ mass data were collect d.  Data 
were analyzed as a randomized complete block design with a 2 × 2 factorial arrangement 
of treatments and steer as the experimental unit.  From d -3 to 4, steers challenged with 
M. haemolytica had lower (P = 0.04) ADG than steers not challenged with M. 
haemolytica.  In addition, across the entire finishing period, steers exposed to steers PI 
with BVDV tended (P = 0.09) to have lower ADG and G:F than steers not exposed to 
BVDV.  Prior to slaughter, retained N expressed as g/d (P = 0.03) and as a % of N intake 
(P = 0.04) was lower in BVD steers compared with steers not exposed to steers PI with 
BVDV.  There were no effects (P > 0.10) of BVDV exposure or M. haemolytica 
challenge on carcass characteristics or empty BW (EBW).  Expressed a  a percent of 
EBW, HCW was lower (P = 0.02) and blood plus total offal weight was greater (P = 
0.02) for steers challenged with M. haemolytica compared with steers not challenged.  
Results are in agreement with those reported in larger scale finishing studies an  suggest 
that acute exposure to BRD-related pathogens can have long-term effects on animal 
performance. 
   
Key words: bovine, bovine respiratory disease, bovine viral diarrhea, carcass merit, 








Bovine respiratory disease (BRD) involves the complex interaction between 
stress, bacteria, viruses and the environment (Duff and Galyean, 2007).  Booker et al. 
(2008a) reported that Mannheimia haemolytica was the most common pathogen isolated 
at necropsy from animals that died from BRD.  In addition, Haines et al. (2001, 2004) 
and Shahriar et al. (2002) reported a high incidence of bovine viral diarrhea viruses 
(BVDV) in animals that died due to BRD.  These studies were conducted on individual 
animals, and indicated a negative effect of these pathogens on the economics of cattle 
production due to mortalities.  However, in experiments using feedlot pens, contradictory 
information regarding the effects of animals persistently infected (PI) with BVDV on 
animal health, performance and carcass quality have been reported (Loneragan et l., 
2005; O’Connor et al., 2005; Booker et al., 2008a, 2008b).  Loneragan et al. (2005) 
reported a negative effect on health and performance of cattle when a PI animal was 
present in a pen or adjacent pens.  O’Connor et al. (2005) and Booker et al. (2008b) 
reported no difference in performance but observed an increased morbidity in pens 
containing a PI animal.  Despite differences in animal health and performance of feedlot 
cattle in response to individual pathogens, strong evidence exists (Gardner et al 1999;
Thompson et al., 2006) which indicates that animals treated against BRD have decreased 
performance and lower carcass quality compared with animals never treat d against BRD 
during the finishing period.  An improved understanding of the etiologic agents involved 
in BRD and their relationship with animal performance and carcass quality is essential 
for the development of preventive and therapeutic strategies.  The objective of this 
experiment was to evaluate the effects of short-term (72 h) exposure to steers PI with 
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BVDV with or without an intratracheal M. haemolytica challenge on performance, N 
balance, organ mass and carcass characteristics of beef steers. 
MATERIALS AND METHODS 
Twenty-four Angus crossbred steers (initial BW = 313 ± 31 kg) were individually 
housed at the Nutrition Physiology Research Center (NPRC), Oklahoma State University, 
Stillwater during the experiment.  All steers were considered clinically healthy and were 
seronegative to all pathogens involved in the study as determined by paired serum 
samples collected 14 d apart prior to the start of the experiment. Steers were randomly 
allocated to 1 of 4 treatments (6 animals/treatment) arranged as a 2 × 2 factorial.  
Treatments were: 1) steers not challenged with BVDV or M. haemolytica (Control); 2) 
steers exposed for 72 h to two steers PI with BVDV (B D); 3) steers intratracheally 
challenged with M. haemolytica on d 0 (MH); and 4) steers exposed for 72 h to two 
steers PI with BVDV immediately followed by intratracheal challenge with M. 
haemolytica on d 0 (BVD+MH).  Steers exposed to calves PI with BVDV were 
transported 3.22 km to the Willard Sparks Beef Research Center, Stillwater, OK and were 
commingled in a 6 × 10.8 m pen with 2 steers previously diagnosed via 
immunohistochemistry as being PI with BVDV Type 1b (Fulton et al., 2006).  Following 
exposure to BVDV Type 1b, steers were returned to the NPRC for the remainder of the 
experiment.  Steers challenged with M. haemolytica received 10 mL of a solution 
containing 6 × 109 CFU of M. haemolytica serotye A-1 which was reconstituted and 
grown prior to the challenge as described by Mosier et al. (1998).  Challenge with M. 
haemolytica occurred immediately following return of the BVDV-exposed steers to the 
NPRC and on the same d for all treatment groups beginning at 0800.  Steers not 
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challenged with M. haemolytica were intratracheally dosed with 10 mL of a sterile 
phosphate-buffered saline (PBS) solution.  Inoculation of the PBS solution for Control 
and BVD groups and the solution containing the M. haemolytica culture for the MH and 
BVD+MH groups was performed as described by Burciaga-Robles et al. (2009). 
During the length of the experiment, steers were offered feed for ad libitum 
consumption.  Feed was delivered twice daily based on the previous day’s intake.  Feed 
refusals were collected daily and any feed remaining was dried at 60oC for determination 
of DMI.  Steers were adapted to a high-concentrate finishing diet using adaptation die s 
shown in Table 1.  Steers were fed Diet 1 for 2 wk prior to the beginning of the 
experiment and remained on this diet during the first 15 d following M. haemolytica 
challenge.  Beginning on d 16, animals were fed Diet 2 for 3 consecutive d; on d 19, 
animals were fed Diet 3 for an additional 3 d (d 19 to 22 post M. haemolytica challenge).  
On d 23 steers were fed the finisher diet and remained on this diet until harvest.  Animals 
were weighed on d -3, 0, 7, 14, 28, 56, 84 and 112 (heavy block) or 126 (light block).  
Average daily gain was calculated using BW and days on feed and G:F was calculated 
using DMI for the corresponding periods. 
Nitrogen Balance 
To facilitate sample collection, steers were blocked by BW into 2 groups of 
twelve, and the challenge procedures and sample collections were staggered by a 2 wk 
interval between periods to allow for total urine and fecal collections in metabolism 
stanchions.  Steers were housed in individual 3.7 × 3.7 m pens with the exception of d 0 
to 4, 7 to 11, 28 to 32, and on d 101 to 105 for the heavy block and d 111 to 116 for the 
light block (prior to slaughter), when animals were placed in metabolic stanchions for 
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collection of total feces and urine.  Fecal and urinary excreta were collected for each steer 
and weighed to determine total daily output.  Representative sub-samples of total feces 
(10%) and total urine (1%) were collected, composited by period, and frozen (-20ºC) for 
later analyses.  To prevent the loss of NH3, daily urine output was collected into buckets 
containing 400 mL of 6 N HCl to decrease pH to < 3.0.  Composite samples of diet and 
feces were analyzed for DM and OM (AOAC, 1990) to calculate total tract digestibility.  
In addition, diet, feces, and urine were analyzed for total N (Leco® FP-528, Leco 
Corporation, St. Joseph, MI) to calculate N digestibility and retention. 
Carcass and Organ Mass Collection 
Approximately 16 h prior to harvest (d 112 and 126 for heavy and light block, 
respectively) steers were transported to the Oklahoma Food and Agricultural Products 
Research and Technology Center abattoir.  On the morning of harvest, steers were 
stunned with a captive bolt and exsanguinated.  Weight of blood, feet and ears, hide, 
head, heart, lungs, kidneys, emptied gastrointestinal tract (GIT; reticulorumen, omasum, 
abomasum, small and large intestine, and cecum), mesenteric fat trimmed fro  GIT 
organs, omental fat, pancreas, spleen, liver, and hot carcass were recorded. Total offal 
mass was calculated as the sum of blood, feet and ears, hide, trim (tail, spinal cord, nd 
carcass trim), all organs, and mesenteric and omental fat.  The reticulorumen, o asum, 
and abomasum were cut open, contents removed, and organs were rinsed free of 
remaining feed particles before weighing.  Intestinal contents were removed by gently 
squeezing contents through the length of the organ. Empty-body weight was calculated as 
hot carcass mass plus total offal mass, and total splanchnic tissue (TST) mass was 
calculated as GIT plus liver, spleen, pancreas, and mesenteric/omental fat.  In addition, 
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carcasses were evaluated for marbling score, fat thickness at the 12th rib, adjusted 
preliminary yield grade, LM area, and percentage of kidney, pelvic, and heart fat (KPH; 
USDA, 1997).  Dressing percent and yield grades were calculated. 
Statistical Analyses  
The experiment was designed as a randomized complete block with a 2 × 2 
factorial arrangement of treatments and animal served as the experimental unit.  Animal 
performance (BW, ADG, DMI and G:F), total tract digestibility, N balance, organ mass, 
and carcass quality were analyzed with the MIXED procedure of SAS (SAS Inst. Version 
9.1, Inc., Cary, NC).  The model for all variables included the main effects of BVD, MH 
and the possible interaction between BVD and MH.  Weight block (heavy or light) was 
included as a random effect in the model. Results are discussed as being significant if P ≤ 
0.05 and as a tendency if P > 0.05 to P < 0.10. 
 
RESULTS 
Effects of M. haemolytica challenge following short-term (72 h) exposure to 
steers PI with BVDV on animal performance is shown in Table 2.  Body weight was not 
affected (P > 0.35) by BVD, MH, or the BVD × MH interaction.  From d -3 to 4, steers 
challenged with M. haemolytica had lower (P = 0.04) ADG than steers not challenged 
with M. haemolytica.  In addition, across the entire finishing period, steers exposed to 
steers PI with BVDV tended (P = 0.09) to have lower ADG than steers not exposed to 
BVDV.  There was a tendency (P = 0.10) for a BVD × MH interaction for DMI from d -3 
to 4.  This resulted from steers with exposure to steers PI with BVDV and challenged 
with M. haemolytica having the lowest DMI, whereas steers with exposure to steers PI 
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with BVDV but not challenged with M. haemolytica had DMI similar to controls.  This 
trend occurred throughout the entire finishing period (d -3 to finish; P = 0.10).  In 
addition, from d -3 to 4, steers exposed to steers PI with BVDV tended (P = 0.08) to have 
lower DMI than steers not exposed to BVDV, and from d 84 to finish, steers challenged 
with M. haemolytica had lower DMI than steers not challenged with M. haemolytica.  
Exposure to steers PI with BVDV for 72 h decreased (P = 0.05) DMI as a percent of BW 
from d -3 to 4, and tended (P = 0.08) to result in a BVD × MH interaction, similar to 
DMI (kg/d).  From d -3 to 4, G:F tended (P = 0.08) to be lower for steers exposed to 
steers PI with BVDV, and was lower (P = 0.04) for steers challenged with M.
haemolytica.  Across the entire finishing period, steers exposed to steers PI with BVDV 
had lower (P = 0.04) G:F than steers not exposed to animals PI with BVDV. 
From d 1 to 4, DMI tended (P = 0.09) to be lower and fecal DM output was lower 
(P = 0.04) for steers challenged with M. haemolytica (Table 3).  Apparent DM 
digestibility was lower (P = 0.004) for steers exposed to steers PI with BVDV compared 
with steers not exposed to BVDV.  Similar to DMI, N intake tended (P = 0.09) to be 
lower and fecal N output was lower (P = 0.04) for steers challenged with M. haemolytica, 
and apparent N digestibility was lower (P = 0.01) for steers exposed to steers PI with 
BVDV compared with steers not exposed to PI steers.  Urinary N output tended (P = 
0.09) to be greater for steers challenged with M. haemolytica.  Nitrogen retained 
expressed as g/d tended (P = 0.09) for steers challenged with M. haemolytica. In addition, 
Nitrogen retained as a % of N intake tended (P = 0.07) to be lower for steers exposed to 
steers PI with BVDV compared with steers not exposed to steers PI with BVDV whereas 
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steers challenged with M. haemolytica had lower (P = 0.01) Nitrogen retained as a % of 
N intake compared with non-challenged animals. 
From d 7 to 11 and d 28 to 32, there were no effects (P > 0.12) of BVDV 
exposure or M. haemolytica challenge on DM or N intake or apparent total tract 
digestibility (Table 3).  Steers challenged with M. haemolytica had lower (P = 0.03) 
urinary N output on d 7 to 11 than steers not challenged with M. haemolytica.  In 
addition, there was a tendency for a BVD × MH interaction on d 7 to 11 (P = 0.07) and d 
28 to 32 (P = 0.06).  This resulted from the steers exposed to steers PI with BVDV and 
challenged with M. haemolytica having lower urinary N output than steers exposed to 
steers PI with BVDV but not challenged with M. haemolytica, whereas urinary N output 
for treatments with steers not exposed to BVDV was similar.  Although urinary output 
tended to be different among treatments, there was no effect (P > 0.12) of BVDV 
exposure or M. haemolytica challenge on N retention on d 7 to 11 or d 28 to 32. 
  Prior to slaughter, there was a BVD × MH interaction (P = 0.02) for DM and N 
intake (Table 3).  For steers not exposed to steers PI with BVDV, DM and N intake were 
lower for control steers than for steers challenged with M. aemolytica.  In contrast, for 
BVD steers, DM and N intake were lower for steers challenged with M. haemolytica than 
for steers not challenged with M. haemolytica.  Retained N expressed as g/d was lower (P 
= 0.05) and as a percent of N intake tended (P = 0.09) to be lower lower in BVD steers 
compared with steers not exposed to steers PI with BVDV. 
There were no effects of BVDV exposure or M. haemolytica challenge on carcass 
characteristics (Table 4) or empty BW (EBW; Table 5).  Expressed as a percent of EBW, 
HCW was lower (P = 0.02) and total offal weight was greater (P = 0.02) in steers 
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challenged with M. haemolytica compared with steers not challenged (Table 5).  There 
was BVD × MH interaction (P = 0.05) for total offal weight.  For steers not exposed to 
steers PI with BVDV, total offal weight was lower for control steers than for steers 
challenged with M. haemolytica.  In contrast, for BVD steers, total offal weight was 
similar for steers challenged with M. haemolytica.  Blood weight expressed as kg (P = 
0.06) and as % of EBW (P = 0.05) was greater for steers challenged with M. haemolytica 
than for steers not challenged with M. haemolytica.  Weight of the head tended (P = 0.06) 
to be lower for BVD steers compared with steers not exposed to steers PI with BVDV.  In 
addition, weight of the feet, forelegs, and tail were lower (P < 0.03) for BVD steers than 
for steers not exposed to steers PI with BVDV.  Weight of the feet, forelegs, and tail 
expressed as a percent of EBW tended (P = 0.08) to be greater for steers challenged with 
M. haemolytica than for steers not challenged with M. haemolytica.  Kidney weight (kg) 
tended (P = 0.10) to respond with a BVD × MH interaction.  For steers not exposed to 
steers PI with BVDV, kidney weight was lower for control steers than for stee s 
challenged with M. haemolytica.  In contrast, for BVD steers, kidney weight was lower 
for steers challenged with M. haemolytica than for steers not challenged with M. 
haemolytica.  No other differences (P > 0.12) in organ mass due to exposure to steers PI 
with BVDV or M. haemolytica were observed. 
 
DISCUSSION 
Immune response by steers used in the present experiment to exposure to steers PI
with BVDV and M. haemolytica challenge has been reported (Burciaga-Robles et al., 
2009).  Briefly, BVDV antibody production was increased across time for steers expo ed 
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for 72 h to steers PI with BVDV compared with non-exposed animals, and whole cell M. 
haemolytica antibody concentrations were greater and increased over time in steers 
challenged with M. haemolytica.  Rectal temperature increased over time in BVD and 
MH steers, but the extent and time of the increase depended on the pathogen involved in 
the challenge.  We observed changes in total and differential white blood cell count 
(WBC), cytokine concentrations, and blood gases consistent with an immune challenge in 
feedlot cattle (Burciaga-Robles et al., 2009).  
In previous experiments, the number of antimicrobial treatments required for 
BRD has been associated with decreased performance during the feedlot phase (Gardn r 
et al., 1999; Roeber et al., 2001).  Roeber et al. (2001) showed that calves that required 
two or more antimicrobial treatments for BRD had lower ADG during the first 56 d on 
feed than calves that did not require an antimicrobial treatment, but there was no 
difference between animals that required one antimicrobial treatment compared with 
animals that did not require an antimicrobial treatment.  This might suggest that calves
receiving a single antimicrobial treatment were misdiagnosed or that severity or number 
of times a BRD event occurs plays a role in how the disease affects overall performance 
of beef cattle.  In the present experiment, ADG was decreased from d -3 to 4 in steers 
challenged with M. haemolytica, and overall (d -3 to finish) ADG tended to be decreased 
due to exposure of BVDV.  Our data suggests that the long-term negative effects 
associated with BRD might be related to the type and potentially the number of 
pathogens involved in the BRD event.  
Hesseman (2006) concluded that the incidence of calves PI with BVDV arriving 
at the feedlot is approximately 0.3% of total cattle, and that PI and acutely infected cattle 
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are the main sources of transmission of this disease to susceptible animals.  However, the 
negative effects that PI calves have on health and performance has been debated.  
O’Connor et al. (2005) reported that in a population of 5,041 calves (40 pens), the 
presence of a PI calf had no negative effects on overall health of cattle in the pens.  In 
contrast, Loneragan et al. (2005) attributed an increased risk of developing BRD to 
animals PI with BVDV present in pens of feedlot cattle.  Stevens et al. (2007) reported 
that the presence of PI calves in a pen increased morbidity (18.8 vs. 29.6%) compared 
with non-exposed cattle.  In addition, these authors evaluated the epidemiological curve 
of BRD when a PI calf was present in a pen, and reported a twofold increase (15.3 vs. 
31.7%) in the number of animals requiring an antimicrobial treatment during the first 7 d 
on feed.  Booker et al. (2008a) evaluated the effects of the presence of a PI animal and 
also the type of BVDV involved on health and performance of non-exposed cattle.  They 
concluded that the presence of a PI BVDV type 1 animal in a pen resulted in an increased 
number of BRD treatments and mortalities compared with non-exposed pens, but a PI 
BVDV type 2 animal had no negative effects on health of finishing cattle.  Elam et l. 
(2008) reported that short-term (60 d) or long-term (215 d) exposure to calves PI with 
BVDV did not affect DMI or final BW at the end of the finishing period; however, they 
did observe a tendency for decreased ADG during the first 28 d in exposed cattle, which 
they attributed to the cost of developing immunity to the wild type strain of BVD.  It is 
important to mention that in the study conducted by Elam et al. (2008), all animals had 
been vaccinated at least twice against BVDV before entering the feedlot, and at the time 
of entry to the feedlot received a metaphylactic antimicrobial treatment reducing the 
possibility of sickness not only to BVDV, but also to M. haemolytica and other 
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microorganisms associated with BRD.  In the present experiment, animals exposed to 
steers PI with BVDV tended to have lower ADG than non-exposed steers across the 
entire finishing period.  Our results suggest that short-term exposure to steers PI with 
BVDV type 1b can have long-term effects on animal performance. 
Olchowy et al. (2000) and Corrigan et al. (2007) have reported effects of M. 
haemolytica in challenge studies on animal performance, although the length of their 
experiments was relatively short (16 d and 136 h, respectively).  In addition, Gånheim et 
al. (2003, 2005) reported the effects of an aerosolized challenge with BVDV with or 
without a subsequent M. haemolytica challenge.  In these studies authors characterized 
the production of acute phase proteins (Gånheim et al., 2003) and changes in white blood 
cell counts (Gånheim et al., 2005) due to the bacterial and/or viral challenges, and the 
length of the experiments were only 23 d.  To our knowledge, no long-term effects of 
acute M. haemolytica challenge on performance and carcass characteristics in cattle have 
been reported.  Olchowy et al. (2000) reported decreased ADG of calves chall nged with 
M. haemolytica which did not receive an antimicrobial treatment.  These results are in 
agreement with results from the present experiment, in which steers challenged with M. 
haemolytica had lower ADG compared with control steers.  However, in the present 
study the duration of the decreased ADG due to M. haemolytica lasted for only 4 d after 
the M. haemolytica challenge.  The discrepancy in results might be explained by the 
difference in age (3 mo vs. 8 mo), breed (Holstein vs. Angus cross) and/or BW (76 vs. 
314 kg) of calves used by Olchowy et al. (2000) compared with the present experiment. 
Pro-inflammatory cytokines secreted by activated cells of the immune system 
have been reported to decrease feed intake (Johnson, 1997).  In the present experiment, 
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there was a tendency for decreased DMI during days -3 to 4 for steers with exposure to 
steers PI with BVDV.  In addition, steers exposed to calves PI with BVDV and 
challenged with M. haemolytica tended to have lower DMI than steers on the remaining 
treatments from d -3 to 4 and from d -3 to finish.  According to Hutchenson and Cole 
(1986), when expressed as a percentage of BW, DMI may be decreased from 1.55 to 
0.90% during the first wk after arrival to the feedlot and that depression in DMI can last 
up to 28 d post arrival.  In our study, exposure to steers PI with BVDV decreased DMI as
a % of BW during the first 7 d of the experiment compared with animals not exposed to 
BVD (1.67 vs. 1.99%). 
In the present experiment, steers that were either exposed to animals PI with 
BVDV or challenged with M. haemolytica had a negative G:F during d -3 to 4.  This 
might suggest that energy and protein intake during this period was utilized for metabolic 
priorities other than growth (e.g., in support of the immune response).  Haptoglobin 
synthesis by the liver and the anorexia cascade are stimulated by activated cells of the 
immune system.  Klasing (1998) demonstrated a switch in amino acid utilization from 
growth to production of acute phase proteins following an immune challenge in chicks.  
The synthesis of acute proteins by the liver in response to an immune challenge could 
change the amino acid requirements as well as energy required for maintenance in 
support of the acute phase response.  In the absence of stress or infections, animals will 
assimilate nutrients into tissues according to their genetic potential ad ccording to age 
and stage of production (Klassing et al, 1987; Elsasser, 1993).  However, during 
infection, there is an increase in protein turnover (Jepson et al., 1986) due to anorexia 
induced by cytokine production in response to the pathogen (Klassing, 1998b; Johnson, 
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1997), increased amino acid requirements for acute phase protein synthesis by the liver
(Reeds and Jahoor, 2001), and increased mobilization of protein stores from muscle 
either by decreased synthesis or increased catabolism (Ling et al, 1997) providing energy 
precursors for gluconeogenesis or amino acids for protein synthesis by the liver (Espat et 
al., 1994).  As a result of these changes in protein metabolism and or turnover, animals 
can experience a negative N balance (Ling et al., 1997) reflected in decreas d growth (Le 
Floc’h et al., 2004).  Although the most recent edition of the NRC for Beef Cattle (1996) 
reports that there are no differences in protein requirements in stressed vs. non-stressed 
calves, recent evidence suggests that different stressors (and disease) can affect the 
metabolism of dietary protein that could lead to increased protein requirements and 
increased requirements for specific amino acids (Gilliam et al., 2008; Wagoner et al., 
2008).  Cole et al. (1986) conducted a series of experiments to evaluate N metabolism in 
calves challenged with either bovine adenovirus-3 (PI-3) or infectious bovine 
rhinotracheitis (IBR).  Cole et al. (1986) reported that during the first 7 d after inoculation 
with IBR, calves that developed a febrile response had lower N digestion and N balance 
that non-febrile calves that were also challenged.  In the present experiment, we 
measured N balance during the acute phase and long-term effects in steers chall nged 
with two of the most common pathogens isolated in BRD cases.  Our results indicate 
decreased N digestibility during the wk of the challenge for calves exposed to BVDV.  In 
addition, N retained tended to be decreased by exposure to steers PI with BVDV during 
the wk of exposure and was decreased prior to harvest.  Prior to harvest, N retained (g/d) 
tended to be lower for steers exposed to steers PI with BVDV and challenged with M. 
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haemolytica.  Our results suggest that acute exposure to BRD pathogens has the potential 
to have long-term effects on N retained. 
Recently, Gilliam et al. (2008) reported N balance of steers with or without 
supplementation of branched-chain amino acids following (d 2 to 7) a bacterial 
lipopolysaccharide (LPS) intravenous challenge.  In their study, there was a lower N 
retention by steers when LPS was administered, and these differences were due to lower 
N intake and increased urinary N excretion.  In our experiment, total urinary N excretion 
tended to be greater for animals in the MH group during the first 4 d post M. haemolytica 
challenge.  Our results due to M. haemolytica challenge are also in agreement with 
Waggoner et al. (2008) where animals were challenged with LPS, and Cole et al. (1986) 
who challenged with IBR virus.  Cole et al. (1986) reported that in animals challenged 
with IBR, only animals that developed a rectal temperature of > 39.7oC had increased 
urinary N excretion for the first 3 d after IBR challenge.  Consistent with Cole et al. 
(1986), rectal temperatures were greater for steers challenged with M. haemolytica from 2 
to 24 h, reaching a maximum of 41.5oC 6 h after the M. haemolytica challenge (Burciaga-
Robles et al., 2009).  During the subsequent wk (d 7 to 11) results were reversed 
suggesting a potential compensatory mechanism for urinary N output. 
Gilliam et al. (2008) reported a decrease in DMI and fecal N output during the 
first 6 d after LPS challenge.  Our results are in agreement with Gilliam et al. (2008); M. 
haemolytica challenge decreased fecal N output but had no effect on DM digestibility.  
However, exposure to steers PI with BVDV decreased apparent DM and N digestibility 
during the wk of exposure in the present experiment.  In addition to being associated with 
BRD, BVDV can also affect other organs in the body, including the digestive tract 
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(Radostits et al., 2007).  For longer-term effects (>7 d) of either LPS (Gilliam et al., 
2008) or MH and BVD effects on N retention, no previous reports were found in the 
literature.   
Although our results suggest long-term effects of BVD type 1b on N retention and 
performance, exposure to steers PI with BVDV and challenge with M. haemolytica did 
not affect carcass characteristics in the present experiment.  Roeber et al. (2001) reported 
that animals requiring only one antimicrobial treatment (exhibiting clinical signs of BRD 
only once) during the finishing period had decreased performance during the first 56 d on 
feed, but compensated after that period of time and no differences in carcass quality were 
detected compared with animals that required at least two antimicrobial treatments for the 
disease.  In the present experiment, our challenge model was administered only once, and 
carcass quality was not affected.  However, differences in carcass merit are d fficult to 
detect with small numbers of animals. 
Although reports in the literature exist showing effects that anabolic implants 
(Hutcheson et al., 1997), postruminal carbohydrate load (McLeod et al., 2007), different 
winter grazing strategies (Hersom et al., 2004), protein levels (Baldwin et al., 2000), and 
mineral content of the diet (Soto-Navarro et al., 2004) have on visceral organ mass, to our 
knowledge this is the first attempt made to characterize the long-term effects o  BVDV 
and M. haemolytica on the mass of splanchnic tissues.  Hersom et al. (2004) observed 
differences in several components of the GIT due to different grazing strategies during 
the growing phase.  In addition, Sainz and Bentley (1997) reported differences in visceral 
organ mass attributed to the utilization of different levels of concentrate or forage in 
diets.  In the present study, no differences in splanchnic organ mass were detect  
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suggesting organ mass may be more influenced by diet than disease.  Gardner et al. 
(1999) and Thompson et al. (2007) reported a decreased HCW in animals affected by 
BRD.  In our experiment, although HCW was not affected by the experimental 
treatments, when HCW was expressed as a percentage of EBW, M. haemolytica 
decreased and M. haemolytica plus exposure to steers PI with BVDV tended to decrease 
the proportion of carcass and increase the proportion of total offal relative to EBW, 
suggesting BRD pathogens might result in nutrient partitioning towards non-edible 
tissues. 
Conclusion 
In the present experiment, we observed decreased performance during the first 7 d
of the experiment due to M. haemolyica challenge, and a tendency for decreased 
performance across the entire feeding period in animals exposed for 72 h to steers PI with 
BVDV.  In addition, we observed decreased N retention across the feeding period in 
steers exposed to BVDV and challenged with M. haemolyica.  Our results suggest that 
acute exposure to pathogens associated with BRD can have long-term effects on 
performance of feedlot cattle. 
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ucts, New Orleans, LA. 
2Elanco Animal Health, Indianapolis, IN. 
3All values are from laboratory analyses and are presented on a 100% DM basis (except
DM).
Table 1. Composition of diets (DM basis) 
 Adaptation diets  







Corn dent 46.6 55.1 63.1 69.9 
Dried corn distillers 
grain 
9.0 11.5 14.0 15.7 
Alfalfa hay 40.0 28.0 16.0 6.00 
Synergy 19-141 1.00 2.00 3.50 5.00 
Wheat midds 1.12 1.12 1.12 1.12 
Limestone, 38% 1.27 1.27 1.27 1.22 
Dicalcium phosphate 0.25 0.25 0.25 0.25 
Salt 0.33 0.33 0.33 0.33 
Manganous oxide 0.003 0.003 0.003 0.003 
Zinc sulfate 0.020 0.020 0.020 0.004 
Potassium chloride 0.260 0.260 0.260 0.260 
Magnesium oxide 0.110 0.110 0.110 0.110 
Vitamin A-3,000 0.003 0.003 0.003 0.003 
Vitamin E-50% 0.002 0.002 0.002 0.002 
Rumensin 802 0.018 0.018 0.018 0.018 
Tylan 402 0.010 0.010 0.010 0.010 
     
Nutrient, % DM 
basis3 
    
  DM, % 89.3 88.6 87.7 86.9 
NEm, Mcal/kg 1.79 1.85 2.05 2.16 
NEg, Mcal/kg 1.12 1.22 1.33 1.42 
NDF, % 26.5 23.0 19.4 16.3 
Crude fat, % 3.89 4.52 5.25 5.88 
Crude protein, % 14.8 14.4 14.2 14.0 
Ca, % 1.05 1.02 0.85 0.70 
P, % 0.38 0.39 0.41 0.43 
K, % 1.10 1.07 0.91 0.67 
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Table 2. Effects of short term PI BVDV exposure and/or M. haemolytica intractracheal challenge on performance during the finishing 
period in beef steers. 
 No BVD BVD  
Item No MH MH No MH MH SEM BVD 
BW, kg       
d -3 303 307 307 305 20.8 0.88 
d 4 313 302 307 302 26.8 0.72 
d 14 316 312 314 305 28.4 0.63 
d 28 349 346 346 344 28.9 0.82 
d 56 408 407 410 401 34.8 0.85 
d 84 474 470 466 461 39.6 0.52 
Final1 527 528 527 511 16.8 0.43 
ADG, kg       
d -3 to 4 1.41 -0.61 -0.01 -0.34 0.97 0.30 
d 5 to 14 0.33 0.96 0.60 0.31 0.33 0.57 
d 15 to 28 2.36 2.39 2.29 2.79 0.40 0.68 
d 28 to 56 2.10 2.17 2.31 2.00 0.26 0.89 
d 56 to 84 2.31 2.25 1.99 2.15 0.23 0.30 
d 84 to finish 1.42 1.60 1.67 1.38 0.43 0.94 
d -3 to finish1 1.84 1.82 1.74 1.64 0.08 0.09 
DMI, kg/d       
d -3 to 4 5.78 6.46 5.73 4.77 1.26 0.08 
d 5 to 14 6.31 6.84 7.60 6.44 1.02 0.42 
d 15 to 28 8.30 8.49 9.20 8.38 0.84 0.50 
d 28 to 56 9.27 9.52 9.98 9.45 1.07 0.57 
d 56 to 84 10.0 10.4 10.5 9.63 0.82 0.78 
d 84 to finish 10.8 10.7 11.2 9.64 0.51 0.50 
d -3 to finish1 9.25 9.66 9.90 8.85 0.72 0.84 
DMI, %BW       
d -3 to 4 1.87 2.12 1.83 1.52 0.28 0.05 
d 5 to 14 1.94 2.16 2.23 1.92 0.17 0.82 
d 15 to 28 2.57 2.66 2.86 2.66 0.15 0.36 
d 28 to 56 2.44 2.52 2.64 2.52 0.12 0.45 
d 56 to 84 2.28 2.37 2.40 2.23 0.10 0.90 
d 84 to finish 2.18 2.16 2.28 1.99 0.09 0.69 
d -3 to finish1 2.45 2.58 2.64 2.40 0.10 0.97 
Gain:Feed, kg/kg       
d -3 to 4 0.243 -0.009 -0.001 -0.071 0.022 0.08 
d 5 to 14 0.052 0.140 0.078 0.048 0.052 0.49 
d 15 to 28 0.284 0.281 0.248 0.332 0.044 0.75 
d 28 to 56 0.227 0.231 0.235 0.216 0.017 0.82 
d 56 to 84 0.229 0.217 0.188 0.223 0.016 0.30 
d 84 to finish 0.135 0.151 0.149 0.142 0.044 0.90 
d -3 to finish1 0.201 0.190 0.176 0.187 0.013 0.04 




Table 3. Effects of short term PI BVDV exposure and/or M. haemolytica intractracheal 
challenge on DMI, DM digestibility, nitrogen digestibility, and total nitrogen retained in 
beef steers 





MH SEM BVD MH BVD*MH  
Wk 1 (d 1 to 4)         
DMI, kg 7.05 6.60 6.70 5.22 1.57 0.12 0.09 0.35 
Fecal DM 
output, kg 




















N intake, g 166 155 157 122 36.9 0.12 0.09 0.35 
Fecal N 
output, g 






















63.7 75.5 63.1 70.3 8.99 0.59 0.09 0.68 
Total N 
output, g 
83.0 98.7 89.1 90.3 9.78 0.44 0.32 0.44 
N retained, g 76.9 56.5 57.9 32.6 28.5 0.11 0.09 0.85 
N retained, % 
NI 
45.4 34.5 40.9 5.75 16.5 0.07 0.01 0.18 
Wk 2 (d 7 to 
11) 
        
DMI, kg 6.49 6.91 8.03 6.67 1.22 0.25 0.41 0.12 
Fecal DM 
output, kg 




















N intake, g 145 154 180 149 27.4 0.25 0.41 0.12 
Fecal N 
output, g 






















60.2 58.4 75.6 57.9 10.5 0.09 0.03 0.07 
Total N 
output, g 
81.7 86.8 101 83.0 19.7 0.27 0.36 0.11 
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N retained, g 51.7 59.5 78.0 66.5 16.9 0.16 0.87 0.40 
N retained, % 
of NI 
38.8 38.8 43.7 42.6 3.63 0.22 0.87 0.87 
Wk 4 (d 28 to 
32) 
        
DMI, kg 8.47 8.48 8.98 8.69 0.73 0.61 0.84 0.82 
Fecal DM 
output, kg 




















N intake, g 189 190 201 194 16.3 0.61 0.84 0.82 
Fecal N 
output, g 






















90.8 105 94.4 83.4 18.0 0.77 0.16 0.06 
Total N 
output, g 
124 127 141 116 23.4 0.70 0.18 0.08 
N retained, g 65.3 62.3 59.5 78.1 19.1 0.75 0.63 0.50 
N retained, % 
of NI 
33.3 30.4 27.5 39.9 10.0 0.76 0.45 0.23 
Pre-harvest1         
DMI, kg 9.51a 11.0b 10.3b 9.08a 0.64 0.38 0.88 0.02 
Fecal DM 
output, kg 




















N intake, g 213a 246b 232b 203a 14.4 0.38 0.88 0.02 
Fecal N 
output, g 






















102 101 131 110 23.4 0.14 0.39 0.42 
Total N 
output, g 
137 136 171 147 29.5 0.11 0.38 0.42 
N retained, g 76.6 109 72.6 65.0 32.8 0.05 0.29 0.10 
N retained, % 
of NI 
33.5 45.0 30.3 31.3 13.4 0.09 0.21 0.29 
a,bWithin a row means with different superscripts are different (P < 0.05).
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Table 4. Effects of short-term PI BVDV exposure and/or M. haemolytica intractracheal 
challenge on carcass characteristics of finishing steers 





MH SEM BVD MH BVD*MH  
HCW, kg 330 329 328 317 8.08 0.37 0.40 0.49 
Dress, % 62.9 62.5 62.6 62.5 1.08 0.78 0.59 0.78 
LM area, cm2 13.3 12.7 13.0 12.6 0.82 0.57 0.21 0.82 
12th-rib fat, cm 0.51 0.55 0.53 0.50 0.03 0.67 0.91 0.29 
KPH, % 1.91 2.08 2.25 1.91 0.20 0.68 0.68 0.23 
Marbling score 403 440 495 420 55.7 0.36 0.62 0.16 
Preliminary yield 
grade 
2.93 3.25 2.96 3.06 0.12 0.56 0.11 0.40 
Calculated yield 
grade 
2.63 2.98 2.83 2.73 0.27 0.85 0.41 0.16 
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Table 5. Effects of short-term PI BVDV exposure and/or M. haemolytica intratracheal 
challenge on organ mass of beef steers 





MH SEM BVD MH BVD*MH  
Empty body weight 
(EBW), kg 
470 478 472 458 10.9 0.38 0.76 0.26 
HCW, kg 330 329 328 317 8.08 0.37 0.40 0.49 
HCW, % of EBW 70.1 68.4 69.3 69.1 0.37 0.87 0.02 0.09 
Total offal, kg 140a 151b 145a 142a 3.90 0.45 0.29 0.05 
Total offal, % of 
EBW 
29.9 31.6 30.7 30.9 0.37 0.87 0.02 0.09 
Blood, kg 14.8 18.9 15.3 16.3 1.27 0.44 0.06 0.26 
Blood, % of EBW 3.13 3.95 3.23 3.55 0.29 0.59 0.05 0.64 
Head, kg 15.6 16.3 15.4 15.1 0.39 0.06 0.63 0.21 
Head, % of EBW 3.33 3.40 3.25 3.29 0.06 0.18 0.40 0.82 
Hide, kg 39.9 40.9 39.9 38.5 0.93 0.22 0.84 0.19 
Hide, % of EBW 8.47 8.52 8.43 8.41 0.17 0.66 0.93 0.82 
Feet, legs, and tail, kg 12.3 13.0 11.7 11.9 0.30 0.009 0.17 0.44 
Feet, legs, and tail, % 
of EBW 
2.62 2.72 2.47 2.59 0.09 0.03 0.08 0.85 
Esophagus, kg 0.32 0.35 0.33 0.36 0.02 0.72 0.32 0.87 
Esophagus, % of 
EBW 
0.06 0.07 0.07 0.07 0.005 0.63 0.30 0.77 
Reticulo-rumen, kg 10.3 11.0 11.0 11.7 0.79 0.27 0.29 0.95 
Reticulo-rumen, % of 
EBW 
2.19 2.29 2.33 2.57 0.15 0.19 0.27 0.64 
Omasum, kg 3.37 3.10 3.30 2.72 0.34 0.52 0.23 0.65 
Omasum, % of EBW 0.71 0.64 0.69 0.58 0.06 0.55 0.21 0.80 
Abomasum, kg 1.42 1.33 1.34 1.45 0.08 0.82 0.89 0.26 
Abomasum, % of 
EBW 
0.30 0.27 0.28 0.31 0.01 0.64 0.82 0.12 
Small intestine, kg 5.05 4.97 4.91 4.65 0.30 0.45 0.57 0.76 
Small intestine, % of 
EBW 
1.07 1.03 1.03 1.00 0.05 0.56 0.56 0.96 
Cecum/large 
intestine, kg 
5.02 5.16 5.10 4.56 0.42 0.54 0.64 0.43 
Cecum/large 
intestine, % of EBW 
1.06 1.07 1.07 0.98 0.08 0.67 0.64 0.52 
Mesenteric/omental 
fat, kg 
16.7 16.8 18.3 16.2 1.00 0.58 0.32 0.29 
Mesenteric/omental 
fat, % of EBW 
3.54 3.51 3.87 3.52 0.19 0.39 0.34 0.43 
Pancreas, kg 0.51 0.56 0.52 0.51 0.07 0.74 0.64 0.57 
Pancreas, % of EBW 0.10 0.11 0.11 0.11 0.01 0.92 0.56 0.76 
 112
Spleen, kg 0.94 1.18 1.13 1.23 0.12 0.36 0.21 0.58 
Spleen, % of EBW 0.20 0.24 0.23 0.26 0.02 0.29 0.17 0.68 
Liver, kg 6.74 6.65 6.64 6.47 0.27 0.57 0.60 0.89 
Liver, % of EBW 1.43 1.38 1.40 1.40 0.04 0.89 0.61 0.54 
Lungs/heart, kg 8.23 8.09 8.01 8.30 0.32 0.99 0.80 0.52 
Lungs/heart, % of 
EBW 
1.74 1.68 1.69 1.80 0.05 0.56 0.61 0.13 
Kidneys, kg 1.62 2.09 1.90 1.42 0.45 0.47 0.97 0.10 
Kidneys, % of EBW 0.37 0.43 0.44 0.33 0.09 0.74 0.69 0.18 



























EFFECTS OF SHORT-TERM FOOD DEPRIVATION AND INTRATRACHEAL 
CHALLENGE WITH MANNHEIMIA HEMOLYTICA ON BLOOD FLOW AND 
NET PORTAL AND HEPATIC FLUX OF AMINO ACIDS DURING AN ACUTE 
PHASE IMMUNE RESPONSE IN THE BOVINE 
Abstract   
Respiratory disease is the most common disease in bovine. During an immune response, 
cytokines induce protein catabolism and amino acids (AA) are used for the acute phase 
response. Our objective was to evaluate blood flow and net splanchnic flux of AA during 
a bovine respiratory disease (BRD) challenge. Twenty two castrated mals with chronic 
indwelling catheters were used. Treatments included: 1) fed ad libitum and not 
challenged (FED/CON); 2) fed ad libitum and intratracheally challenged with 6 × 109 
CFU/mL of Mannheimia hemolytica (FED/CH); 3) deprived of feed for 14 h and not 
challenged (FAST/CON); and 4) deprived of feed for 14 h and intratracheally challenged 
with 6 × 109 CFU/mL of M. hemolytica (FAST/CH). Arterial, portal, and hepatic blood 
samples were simultaneously drawn at 1.5 h intervals on the d of challenge. By design,
FAST had lower intake than FED, and FED/CH had lower intake than FED/CON (diet × 
disease, P = 0.003). Tumor necrosis factor-α and interleukin-1β increased across time and 
were greater for CH than CON (disease × h, P < 0.0002). Arterial concentrations of 
BCAA, essential AA (EAA), and total AA (TAA) were decreased (P < 0.03) in CH
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compared with CON. Feed deprivation decreased (P < 0.04) net flux of EAA, non-EAA, 
and TAA across the PDV. Net removal of EAA, non-EAA, and TAA by the liver was 
greater (P < 0.02) for CH compared with CON. BRD results in greater removal of AA by 






















 Bovine respiratory disease (BRD)8 involves the complex interaction between stress, 
bacteria, viruses, and the environment (1).  Economic losses have been associated with 
direct costs due to BRD treatment, but also due to indirect costs associated with 
decreased animal growth (2,3).  During the acute phase of bacterial infection, decreased 
growth rates have been observed in chicks (4), pigs (5) and cattle (6).  Decreased gowth 
rates can be attributed to activation of the immune system with an associated decrease in 
intake (6,7) and increase in cytokine concentration (8), which can redirect nutrient se 
away from growth towards mounting an adequate immune response (9,10).  Immune 
response may result in increased nutrient requirements for animals infected with virulent 
pathogens, which results in decreased animal growth compared with animals not infected 
(11).   
 Differences in plasma amino acid (AA) composition due to lipopolysaccharide (LPS) 
challenge in the castrated male bovine (i.e., steers) have been reported (12) even though 
the magnitude of the response to an LPS challenge has been suggested to be of smallr 
duration and magnitude compared to a true pathogen infection (11).  During the acute 
phase response to a pathogen, animals produce significant amounts of nitrogenous 
compounds (e.g., acute phase proteins, antibodies, cytokines) and develop specific 
immune cells that can redirect nutrients in support of the immune response (10,11).  In 
addition to the induced anorexia, hyperthermia, and increased acute phase protein 
synthesis by the liver, cytokines induce muscle protein catabolism and AA are used for 
gluoconeogenesis and immune cell proliferation (13).  However, little is known about 
how net flux of AA and other nutrients by the portal-drained viscera (PDV) and liver 
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might be altered due to inflammation and immune response.  Better knowledge of net 
nutrient flux and requirements during an immune challenge could help in the 
development of feeding and management strategies to preserve both body growth and 
defenses in stressed animals.  The objective of this experiment was to determine blood 
flow, oxygen consumption, and net flux of AA across the PDV and liver in the bovine fed 
or deprived of feed for 14 h prior to an intratracheal challenge with Mannheimia 
hemolytica.  
Materials and Methods 
Animals.  All procedures were approved by the Oklahoma State University Institutional 
Animal Care and Use Committee.  Twenty two castrated male calves (initial body weight 
= 320 ± 24 kg) were equipped with chronic indwelling catheters to measure blood flow 
and net nutrient flux across the PDV and liver.  Catheters were surgically placed in the 
portal vein, a hepatic vein, a mesenteric vein, and an adjacent mesenteric artery (14).  
Catheter patency was maintained by filling catheters with a 1,000 U/mL heparinized-
saline solution prior to the start of the experiment and with a 100 U/mL heparinized-
saline solution between sampling periods.  Animals were allowed a minimum of 14 d to 
recover from surgery before beginning the initial collection period.  Animals were
individually housed at the Oklahoma State University Nutrition Physiology Research 
Center, Stillwater. 
Treatments.  Prior to the experiment, all animals were determined to be sero-negative to 
M. haemolytica and were considered clinically healthy.  Animals were randomly 
allocated to 1 of 4 treatments arranged as a 2 × 2 factorial: 1) ad libitum feeding and not 
challenged with M. haemolytica (FED/CON); 2) ad libitum feeding and intratracheally 
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challenged with M. haemolytica (FED/CH); 3) 14-h feed deprivation and not challenged 
(FAST/CON); 4) 14-h feed deprivation and intratracheally challenged with M. 
haemolytica (FAST/CH).  Six animals/treatment were used for the experiment.  To 
facilitate intensive blood collections, sampling occurred during two sampling periods 
spaced 18 d apart.  Two animals from the FED/CON group in the first sampling period 
were randomly allocated to treatment in the second period.  Feed deprivation for the 
FAST groups occurred beginning 14 h (feed removed at 1700 on d 0) prior to the 
challenge with M. haemolytica (0700 on d 1) and continued throughout the sampling 
period.  Animals were challenged with M. haemolytica using the same protocol as 
described (8).  Briefly, animals challenged with M. haemolytica received 10 mL of a 
solution containing 6 × 109 CFU of M. haemolytica serotype 1, which was reconstituted 
and grown prior to the challenge (15).  Animals not challenged with M. aemolytica were 
intratracheally dosed with 10 mL of a sterile phosphate-buffered saline solution.  Pr r to 
the start of the experiment (14-d diet adaptation period for FED and FAST) and during 
the sampling period (FED), animals received a pelleted diet formulated to mee or exceed 
their nutritional requirements (16; Table 1).  During periods of feeding, animals were fed 
twice daily at 0800 and 1700 throughout the experiment. 
Sample Collection.  Calves were placed in metabolism stanchions in a climate-controlled 
room (23 to 27°C) 24 h before the initiation of the blood collection period.  Rectal 
temperatures were recorded using a digital thermometer (GLA M-500; GLA Agricultural 
Electronics, San Luis Obispo, CA) prior to M. haemolytica challenge and at 3, 6, 12, 18, 
and 24 h after the bacterial challenge.  At 0600 on the morning of M. haemolytica 
challenge and blood sampling, a priming dose of 20 mL of 10% (wt/vol) para-
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aminohippurate (pH = 7.4) was administered through a 0.45 µm sterile filter (Millipore, 
Bedford, MA) into the mesenteric vein catheter.  Para-aminohippurate was continuously 
infused (PHD 2000 Syringe pump; Harvard Apparatus Inc., Holliston, MA) at 0.7 
mL/min for 10 h following the priming dose.  Blood was collected 1 h prior to the M. 
haemolytica challenge (0700), and continued every 1.5 h from 0830 until 1600 (total of 7 
samples).  At every sampling time, 30 mL of blood were simultaneously drawn from the 
portal vein, hepatic vein, and mesenteric artery catheters into syringes, and blood was 
placed into tubes (Becton Dickinson Vacutainer Systems, Franklin Lakes, NJ) for plasma 
and serum harvest.  Blood samples were immediately capped and placed on ice for 
transport to the laboratory.  Immediately after collection, 90 µL of arteri l, portal and 
hepatic whole blood samples were analyzed for blood gasses using a blood gas analyzer 
(1304 pH/Blood Gas Analyzer, Instrumentation Laboratory, Lexington, MA).  An 
additional 40 µL of whole blood was used to determine packed cell volume.  Remaining 
blood was centrifuged (3,000 × g, 4°C, 20 min) and plasma and serum harvested and 
frozen (−40°C) for further analysis.  
Cytokines.  Arterial serum samples collected at -0.5, 1.0, 2.5, 4.0, 5.5, 7.0, 8.5, and 24 h 
of the M. haemolytica challenge were analyzed in duplicate for bovine specific tumor 
necrosis factor-alpha (TNFα; R&D Minneapolis, MN), interleukin-1 beta (IL-1β; Pierce 
Protein Research Products, Thermo Fischer Scientific, Rockford, IL) and interleukin-6 
(IL-6; Pierce Protein Research Products, Thermo Fischer Scientific) as previously 
described (8). The inter-assay coefficient of variation was below 10% and duplicates with 
a coefficient of variation greater than 7.5% were re-analyzed. 
Serum Haptoglobin.  Haptoglobin concentrations in arterial, portal and hepatic serum 
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samples collected at -0.5, 1.0, 2.5, 4.0, 5.5, 7.0, 8.5, and 24 h of the M. haemolytica 
challenge were analyzed in duplicate using a Bovine Haptoglobin ELISA kit 
(Immunology Consultants Lab, Portland OR) as previously described (8).  The intra- and 
inter-assay coefficients of variation were below 7.5%.   
Plasma Metabolites and Para-Aminohippurate Determinations.  Arterial, portal, and 
hepatic plasma samples collected at -0.5, 1.0, 2.5, 4.0, 5.5, 7.0, and 8.5 h of the M. 
haemolytica challenge were analyzed for para-aminohippurate and metabolite 
concentrations.  Plasma para-aminohippurate concentrations were determined 
colorimetrically (17).  Commercially available kits were used for the colorimetric 
determination of plasma urea nitrogen (Urea Nitrogen Reagent, Teco Diagnostic, 
Anaheim, CA), ammonia (Ammonia Reagent Set, Pointe Scientific) and total protein 
(arterial blood samples only; Total Protein [Biuret] Reagent Set, Pointe Scientifi ) 
concentrations.  Microplates (Beckman Coulter, Fullerton, CA) were used for all 
analyses, and absorbance was measured according to manufacturer recommendations for 
each metabolite using a plate reader (Multiskan Spectrum; Thermo Scientific, Waltham, 
MA).  Intra- and inter-assay coefficients of variation for each metabolite wer  kept below 
5 and 7.5%, respectively.  
 Free plasma AA were determined via GLC using a commercially available kit 
(EZ:FAAST #KGO-7165; Phenomenex, Torrance, CA).  The kit supplied all necessary 
reagents for solid phase extraction and derivatization as described (12).  Briefly, 100 µL 
of plasma were derivatized following the manufacturer’s procedures and reagents.  After 
a 2 min incubation period, the organic layer was aspirated from the aqueous layer and an 
aliquot was placed into a glass scintillation vial and analyzed for AA on a gas 
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chromatograph (Varian CP-3800, Varian, Walnut Creek, CA) using a split injection 
protocol (2 µL of sample at 250°C) with helium (1.5 mL/min) as the carrier gas.  Intra-
and inter-assay coefficients of variation for amino acid determination were less than 15%.   
Blood Flow and Net Nutrient Flux Calculations.  Calculations for blood oxygen 
concentrations and plasma flows through the portal and hepatic vein and net flux of 
nutrients across the PDV, hepatic, and total splanchnic vascular beds were calculated as 
previously described (18,19).  A positive net flux indicates a release or absorption of a 
nutrient, whereas a negative net flux represents uptake or utilization.  All animals were 
sampled for each treatment during the experiment (n = 6).  However, hepatic samples 
were not collected from 1 animal in the FED/CON and 1 animal in the FAST/CH 
treatment groups, and individual samples were periodically missed due to loss of catheter 
patency.  Therefore, PDV plus hepatic flux does not always equal total splanchnic flux.  
The hepatic extraction ratio (HER) was calculated using the formula: HER =(Fpv(Cpv – 
Chv) + Fa (Ca – Chv))/FpcCpv + FaCa, where Fpv is the portal plasma flow (L/h), Cpv, Chv 
and  Ca are the portal and hepatic vein, and arterial plasma concentrations of the 
metabolite, and Fa is the hepatic arterial plasma flow (20). 
 Aromatic AA were calculated as the sum of tyrosine, tryptophan and 
phenylalanine; BCAA as the sum of leucine, isoleucine and valine; gluconeogenic AA as 
the sum of alanine, glycine, glutamine, glutamic acid, serine, and threonine; sulfur 
containing AA as the sum of cysteine and methionine; essential AA (EAA) as thesum of 
histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, 
and valine; non-essential AA (NEAA) as the sum of alanine, asparagine, aspartic acid, 
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cysteine, glutamine, glutamic acid, glycine, hydroxyproline, proline, serine, and tyrosine; 
and total AA as the sum of all amino acids reported.  
Statistical Analysis 
Initial body weight and dry matter intake were analyzed using the Mixed Procedure 
(SAS, version 9.1; SAS Institute) with animal as the experimental unit.  Fixed effects 
included diet, disease and diet × disease; period was included as a random effect in the 
model.  Blood flow, rectal temperature, cytokine, haptoglobin and metabolite data were 
analyzed with a repeated measures analysis using a first order autoregressive covariance 
structure (SAS, version 9.1; SAS Institute). Animal was the experimental uni and the 
repeated measure statement was sampling time within animal.  Fixed effects were diet, 
disease, time, and all possible interactions, and period was included as a random effect.  




During the adaptation period, DMI expressed as kg/d (P > 0.21) or as a % of BW (P > 
0.13) did not differ among treatments (Table 2).  By design, FAST animals had lower (P 
< 0.0001) DMI than FED animals, and FED/CH animals had lower DMI than FED/CON 
animals (diet × disease, P = 0.003).  Rectal temperature was greater for CH than CON 
animals at 6, 12, 18, and 24 h post challenge regardless of diet (disease × h, P < 0.0001; 
Figure 1).  Serum haptoglobin concentration responded with a disease × h interaction (P 
< 0.0001; Figure 2).  Serum haptoglobin was similar among treatments across the 
sampling d, but was greater for CH animals compared with CON animals at 24 h post M. 
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haemolytica challenge.  Pre-challenge concentrations of TNF-α, IL-1β, and IL-6 were not 
different (P > 0.13) among treatments (Table 2).  However, change of TNF-α (disease × 
h, P = 0.0002; Figure 3a) and IL-1β (disease × h, P < 0.0001; Figure 3b) concentrations 
across time was greater for CH than CON animals.  Interleukin-6 responded with a die  × 
h interaction (P = 0.04; Figure 4).  Change of IL-6 concentration was greater at 5.5, 7.0, 
and 8.5 h post challenge in FED compared with FAST animals.  Change of IL-6 
concentration was also greater (P = 0.01) for CH compared with CON animals, and the 
magnitude of increase was greater for FED compared with FAST animals (diet × disease 
interaction, P = 0.04; Table 2). 
 There were no diet × disease × h interactions (P > 0.10) for arterial concentrations 
of metabolites (Table 3).  Concentration of oxygen in arterial blood was lower (P = 0.01) 
for CH compared with CON animals.  Ammonia concentration tended (P = 0.06) to 
respond with a diet × disease interaction.  Arterial ammonia was lower in FED/CH and 
FAST/CON animals than FED/CON and FAST/CH animals.  Arterial plasma 
concentrations of urea N, total protein, alanine, asparagine, cysteine, glycine, 
hydroxyproline, lysine, ornithine, phenylalanine, tryptophan, and glucogenic AA were 
not affected (P > 0.11) by treatment.  Arterial concentration of aspartic acid was lower (P 
= 0.007) in CH animals compared with CON animals, and tended (P = 0.06) to greater in 
FAST than in FED animals.  Arterial concentrations of glutamine (P = 0.01) and 
glutamic acid (P = 0.004) were greater in FAST compared with FED animals.  Challenge 
with M. haemolytica tended (P = 0.07) to decrease arterial concentration of histidine, and 
decreased arterial concentrations of isoleucine (P = 0.01), leucine (P = 0.02), methionine 
(P = 0.002), proline (P = 0.008), threonine (P = 0.05), and valine (P = 0.02).  In addition, 
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arterial concentration of BCAA (P = 0.01), sulfur-containing AA (P = 0.02), EAA (P = 
0.02), and total AA (P = 0.03) were decreased in CH compared with CON animals.  
Arterial concentration of serine was increased (P = 0.03), and concentrations of tyrosine 
(P = 0.10), aromatic (P = 0.09), and NEAA (P = 0.10) tended to be increased in FAST 
compared with FED animals. 
Animals challenged with M. haemolytica had greater (P = 0.01) arterial blood flow and 
tended (P = 0.06) to have greater hepatic blood flow than CON animals (Table 4).  In 
addition, portal (P = 0.08) and hepatic (P = 0.09) blood flow tended to be lower in FAST 
than FED animals.  Oxygen consumption by the PDV (P = 0.03), liver (tendency, P = 
0.06), and TST (P = 0.01) was lower in FAST compared with FED animals, and PDV 
oxygen consumption was increased (P = 0.03) in CH compared with CON animals. 
There were no effects (P > 0.14) of diet, disease, or diet × disease for net PDV, liver, or 
TST flux of ammonia or urea N (Table 4).  Net flux of haptoglobin across TST responded 
with a diet × disease interaction (P = 0.05).  Net removal of haptoglobin was greater for 
FED/CH and FAST/CON animals compared with FED/CON and FAST/CH animals.  
Net release of haptoglobin by liver and TST was observed for FAST/CH animals.  Net 
flux of alanine across the liver responded with a diet × disease interaction (P = 0.01).  
Increased removal of alanine by the liver was greater for FED/CH animals than for 
FAST/CH relative to FED/CON and FAST/CON, respectively.  Removal of alanine by 
TST (P < 0.03) and HER (P < 0.003) was greater for CH animals than CON animals.  
Similar to alanine, increased removal of asparagine by the liver tended to be greater for 
FED/CH animals than for FAST/CH relative to their respective controls (diet × disease 
interaction, P = 0.06).  Net TST flux of asparagine acid tended (P = 0.10) to be lower in 
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FAST compared with FED animals, and tended (P = 0.09) to be lower in CH compared 
with CON animals.  There was a diet × disease interaction (P = 0.006) for hepatic 
extraction ratio.  Hepatic extraction ratio increased when FED animals were challenged 
with M. haemolytica and decreased when FAST animals were challenged with M. 
haemolytica.  Net PDV release (P = 0.08) and liver removal (P = 0.04) of aspartic acid 
were lower for FAST compared with FED animals.  This resulted in a lower (P = 0.01) 
HER for aspartic acid in FAST compared with FED animals.  Net flux of cysteine across 
the PDV was lower (P = 0.01) in FAST compared with FED animals, and was lower (P = 
0.02) in CH animals compared with CON animals.  In addition, there was a net removal 
of cysteine by TST for CH animals, and a net release for CON animals (disease effect, P 
= 0.01).  Net PDV flux of glutamine responded with a diet × disease interaction (P = 
0.04).  Net PDV flux of glutamine was lower for FED/CH and FAST/CON animals 
compared with FED/CON and FAST/CH animals, respectively.  In addition, TST flux of 
glutamine was lower in FAST vs. fed animals (P = 0.005), and CH vs. CON animals (P = 
0.02).  Net PDV (P = 0.03) and TST (P = 0.01) flux of glutamate were lower and HER 
was greater (P = 0.004) for FAST compared with FED animals.  Net PDV release (P = 
0.02) and liver removal (P = 0.002) of glycine were lower in FAST compared with FED 
animals.  In addition, liver (P = 0.003) and TST (P < 0.0001) removal and HER (P = 
0.05) of glycine were greater for CH compared with CON animals.  Fasting increased 
removal of histidine by the PDV (P = 0.01) and TST (P = 0.05).  In addition, PDV flux of 
hydroxyproline was lower (P = 0.01) in FAST than in FED animals.  Challenge with M. 
haemolytica increased removal of hydroxylproline by the PDV (P = 0.01), liver (P = 
0.0001), and TST (P = 0.001), and increased the HER (P = 0.004).  Net PDV, liver or 
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TST flux of isoleucine was not affected (P > 0.10) by diet or disease.  However, HER of 
isoleucine was greater (P = 0.05) in CH compared with CON animals.  Net flux of 
leucine across the liver responded with a diet × disease interaction (P = 0.05).  Net 
removal of leucine was greater for FED/CH and FAST/CON animals compared with 
FED/CON and FAST/CH animals.  Fasting increased removal of lysine by the PDV (P = 
0.01) and TST (P = 0.03).  In addition, net removal of lysine by the liver (P = 0.02) and 
TST (P = 0.004) was greater for CH compared with CON animals.  A similar response 
was observed for ornithine, except ornithine flux across the liver was not affected (P = 
0.13) by disease.  Net PDV flux of phenylalanine was lower (P = 0.03) in FAST than in 
FED animals.  The magnitude of difference in removal of phenylalanine by the liver was 
greater for FED than FAST when animals were challenged with M. haemolytica (diet × 
disease interaction, P = 0.03).  Similarly, there was a greater removal of proline by the 
liver for FED than FAST animals when animals were challenged with M. aemolytica 
(diet × disease interaction, P = 0.007).  Removal of proline by TST (P = 0.006) and HER 
(P = 0.007) were greater in CH compared with CON animals.  Serine and threonine 
removal by the liver and removal of threonine by TST was greater (P < 0.05) in CH than 
in CON animals.  The PDV removed tryptophan (P = 0.01) and tyrosine (P = 0.01) in 
FAST compared with a net release in FED animals.  In addition, net removal of 
tryptophan (P = 0.003) and tyrosine (P = 0.03) by TST was observed in FAST vs. FED 
animals, and greater (P < 0.03) removal occurred in CH than in CON animals.  The 
increased HER was greater for FED compared with FAST when animals were challenged 
with M. haemolytica (diet × disease interaction, P = 0.007).  Removal of valine by the 
liver was increased (P = 0.04) in CH compared with CON animals. 
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There was a net removal of aromatic AA across the PDV in FAST animals compared 
with a net release in FED animals (P = 0.006; Table 4).  In addition, removal of aromatic 
AA by the liver and TST was greater (P = 0.02) for CH than for CON animals.  Net liver 
removal of aromatic AA was greater at 7.0 and 8.5 post M. haemolytica challenge for CH 
vs. CON animals (disease × h interaction, P = 0.02; Figure 5a).  The magnitude of the 
increase in HER of aromatic AA was greater for FED than for FAST animals when 
animals were challenged with M. haemolytica (diet × disease interaction, P = 0.04; Table 
4).  There was a tendency (P = 0.06) for the liver to remove a greater amount of BCAA in 
CH compared with CON animals.  Net liver removal of BCAA was greater at 2.5 post M. 
haemolytica challenge for CH vs. CON animals (disease × h interaction, P = 0.05; Figure 
5b).  Net PDV flux of glucogenic AA was lower (P = 0.03) in FAST than FED animals 
(Table 4).  In addition, the magnitude of the increase in removal of glucogenic AA by the
liver was greater for FED than for FAST animals when animals were challenged with M. 
haemolytica (diet × disease interaction, P = 0.01).  Net liver removal of glucogenic AA 
was greater at 2.5, 7.0, and 8.5 post M. haemolytica challenge for CH vs. CON animals 
(disease × h interaction, P = 0.01; Figure 5c).  Total splanchnic tissues removed 
glucogenic AA in CH animals and released glucogenic AA in CON animals (P = 0.003; 
Table 4).  Net PDV flux of sulfur containing AA was decreased (P = 0.02) in FAST 
compared with FED animals, and was lower (P = 0.04) in CH compared with CON 
animals.  Feed deprivation decreased (P < 0.04) net flux of EAA, NEAA, and total AA 
across the PDV and TST.  In addition, net removal of EAA, NEAA, and total AA by the 
liver and TST was greater (P < 0.02) for CH compared with CON animals.  Disease × h 
interactions for net liver flux of NEAA, EAA, and total AA are shown in Figure 6a, b, 
 127
and c, respectively. 
Discussion 
Similar to other animal models, decreased intake can be anticipated for morbid/stressed 
calves (16,21). Decreased intake can occur for 2 or more wk, and therefore nutrient 
intake during this period might be limiting to achieve adequate immune function and/or 
maximum growth potential (22).  In the present experiment, we deprived animals of feed 
for 14 h prior to and during the M. haemolytica challenge in order to compare potential 
effects of feed deprivation and bacterial challenge on net nutrient flux.  The M. 
haemolytica challenge in FED animals decreased intake compared with CON animals, in 
agreement with previous data (16,21).   
During the acute phase response to a pathogen, cytokines are produced by cells of the 
immune system (23).  The increase in cytokines has been associated with decreased 
intake (9), consistent with the present experiment.  In addition, IL-1β increased 30-fold 
over pre-challenge concentrations in animals challenged with M. haemolytica in the 
present study, which was associated with increased rectal temperature for at least 24 h 
post M. haemolytica challenge.  Rectal temperature response in animals challenged with 
LPS has responded similarly, but for a shorter duration (12,24).  Increased body 
temperature during a febrile process in humans and rats has been reported to increase
metabolic rate by 13% for every 1oC increase in body temperature (25).  Therefore, the 
magnitude and duration of the increase in rectal temperature might impact maintenance 
requirements in morbid animals due to the increased energy cost for this metabolic 
process.   
Cytokines induce a shift in the partitioning of dietary nutrients away from tissue accretion 
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towards support of the immune system (26).  This change in metabolism of nutrients, 
including increased lipolysis and protein catabolism (23), results in decreased growth and 
feed utilization as a consequence of disease.  This systemic response has been associated 
with hypermetabolism and increased energy expenditure in humans (27) and activation of 
peripheral protein catabolism and increased metabolic activity in splanchnic tissues (28).  
The increased protein catabolism in peripheral tissues results in increased availability of 
free AA for acute phase protein synthesis and gluconeogenesis in the liver (29).  
Haptoglobin is an acute phase protein synthesized in the liver that has been reported to 
have antibacterial, anti-inflammatory functions during immunological stress (30).  In 
cattle, haptoglobin has been evaluated as a predictor of BRD (31) and correlated with the 
number of antimicrobial treatments for BRD (32,33,34).  In the present experiment, an 
increase in arterial serum haptoglobin concentrations due to challenge with M. 
haemolytica was observed, although the increase was not measured until 24 h post M. 
haemolytica challenge.  These data are in agreement with previous studies utilizing M. 
haemolytica challenge to study the immune response in cattle (8).  During the first 6 h 
after M. haemolytica challenge there was no increase in liver flux of haptoglobin in the 
present experiment.  However, other acute phase proteins can be increased prior to 
haptoglobin (35) which were not measured in the present study. 
Although several studies have addressed changes in blood flow and net PDV flux of AA 
in cattle due to different dietary sources and management strategies (36,37,38,39), to our 
knowledge, this is the first experiment to measure changes in PDV and liver flux of AA 
in healthy animals challenged with a BRD pathogen in fed and feed deprived animals.  In 
growing and lactating animals, the splanchnic bed provides the majority of nutrients 
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required for growth and milk synthesis (36).  Therefore, any change in the meabolic 
status of the animal that affects intake or alters metabolism by splanchnic tissues can 
have a detrimental effect on growth and lactation of food producing animals.  In Holstein 
calves, feed deprivation decreased portal blood flow when animals were fasted for 36 h 
(37).  In addition, in lactating and non-lactating cows, portal blood flow was lower in 
feed deprived animals 2 d after feed deprivation occurred, and continued for 6 d, which 
was the end of the fasting period (36).  Hepatic blood flow decreased 2 d after feed 
deprivation occurred in lactating animals, but remained unchanged in non-lactating ows 
(36).  In the present experiment, feed deprivation tended to decrease portal blood flow 
compared with fed animals, in agreement with previous results (36,37). 
No previous experiments have evaluated the effect of M. haemolytica challenge on blood 
flow across the PDV and liver in cattle.  In the present experiment, animals challenged 
with M. haemolytica had increased arterial blood flow and tended to have increased 
portal and hepatic blood flow, with no interactions with intake.  This indicates that when 
homeostasis is lost due to an infection, the regulation of blood flow across total 
splanchnic tissues might be regulated by substances released in response to the immune 
challenge (e.g., cytokines).  Specific non-nutritional effects of an immune response are 
difficult to elucidate due to the complex interactions that occur in infected animals.  The 
increase in blood flow might result in an increased availability of energy and protein 
substrates to the liver for synthesis of proteins to successfully mount an immune response 
to the M. haemolytica challenge.  An increase in splanchnic blood flow in humans 30 min 
after an intravenous infusion of recombinant IL-6 has been reported (40).  However, the 
authors were not able to conclude if the increased blood flow was due to a direct effect of 
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IL-6 or another substance as a consequence of the activation of the immune system by 
IL-6.  Lyngsø and others (40) hypothesized that the increased blood flow across the 
splanchnic tissues was due to an increase in portal blood flow, and unlikely due to an 
increased arterial blood flow to the liver.  In contrast, arterial blood flow was increased 
and portal blood flow tended to be increased in CH animals compared with CON animals 
in the present experiment.  The discrepancies in results might be explained by the fact
that the model utilized attempted to simulate a very small increase in circulating levels of 
IL-6 as observed 3 h post exercise (40).  In the present study, a more drastic increase i  
cytokines due to the cellular and humoral response to M. haemolytica was observed.   
IL-1, IL-6 and TNFα are the link that exists between the immune system and changes in 
amino acid metabolism during infection (41).  Total plasma AA concentrations have been 
demonstrated to be decreased during sepsis in humans (42).  In cattle (12) and pigs (13), 
individual AA have been reported to be decreased or increased after LPS (cattle) or 
complete Freund’s adjuvant (pigs) infusion when blood samples were collected from the 
jugular vein.  Plasma concentrations of free AA can decrease due to protein syn hesis or 
amino acid degradation, whereas free AA can be increased by protein degradation or 
increased absorption from the gastrointestinal tract (13).  In homeostasis, AA are added 
to plasma as blood traverses the gastrointestinal tract (37).  In the present experim nt, 
PDV flux of cysteine, glutamine, glutamic acid, glycine, histidine, hydroxyproline, 
lysine, ornithine, phenylalanine, tryptophan, tyrosine, gluconeogenic, sulfur-containing, 
essential, non-essential and total AA were decreased when animals were feed d prived.  
Several studies in many species have reported a net removal of glutamine and glut mic 
acid by the PDV (43,44,45).  Glutamine is the preferred fuel for enterocytes (46).  When 
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dietary sources of glutamine become limiting, or by the enhancing action of 
corticosteroids on glutamine observed in animal models (47,48,49), an increased PDV 
uptake of glutamine has been reported.  In our experiment, feed deprivation increased n t 
removal of glutamine and glutamic acid by the PDV. 
In addition to an increased uptake of glutamine by the PDV, there was a net removal of 
glutamine across the TST for animals challenged with M. aemolytica. The removal of 
glutamine across the TST in FAST/CH animals can be explained by a decrease in the 
dietary source of this AA or an increased uptake by the PDV to maintain integrity of the 
enterocytes or both.  The latter is supported by previous data which suggests that most of 
the glutamine uptake and metabolism occurred in the small intestinal mucosal cells (46).  
In addition, the increased removal of glutamine across the splanchnic tissues might be 
explained due to an increased utilization of glutamine by macrophages and lymphocytes 
in gut associated lymphoid tissue due to the activation and release of these cells into the 
blood stream (49).  Increased glutamine removal might also increase the availability of 
arginine via citrulline synthesis (50) for the production of nitric oxide, another molecule 
that has been implicated in the immune response of animals.   
In humans, acute phase proteins have a much higher content of aromatic AA when 
compared to muscle or other dietary sources (51).  Therefore, in order for the liver to
synthesize acute phase proteins, muscle catabolism may need to occur in order to achi ve 
the requirements for acute phase protein synthesis.  It has been proposed that the ratio of 
endogenous protein that needs to be mobilized relative to exogenous sources for the 
synthesis of acute phase proteins is 2:1 (52).  In the present experiment there was an 
increased net removal of aromatic AA beginning at 7.5 h post bacterial challenge.  The 
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lag time before the increased removal of aromatic AA by the liver might be explained by 
the length of time required for the immune cells to release cytokines which impact 
muscle catabolism and the subsequent release of AA required to support the immune 
response.  This increased requirement for aromatic AA has been proposed to be firs 
limiting for the host animal to mount an immune response while maintaining “normal” 
growth (51).  Because the predominant source of aromatic AA is potentially muscle 
degradation, changes in the concentration or metabolism of aromatic AA has been 
described as a potential tool to measure skeletal muscle degradation (53).  Increased 
muscle degradation has been speculated by Reeds and Jahoor (54) to account for the 
increased N excretion in humans during sepsis due to imbalances between the supply of 
AA derived from tissue protein and the AA composition of acute phase proteins. 
Duration of feed deprivation alters AA metabolism, especially the BCAA (45).  Increased 
concentrations of BCAA have been reported (55) with short-term fasting, probably due to 
muscle protein mobilization, whereas prolonged fasting could induce a protein deficiency 
and decrease concentrations due to liver uptake being greater than release from muscle or 
dietary sources (56).  In the present experiment, arterial concentrations of BCAA were 
not affected by feed deprivation, which might be explained by the short period of time 
(14 h) animals were deprived of feed.  In addition to fasting, decreased arterial 
concentrations of BCAA have been observed in humans with septicemia (57).  Animals 
challenged with M. haemolytica had decreased arterial concentrations of BCAA in the 
present experiment, and BCAA decreased in cattle following an LPS challenge (12).  In 
the present experiment, the decrease in arterial concentration was associated with an 
increased liver uptake of BCAA during the acute phase of the immune response.  
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Although BCAA generally escape hepatic extraction to be taken up by periphereal 
tissues, after intravenous BCAA infusion, hepatic clearance of BCAA was doubled 
compared with healthy patients (57).  The increase in liver removal of BCAA might
suggest that BCAA serve as building blocks for proteins involved in the immune 
response. 
In healthy cattle, glucogenic AA can supply between 15 to 36% of the glucogenic 
substrates removed by the liver (58).  In the present study, no differences in arterial 
concentrations of glucogenic AA were detected due to feed deprivation or bacterial 
challenge, which does not agree with the data reported in pigs (13) and humans (57).  
Pigs suffering chronic lung inflammation or humans with septicemia had decreas d 
plasma concentrations of glucogenic AA.  However, in the present experiment, a net 
removal of glucogenic AA by the liver was detected in CH animals, even though glcose 
concentration and net glucose flux across splanchnic tissues were not affected by fe d 
deprivation or bacterial challenge (data not shown).  Increased energy demand due to 
exercise in dogs results in increased net removal of glutamine and glucogenic AA by the 
liver (59).  In addition, increased gluconeogenic activity in the liver during an immune 
challenge has been reported in vitro in hepatic slices from lactating dairy cows following 
LPS challenge (60).  The increased net removal of glucogenic AA by the liver could limit 
the supply needed by the host animal for other anabolic purposes.  The increased liver 
uptake of glucogenic AA without changes in glucose concentration could reflect 
increased energy demand by the liver of the host animal, although hepatic O2 
consumption was not affected by the immune challenge in the present experiment. 
Sulfur-containing AA (methionine and cysteine) are important substrates during isease 
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(41).  Methionine has been classified as a nutritionally EAA in animal species and 
humans. In addition, cysteine is considered a semi-EAA due to the variable capacity of 
the body to synthesize this AA from methionine (41). In the present experiment, sulfur-
containing AA flux across the PDV was lower in FAST and in CH animals, attributed to 
the decreased DMI.  However, the decrease in arterial concentrations of sulfur-containing 
AA in CH animals might also be attributed to an increased utilization of these AA by 
peripheral tissues. The decrease in PDV flux of sulfur-containing AA was driven by 
decreased cysteine, whereas PDV flux of methionine was not affected.  Methionine 
reduces weight loss and improves N balance when added to a protein free diet (61).  
However, the nitrogen sparing effect was due to cysteine and not methionine per se (62).  
In our study, the removal of cysteine by the liver in CH animals suggests that cysteine 
may be required for protein synthesis in response to the immune challenge.  In addition, 
decreased arterial concentration of methionine can result from transsulfuration to cysteine 
(63) to increase the availability of this AA for adequate protein synthesis in reponse to 
an immune challenge. Interestingly, the only other AA that switched from a net liver 
release to a net liver removal in the present experiment was lysine.  In swine reared under 
stressful conditions, the addition of either 0.1 or 0.2% of crystalline lysine improved 
performance and increased antibody production to vaccination (64).  Our results suggest
that growing cattle infected with BRD might have different requirements for AA 
compared with healthy cattle.   
The role of EAA in the immune response has been described in other species (65).  
Chicks fed diets low in EAA had decreased antibody production in response to an 
immune challenge.  In humans, decreased plasma concentrations and increased clearance 
 135
rate of EAA have been reported in patients suffering from septicemia (57).  In the present 
experiment, diet had no effect in plasma concentrations of EAA; however, arterial 
concentrations of EAA were lower in animals challenged with M. aemolytica.  
Tryptophan was the only EAA whose plasma concentration was decreased due to chronic 
lung inflammation in fed and fasted pigs (13).  Although no difference in arterial 
concentration of tryptophan was detected in the present experiment, net liver removal 
was greater in FAST/CH animals than in FED/CON animals.  Increased removal of 
tryptophan during an immune response could lead to decreased availability for growth.  
An acute decrease in the availability (or increased requirement) of EAA to the host 
animal has been reported to cause an almost immediate cessation of growth and 
subsequent weight loss (66).  Increased removal of EAA by TST might partially exp ain 
decreased growth in cattle suffering from BRD (2). 
Hepatic extraction of NEAA provides substrates for synthesis of other metabolites (67).  
However, substantial or complete removal of NEAA could result in insufficient quantities 
entering the systemic circulation to support protein synthesis needs by the rest of the 
body (68).  In septicemic patients, NEAA plasma concentrations are lower and tot l 
hepatic clearance of these AA are increased (57).  These data are in agreement with 
results of the present experiment, where CH animals had greater liver removal of NEAA 
and tended to have decreased arterial concentrations.  A decrease of NEAA during 
disease might imply a change in NEAA metabolism in morbid compared to healthy 
animals.  The increased liver removal of NEAA started at 7 h post bacterial challenge and 
remained increased until the end of the experiment.  The time of increased removal of 
NEAA coincided with the increased removal of aromatic AA.  Increased removal of 
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NEAA by the liver during disease challenge most likely supports synthesis of EAA and 
proteins required for the immune response. 
The overall decreased arterial concentrations of total AA observed in this experiment has 
also been reported in cattle (12), pigs (13), and humans (57) although to our knowledge, 
this is the first evidence in growing cattle to report increased net removal of total AA by 
the liver and total splanchnic tissues in support of an acute phase response.  Although 
many factors remain to be determined, increased demand of AA by total splanchnic 
tissues could ultimately lead to decreased growth rates in bovine.    
Similar to non-ruminant species, inflammation and immune system activation appear to 
be associated with alterations in nutrient utilization by splanchnic tissues in bovine.  In 
addition, AA may be released from peripheral tissues and shifted to the liver for 
promotion of hepatic protein synthesis, gluconeogenesis, and oxidation.  Decreased 
plasma concentrations and increased liver uptake of AA may suggest enhanced metabolic 
clearance and turnover of endogenously released AA.  These changes in AA metabolism 
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Table 1. Diet composition and nutrient analysis on feed utilized during the 
experiment. 
Ingredient % DM basis 
Wheat midds 37.6 
Alfalfa pellets 25.0 
Cotton seed hulls 15.0 
Soybean hulls 15.0 
Soybean meal, 47.7% 3.00 
Cane molasses 3.00 
Salt 0.25 
Calcium carbonate 0.55 
Ammonium sulfate 0.50 
Selenium 600 0.04 
Vitamin A-30,000 0.02 
Vitamin E-50 0.003 
Zinc sulfate 0.002 
Zinc oxide 0.001 
  
Nutrient composition  
NEm, Mcal/kg 1.50 
NEg, Mcal/kg 0.81 
CP, % 16.1 
Fat, % 3.19 
NDF, % 52.5 
eNDF, % 22.3 
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ADF, % 30.5 
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 1 
Table 2. Effect of fasting with or without a M. haemolytica challenge on DMI, rectal temperature and arterial 
concentrations of cytokines and haptoglobin. 
 Fed Fasted  P – value 
Item No MH MH No MH MH SEM Diet Disease Diet ×Disease 
BW, kg 322 324 322 308 10.2 0.45 0.56 0.43 
DMI         
Adaptation, kg 6.47 5.92 7.15 7.15 0.74 0.21 0.71 0.70 
Adaptation, % BW 2.01 1.82 2.19 2.29 0.20 0.13 0.83 0.14 
Day of challenge, kg 6.24 1.62 0 0 0.85 < 0.0001 0.003 0.003 
Day of challenge, % BW 1.92 0.49 0 0 0.26 < 0.0001 0.003 0.003 
Rectal temperature, oC1 38.7 40.0 38.6 39.9 0.15 0.62 < 0.0001 0.80 
Haptoglobin, mg/L1 0.61 2.06 0.31 1.99 0.28 0.49 < 0.0001 0.67 
TNF-α         
Pre challenge, pg/mL 144 77 162 69 70.0 0.85 0.13 0.66 
Fold change1 3.9 11.3 2.3 8.5 2.4 0.34 0.006 0.80 
IL-1         
Pre challenge, pg/mL 247 230 247 237 53.3 0.74 0.80 0.80 
Fold change1 3.7 30.1 2.9 29.4 9.2 0.92 0.005 0.99 
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IL-6         
Pre challenge, pg/mL 120 128 122 62 90.3 0.69 0.75 0.69 
Fold change2 1.14a 5.87b 1.37a 3.02c 1.20 0.07 0.01 0.04 
1Disease × h interaction (P < 0.001). 2 
2Diet × h interaction (P < 0.05).3 
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Table 3.  Effects of intratracheal M. haemolytica challenge on arterial concentrations of metabolites in fed or fasted beef 
steers. 
 Fed Fasted  P – value 
Item No MH MH No MH MH SEM Diet Disease Diet × Disease 
Oxygen, mM 2.74 2.58 2.80 2.50 0.09 0.87 0.01 0.42 
Ammonia, mM 0.08 0.07 0.07 0.08 0.01 0.59 0.73 0.06 
Urea N, mM 4.88 4.15 4.61 4.52 0.50 0.91 0.38 0.49 
Total protein, g/L 70.6 73.4 78.5 76.8 4.22 0.19 0.89 0.59 
Alanine, µM 157 130 137 132 9.7 0.36 0.11 0.26 
Asparagine, µM 11.8 8.7 15.7 11.2 2.65 0.22 0.16 0.81 
Aspartic acid, µM2 3.80 2.76 6.67 2.99 0.82 0.06 0.007 0.11 
Cysteine, µM 2.85 1.30 2.36 2.94 0.68 0.39 0.47 0.12 
Glutamine, µM 67 77 129 111 17.9 0.01 0.82 0.45 
Glutamic acid, µM 156 135 220 196 20.5 0.004 0.28 0.94 
Glycine, µM 249 205 203 193 21.9 0.19 0.22 0.42 
Histidine, µM 26.2 14.3 28.3 23.1 4.68 0.24 0.07 0.47 
Hydroxyproline, 
µM 13.9 11.6 13.6 14.1 1.35 0.44 0.50 0.30 
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Isoleucine, µM 123 95 139 101 12.3 0.38 0.01 0.67 
Leucine, µM 157 120 177 134 16.9 0.32 0.02 0.84 
Lysine, µM 101 63 97 71 23.1 0.94 0.17 0.77 
Methionine, µM 5.44 4.38 6.96 3.84 0.61 0.43 0.002 0.10 
Ornithine, µM 98.3 69.0 120.0 77.3 28.4 0.60 0.21 0.80 
Phenylalanine, µM 44.5 45.1 62.5 46.6 7.02 0.17 0.28 0.24 
Proline, µM 65.8 45.1 62.1 50.0 5.18 0.85 0.008 0.59 
Serine, µM 71.9 63.5 85.9 81.6 7.17 0.03 0.37 0.77 
Threonine, µM 51.7 41.6 61.8 44.7 6.70 0.33 0.05 0.60 
Tryptophan, µM 24.8 17.2 33.8 29.9 6.74 0.12 0.39 0.77 
Tyrosine, µM 23.0 18.1 37.0 25.6 6.43 0.10 0.21 0.61 
Valine, µM 295 220 317 248 29.1 0.30 0.02 0.91 
Aromatic amino 
acids, µM 92 81 133 102 17.8 0.09 0.23 0.59 
BCAA, µM 
576 436 635 483 57.7 0.36 0.01 0.92 
Gluconeogenic 
amino acids, µM 765 654 819 766 54.2 0.13 0.13 0.59 
Sulfur containing 
amino acids, µM3 8.32 5.69 12.40 8.50 2.23 0.54 0.02 0.69 
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Essential amino 
acids, µM 830 622 924 704 86.3 0.31 0.02 0.94 
Non-essential 
amino acids, µM 764 641 897 768 78 0.10 0.11 0.96 
Total amino acids, 
µM 1,594 1,263 1,810 1,472 151 0.15 0.03 0.95 
 1Diet × Disease × h interaction (P = 0.05). 
 2Diet × h interaction (P = 0.02). 














Table 4. Effect an intratracheal M. haemolytica challenge on blood flow and net flux of metabolites in fed or fasted beef 
steers 
 Fed Fasted  P –value 
Item No MH MH No MH MH SEM Diet Disease Diet × Disease 
Arterial blood flow, 
L/h 
136 190 105 179 48.3 0.30 0.01 0.58 
Portal blood flow, L/h 536 664 449 519 65.1 0.08 0.11 0.68 
Hepatic blood flow, 
L/h 
626 800 526 621 76.3 0.07 0.06 0.66 
Oxygen consumption, 
mmol/h 
        
PDV -201 -298 -202 -189 27.0 0.03 0.03 0.14 
Liver -343 -447 -135 -162 95.5 0.06 0.41 0.63 
TST -534 -725 -306 -361 127 0.01 0.25 0.52 
HER 1.00 -1.01 -1.02 -1.00 0.005 0.12 0.99 0.92 
Ammonia, mmol/h         
PDV 15.9 12.4 11.1 9.9 3.85 0.38 0.64 0.90 
Liver -16.8 -17.0 -14.2 -8.3 6.23 0.36 0.86 0.51 
TST2 -1.93 -4.32 -1.34 -2.86 3.44 0.14 0.50 0.41 
HER3 0.904 0.377 0.571 0.375 0.293 0.79 0.23 0.83 
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Urea N, mmol/h         
PDV -203 -406 -131 -468 209 0.69 0.42 0.64 
Liver 497 542 443 590 227 0.81 0.50 0.35 
TST 189 226 386 338 271 0.90 0.72 0.52 
HER 0.101 0.059 -0.097 -0.016 0.094 0.15 0.60 0.65 
Haptoglobin         
PDV -0.001 -0.023 -0.006 -0.009 0.008 0.61 0.11 0.22 
Liver -0.57 -15.72 -11.38 2.01 9.06 0.67 0.91 0.09 
TST -0.42 -15.71 -11.02 1.49 7.10 0.69 0.80 0.05 
HER -0.011 0.165 0.156 0.115 0.211 0.68 0.41 0.20 
Alanine, mmol/h         
PDV 22.3 12.5 13.7 3.2 7.06 0.19 0.14 0.94 
Liver -10.6 -31.7 -10.6 -16.1 8.71 0.25 <0.001 0.01 
TST 7.9 20.9 -3.3 -22.0 7.78 0.40 0.03 0.45 
HER4 0.085 0.312 0.140 0.334 0.089 0.97 0.003 0.15 
Asparagine, mmol/h         
PDV 2.94 1.33 1.41 0.70 0.90 0.18 0.20 0.78 
Liver 0.01 -2.55 -1.54 -1.63 1.13 0.43 0.11 0.06 
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TST 2.40 -0.92 -0.53 -1.82 1.18 0.10 0.09 0.38 
HER4 0.008 0.824 0.713 0.531 0.226 0.40 0.83 0.006 
Aspartic acid, mmol/h         
PDV 1.79 0.95 0.83 0.42 0.48 0.08 0.16 0.56 
Liver -1.07 -0.73 -0.08 -0.09 0.45 0.04 0.71 0.57 
TST 0.49 0.27 0.58 0.39 0.51 0.64 0.68 0.78 
HER 0.811 0.692 0.479 0.317 0.314 0.01 0.51 0.93 
Cysteine, mmol/h         
PDV3 0.89 -0.11 -0.14 -0.83 0.37 0.01 0.02 0.69 
Liver 0.46 -0.20 0.19 -0.07 0.35 0.54 0.11 0.24 
TST3,4,5 1.48 -0.30 0.38 -0.86 0.74 0.14 0.01 0.41 
HER 1.35 0.91 0.22 0.89 0.80 0.63 0.84 0.67 
Glutamine, mmol/h         
PDV 41.84 0.75 -13.97 -3.57 11.90 0.01 0.24 0.04 
Liver5 -0.56 -8.84 -1.38 -12.3 11.7 0.59 0.15 0.79 
TST 39.7 -8.1 -12.4 -20.8 11.5 0.005 0.02 0.09 
HER -0.158 0.389 -0.021 -0.772 0.443 0.45 0.13 0.95 
Glutamic acid, mmol/h         
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PDV 5.1 -1.1 -23.5 -18.1 10.7 0.03 0.96 0.56 
Liver 20.3 17.2 15.2 13.9 11.5 0.23 0.35 0.94 
TST2 27.7 16.9 7.6 -9.7 11.0 0.01 0.91 0.19 
HER -0.289 -0.120 0.076 0.106 0.100 0.004 0.09 0.54 
Glycine, mmol/h         
PDV6 28.3 26.2 19.2 5.3 6.95 0.02 0.20 0.34 
Liver6 -21.8 -55.6 -10.1 -16.8 9.88 0.002 0.003 0.06 
TST 5.3 -29.0 6.3 -16.3 6.30 0.09 <0.000
1 
0.23 
HER 0.179 0.380 0.158 0.258 0.096 0.09 0.05 0.34 
Histidine, mmol/h         
PDV 8.28 1.74 -1.56 -1.94 2.91 0.01 0.21 0.26 
Liver6 -0.21 0.33 -1.39 -3.26 2.85 0.11 0.40 0.60 
TST2,4 5.68 2.60 -3.81 -5.47 3.31 0.05 0.56 0.88 
HER 0.21 0.05 0.36 1.92 0.99 0.23 0.45 0.53 
Hydroxyproline, 
mmol/h 
        
PDV6 0.93 0.25 0.13 -1.50 0.41 0.01 0.01 0.27 
Liver 1.73 -1.76 -0.14 -1.21 0.61 0.12 0.0001 0.009 
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TST 0.70 -1.45 0.19 -2.62 0.65 0.45 0.001 0.23 
HER -0.131 0.223 0.085 0.292 0.092 0.14 0.004 0.14 
Isoleucine, mmol/h         
PDV 5.28 5.71 3.50 0.06 3.17 0.19 0.59 0.49 
Liver 1.21 -4.05 -2.11 -3.97 3.98 0.45 0.10 0.16 
TST 6.61 2.47 -0.86 -5.24 4.79 0.25 0.22 0.76 
HER -0.003 0.178 0.102 0.282 0.162 0.83 0.05 0.32 
Leucine, mmol/h         
PDV 9.44 8.98 6.03 1.04 3.40 0.07 0.37 0.45 
Liver 1.29 -9.88 -2.74 -0.94 5.95 0.82 0.10 0.05 
TST6 11.5 1.29 -4.37 -2.06 6.14 0.24 0.18 0.19 
HER 0.001 0.262 0.114 0.156 0.184 0.68 0.39 0.32 
Lysine, mmol/h         
PDV 35.24 7.33 -5.68 -5.33 10.5 0.01 0.16 0.16 
Liver6 10.21 -16.11 -2.21 -8.48 11.4 0.81 0.02 0.25 
TST5 41.87 -7.95 -2.43 -15.97 10.2 0.03 0.004 0.10 
HER -0.163 0.671 0.235 0.363 0.358 0.95 0.24 0.28 
Methionine, mmol/h         
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PDV 1.75 1.35 1.28 1.06 0.50 0.42 0.51 0.84 
Liver -1.02 1.69 -1.16 -0.98 0.46 0.76 0.54 0.27 
TST5 0.45 -0.39 -0.43 -0.04 0.45 0.56 0.71 0.26 
HER6 0.449 0.736 0.902 0.689 0.368 0.69 0.43 0.22 
Ornithine, mmol/h         
PDV 39.11 3.04 -12.33 -6.52 13.5 0.02 0.24 0.10 
Liver3,4,5 9.36 -8.04 -0.63 8.37 15.7 0.39 0.13 0.30 
TST3,5 47.44 -5.33 -7.65 -16.70 15.4 0.03 0.03 0.12 
HER4 -0.253 0.340 0.347 0.254 0.277 0.41 0.88 0.11 
Phenylalanine, mmol/h         
PDV 5.04 4.62 1.59 0.10 2.04 0.03 0.60 0.77 
Liver -3.52 -10.38 -3.45 -3.80 2.84 0.50 0.05 0.03 
TST 0.72 -4.86 -3.23 -4.47 3.07 0.87 0.12 0.33 
HER 0.158 0.442 0.232 0.302 0.206 0.74 0.27 0.25 
Proline, mmol/h         
PDV 4.75 4.80 3.78 1.44 1.31 0.07 0.33 0.31 
Liver -1.52 -9.26 -1.92 -4.11 1.45 0.14 0.0003 0.007 
TST 1.99 -3.71 -0.26 -3.42 1.69 0.88 0.006 0.41 
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HER 0.078 0.232 0.117 0.266 0.09 0.48 0.007 0.23 
Serine, mmol/h         
PDV 10.49 9.08 3.98 5.53 3.82 0.16 0.98 0.67 
Liver -3.99 -15.01 -3.79 -8.27 4.10 0.43 0.04 0.37 
TST 5.11 -5.74 -2.67 -4.34 3.72 0.47 0.12 0.29 
HER 0.082 0.335 0.300 0.209 0.11 0.81 0.95 0.18 
Threonine, mmol/h         
PDV 4.56 4.30 4.32 -0.43 2.10 0.19 0.19 0.24 
Liver -0.70 -4.98 -2.06 -3.52 2.08 0.88 0.03 0.15 
TST 4.61 -0.32 -1.35 -4.73 2.54 0.07 0.05 0.85 
HER 0.020 -.204 0.242 0.315 0.120 0.33 0.34 0.30 
Tryptophan, mmol/h         
PDV 6.51 0.83 -2.54 -2.01 2.51 0.01 0.28 0.19 
Liver3,4,5 2.39 -0.98 -0.004 -2.00 3.05 0.23 0.08 0.28 
TST5 9.07 -0.08 -2.70 -4.95 2.44 0.003 0.03 0.15 
HER2,4 -0.207 0.141 0.262 0.330 0.204 0.08 0.77 0.17 
Tyrosine, mmol/h         
PDV 10.04 2.69 -0.75 -1.09 3.01 0.01 0.18 0.22 
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Liver4 0.07 -5.26 -1.25 -4.12 4.15 0.78 0.07 0.27 
TST5 9.62 -3.57 -2.26 -6.04 3.33 0.03 0.01 0.15 
HER2,4 -0.107 0.697 0.462 0.529 0.292 0.95 0.13 0.007 
Valine, mmol/h         
PDV 6.46 4.79 7.40 -4.12 7.82 0.47 0.38 0.54 
Liver6 4.80 -7.04 -0.31 -2.24 7.91 0.92 0.04 0.17 
TST 9.95 0.68 -6.67 -9.08 8.31 0.21 0.23 0.65 
HER -0.024 0.096 0.070 0.160 0.113 0.85 0.18 0.53 
Aromatic amino acids, 
mmol/h 
        
PDV 22.07 7.60 -0.09 -4.00 6.84 0.006 0.23 0.30 
Liver4 -1.25 -15.85 -4.41 -9.82 7.84 0.78 0.02 0.07 
TST5 19.62 -6.99 8.21 -15.88 7.56 0.03 0.02 0.17 
HER -0.084 0.385 0.272 0.357 0.186 0.57 0.09 0.04 
Branched amino acids, 
mmol/h 
        
PDV 21.0 18.7 18.3 3.6 13.9 0.22 0.38 0.49 
Liver6 7.31 -20.10 -5.18 -7.24 17.3 0.93 0.06 0.11 
TST 28.1 4.7 -12.0 16.6 118.6 0.21 0.19 0.47 
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HER -0.013 0.149 0.089 0.175 0.134 0.79 0.23 0.38 
Gluconeogenic         
PDV 111.2 63.9 31.6 -7.1 33.9 0.03 0.20 0.88 
Liver4 8.4 -104.1 -33.7 -42.1 32.0 0.42 0.001 0.01 
TST5 54.6 -50.6 3.5 -70.7 30.0 0.22 0.003 0.74 
HER -0.030 0.197 0.160 0.199 0.097 0.46 0.09 0.16 
Sulfur containing 
amino acids, mmol/h 
        
PDV 2.55 1.25 1.08 0.20 0.57 0.02 0.04 0.68 
Liver -0.56 -1.90 -1.00 -1.05 0.52 0.92 0.12 0.06 
TST2,6 0.85 -0.80 -0.003 -0.69 0.70 0.93 0.52 0.87 
HER 0.333 0.539 0.527 0.466 0.214 0.91 0.79 0.29 
Essential amino acids, 
mmol/h 
        
PDV 84.1 33.3 19.0 -13.1 29.5 0.02 0.17 0.77 
Liver4 15.4 -54.6 -12.7 -27.8 30.8 0.75 0.01 0.06 
TST 92.2 -6.2 -26.3 -52.0 32.1 0.03 0.02 0.25 
HER -0.05 0.19 0.13 0.22 0.14 0.89 0.21 0.26 
Non-essential amino 
acids, mmol/h 
        
 162
PDV 145.8 49.0 -21.6 -17.7 45.5 0.01 0.28 0.24 
Liver4 5.13 -87.77 -6.97 41.48 43.4 0.88 0.02 0.19 
TST 153 -38.6 -12.9 85.9 43.0 0.04 0.01 0.34 
HER -0.113 0.170 0.184 0.188 0.99 0.37 0.18 0.08 
Total amino acids, 
mmol/h 
        
PDV 228.5 87.7 -4.8 -31.2 71.6 0.01 0.21 0.39 
Liver4 22.3 -141.2 -21.8 -69.0 67.3 0.95 0.01 0.08 
TST5 202.5 -59.5 -28.3 -139.6 68.5 0.02 0.009 0.26 
HER -0.083 0.170 0.150 0.196 0.109 0.63 0.14 0.13 
1PDV = portal-drained viscera; TST = total splanchnic tissues; HER = hepatic xtraction ratio. 
2Diet × h interaction (P < 0.01). 
3Diet × h interaction (P < 0.05). 
4Disease × h interaction (P < 0.01). 
5Diet × Disease × h interaction (P < 0.05). 




Figure 1.  Effect of M. haemolytica challenge on rectal temperature in beef steers during 
the first 24 h post challenge in fed or fasted steers (P < 0.0001; SEM = 0.13).  a,bWithin h, 
means with different superscript letters are different (P < 0.05). 
Figure 2.  Effect of M. haemolytica challenge on arterial haptoglobin concentration 
during the first 24 h post challenge in fed or fasted beef steers (P < 0.0001; SEM = 0.62).  
a,bWithin h, means with different superscript letters are different (P < 0.05). 
Figure 3.  Fold change in arterial concentration of TNFα (A; diet*h, P = 0.96; disease*h, 
P < 0.0001, SEM = 8.37) and IL-1β (B; diet*h, P = 0.95; disease*h, P = 0.0002, SEM = 
2.43) following a M. haemolytica challenge in fed or feed deprived beef steers during the 
first 24 h post challenge.  a,bWithin h, means with different superscript letters are different 
(P < 0.05). 
Figure 4.  Fold change in arterial concentration of IL-6 following a M. haemolytica 
challenge in fed or fasted beef steers during the first 24 h post-challenge (Diet*hour, P = 
0.04; Disease*hour, P = 0.58, SEM = 1.36).  a,bWithin h, means with different superscript 
letters are different (P < 0.05). 
Figure 5.  Changes in aromatic (A; diet*h, P = 0.87; disease*h, P = 0.02, SEM = 12.1), 
branched chain (B; diet*h, P = 0.60; disease*h, P = 0.05, SEM = 25.0), and glucogenic 
(C; diet*h, P = 0.85; disease*h, P = 0.01, SEM = 50.6) AA flux across the liver of fed or 
fasted beef steers during the first 7.5 h following a M. haemolytica challenge.  a,bWithin 
h, means with different superscript letters are different (P < 0.05). 
Figure 6.  Changes in non-essential (A; NEAA; diet*h, P = 0.40; disease*h, P = 0.01, 
SEM = 55.2), essential (B; EAA; diet*h, P = 0.80; disease*h, P = 0.001, SEM = 40.2), 
and total (C; TAA; diet*h, P = 0.49; disease*h, P = 0.01, SEM = 101) AA net flux across 
the liver of fed or fasted beef steers during the first 7.5 h following a M. haemolytica 
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EFFECTS OF FEED DEPRIVATION AND INTRATRACHEAL CHALLENGE 
WITH MANNHEIMIA HAEMOLYTICA ON BLOOD FLOW AND NET PORTAL 
AND HEPATIC FLUX OF NUTRIENTS IN BEEF STEERS 
 
ABSTRACT:  Bovine Respiratory Disease (BRD) is the most common disease in 
stocker and feedlot cattle. Although emphasis has been placed on strategies to prevent, 
diagnose and/or treat BRD, rates of morbidity and mortality have increased. The 
objective of this experiment was to evaluate blood flow and net splanchnic flux of amino 
acids during a BRD challenge. Twenty two steers (initial BW = 320 ± 24 kg) with 
chronic indwelling catheters to measure blood flow and net nutrient flux across the portal 
drained viscera (PDV) and liver were used for this experiment. The experiment consisted 
of two, 3 wk sampling periods with 12 animals sampled in each period. During two 
periods, steers were assigned to one of four treatments: 1) fed ad libitum and not 
challenged (FED/CON); 2) fed ad libitum and challenged (d 0) with 6 × 109 CFU/mL of 
Mannheimia hemolytica via a tracheal tube (FED/CH); 3) fasted for 72 h and not 
challenged (FAST/CON); 4) fasted for 72 h and challenged (d 0) with 6 × 109 CFU/mL 
of M. hemolytica via a tracheal tube (FAST/CH).  Arterial, portal, and hepatic blood 
samples were simultaneously drawn 6 times at 1.5 h intervals on d 1, 2, 3, 4, 7, and 14.  
Statistical analysis was performed for repeated measures using a first-order 
autoregressive correlation structure for all variables.  Diet affected (P < 0.05) portal, 
hepatic, and arterial blood flow, which were greater in FED (460.9, 708.4, and 170.3 L/h, 
respectively) compared with FAST (426.7, 522.1, and 97.2 L/h, respectively) steers. 
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Arterial haptoglobin concentration responded with a diet*disease interaction (P = 0.004). 
Fasting alone caused an increase in arterial haptoglobin concentration, although the 
increase was greater in Fasted/Challenged steers than Fasted/Control steers. Ar erial 
concentration of total amino acids (TAA) was greater (P = 0.01; 1,966 vs. 1,645 µM) in 
Control than in Challenged steers.  In addition, there was a net removal of TAA (-117.8 
mmol/h) by the liver for Challenged steers and a net release for Control steers (21.48 
mmol/h; P = 0.03).  Although there was no difference (P = 0.22) in arterial concentration 
of essential AA (EAA), there was a tendency (P = 0.11) for a greater net removal (-65.2 
vs. -22.3 mmol/h) of EAA by the liver for the Challenge vs. Control steers. Arterial 
concentration of nonessential amino acids (NEAA) was greater (P = 0.001) for the 
Control group (1,173 vs. 924 µM).  Similar to TAA, there was a net removal of NEAA (-
52.8 mmol/h) by the liver for Challenged steers and a net release for Control stee s (42.5 
mmol/L; P = 0.02).  Based on these results and negative N balance in steers challenged 
with M. haemolytica, it appears that BRD results in greater removal of amino acids by the 
liver in support of an acute phase response. 
Key words: bovine, bovine respiratory disease, feed deprivation, immune 











Bovine respiratory disease (BRD) involves the complex interaction between stress, 
bacteria, viruses, and the environment (Duff and Galyean, 2007).  Economic losses have 
been associated with direct costs due to BRD treatment, but also due to indirect costs 
associated with decreased final BW and carcass quality (Gardner et al., 1999; Thompson 
et al., 2006).  During the acute phase of bacterial infection, decreased growth has been 
observed in chicks (Klasing et al., 1987), pigs (Kelley et al., 1994) and cattle (Burciaga-
Robles et al., 2009a).  Decreased growth rates can be attributed to the activation of the 
immune system with an associated decrease in intake (Klasing and Barnes, 1998; 
Burciaga-Robles at el., 2009a) and increase in cytokine concentration (Burciaga-Robles 
et al., 2009b), which can redirect nutrient use away from growth towards mounting an 
adequate immune response (Klasing, 1988; Spurlock et al., 1997). In addition to 
activation of the immune system, release of cytokines has been associated with changes 
in behavior and decreased DMI (Johnson, 1997).  Hutchenson and Cole (1986) reported 
decreased DMI in sick/stressed calves (0.90 ± 0.70% of BW) compared to healthy calves 
(1.55 ± 0.51% of BW) during the first wk after arrival to a feedlot.  In addition, Chirase et 
al. (1991) reported that the decreased DMI in high stressed/sick calves could remain for 
two wk, and therefore nutrient intake during this period might be limiting to achieve 
adequate immune function and/or maximum growth potential (Chirase et al., 1991). 
 Gilliam et al. (2008) and Waggoner et al. (2008) have reported differences in 
plasma AA composition due to lipopolysaccharide (LPS) challenge in steers, even 
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though the magnitude of the response to an LPS challenge has been suggested to be of 
smaller duration and magnitude compared to a true pathogen infection (Sandberg et al., 
2007).  Although the Beef Cattle National Research Council (NRC, 1996) suggested no 
difference in crude protein requirements between healthy and stressed calves, during the 
acute phase response to a pathogen, animals produce significant amounts of nitrogenous 
compounds (e.g., acute phase proteins, antibodies, cytokines) and develop specific 
immune cells that can redirect nutrients in support of the immune response (Spurlock, 
1997; Sanberg et al., 2007).  Therefore, a shift in protein metabolism can be speculated in 
animals suffering from BRD.  In addition to the induced anorexia, hyperthermia, and 
increased acute phase protein synthesis by the liver, cytokines induce muscle protein 
catabolism and AA are used for gluoconeogenesis and immune cell proliferation 
(Melchior et al., 2004).  However, little is known about how net flux of AA by the portal-
drained viscera (PDV) and liver might be altered due to inflammation and immune 
response in cattle.  Better knowledge of net nutrient flux and requirements during an 
immune challenge would help in the development of new feeding and management 
strategies to preserve both growth and body defenses in high-stressed calves entering the 
feedlot.  Therefore, the objective of this experiment was to determine the effects o  an 
intratracheal challenge with Mannheimia hemolytica on net nutrient flux across the PDV 
and liver fed or fasted beef steers.  
 
MATERIALS AND METHODS 
Animals  
 174
All procedures were approved by the Oklahoma State University Institutional Animal 
Care and Use Committee.  Twenty two steers (BW = 320 ± 24 kg) were equipped with 
chronic catheters to measure blood flow and net flux of nutrients across PDV and liver.  
Catheters were surgically placed in the portal vein, a hepatic vein, a mesenteric vein, and 
an adjacent mesenteric artery as described by Ferrell et al. (1991).  Catheter pat ncy was 
maintained by filling catheters with a 1,000 U/mL heparinized-saline solution between 
sampling days and with a 20 U/mL heparinized-saline solution between sampling times.  
Steers were allowed a minimum of 14 d to recover from surgery before beginning the 
initial collection period.   
Steers were individually housed at the Oklahoma State University Nutrition Physiology 
Research Center, Stillwater.  The experiment consisted of 18 d during which the animals 
were kept in individual pens (3.7 × 3.7 m) with the exception of d 0 to 4, 7 to 11 and 14 
to 18.  During those days, animals were placed in metabolic stanchions to facilitate 
intensive blood sampling and allow for the collection of total urine and feces (Burciaga-
Robles et al., 2009c). 
Treatments 
 Prior to enrollment in the experiment, all steers were determined to be sero-
negative to M. haemolytica and were considered clinically healthy.  Steers were randomly 
allocated to 1 of 4 treatments arranged as a 2 × 2 factorial as follows: 1) ad libitum 
feeding and not challenged with M. haemolytica (FED/CON); 2) ad libitum feeding and 
intratracheally challenged (d 0) with M. haemolytica (FED/CH); 3) 74-h fast and not 
challenged (FAST/CON); 4) 74-h fast and intratracheally challenged (d 0) with M. 
haemolytica (FAST/CH).  Feed deprivation for the FAST groups occurred 14 h prior to 
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the challenge with M. haemolytica and continued for 60 h during the sampling period.  
Six steers/treatment were used for the experiment.  To facilitate intensive blood 
collections, sampling occurred during two sampling periods spaced 18 d apart.  Two 
steers from the FED/CON group in the first sampling period were randomly allocated to 
treatment in the second period.  Steers were challenged with M. haemolytica using the 
same protocol as described by Burciaga-Robles et al., 2009b.  Briefly, animals challenged 
with M. haemolytica received 10 mL of a solution containing 6 × 109 CFU of M. 
haemolytica serotype 1, which was reconstituted and grown prior to the challenge as 
described by Mosier et al. (1998).  Steers not challenged with M. haemolytica were 
intratracheally dosed with 10 mL of a sterile phosphate-buffered saline solution.  W th 
the exception of d where feed was withheld, steers were offered feed for ad libitum intake 
with feed delivered twice daily at 0800 and 1700.  The diet was formulated to meet or 
exceed nutrient requirements (NRC, 1996).  Ingredients and nutrient composition were 
reported by Burciaga-Robles et al. (2009d). 
Sample Collection 
 Steers were placed in metabolism stanchions in a climate-controlled room (23 to 
27°C) 24 h before the initiation of the blood collection period.  Rectal temperatures were 
recorded using a digital veterinary thermometer (GLA M-500; GLA Agricultural 
Electronics, San Luis Obispo, CA).  On d 1, rectal temperatures collected at 3, 6, 12, and
18 h after the bacterial challenge were averaged, and for the remaining d, a daily 
measurement was performed at 0800.  Blood samples were collected on d 1, 2, 3, 4, 7, 
and 14 of the challenge.  At 0600 on the morning of challenge (d 1) and 0700 on all 
subsequent blood sampling d, a priming dose of 20 mL of 10% (wt/vol) para-
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aminohippurate (PAH, pH = 7.4) was administered through a 0.45 µm sterile filter 
(Millipore, Bedford, MA) into the mesenteric vein catheter.  Para-aminohippurate was 
continuously infused (PHD 2000 Syringe pump; Harvard Apparatus Inc., Holliston, MA) 
at 0.7 mL/min for 9 h following the priming dose.  On d 1, blood was collected 1 h prior 
to the M. haemolytica challenge (0700), and continued every 1.5 h from 0830 until 1600 
(total of 7 samples).  On d 2, 3, 4, 7, and 14, blood was collected beginning at 0800 and 
continued every 1.5 h until 1530 (total of 6 samples).  At every sampling time, 10 mL of 
blood were simultaneously drawn three times from the portal vein, hepatic vein, and 
mesenteric artery catheters into syringes, and blood was placed into three 10 mL tubes 
(Becton Dickinson Vacutainer Systems, Franklin Lakes, NJ).  The first 10 mL were 
placed into tubes treated with sodium heparin for plasma harvest, the second 10 mL into 
tubes containing potassium oxalate and sodium fluoride for plasma harvest for glucose 
analysis, and the third 10 mL were placed into tubes without anticoagulant for serum 
harvest.  After collection, blood samples were immediately capped and placed on ice for 
transport to the laboratory.  Immediately after collection, 90 µL of arteril, portal and 
hepatic whole blood samples were analyzed using a blood gas analyzer (1304 pH/Blood 
Gas Analyzer, Instrumentation Laboratory, Lexington, MA) for determinatio  of blood 
gas concentrations.  Calibration of the blood gas analyzer was performed prior to each
sampling day using a commercially available calibrator (ContrIL Blood gas control 
#93630, Instrumentation Laboratory) and automated two-point calibration.  An additional 
40 µL of whole blood was used to determine packed cell volume.  Remaining blood was 
centrifuged (3,000 × g, 4°C, 20 min) and plasma and serum harvested and frozen (−40°C) 
for further analysis.  Two milliliters of plasma and serum from each sampling time were 
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composited within site (arterial, portal, hepatic) to provide a daily sample, and frozen 
(−40°C) for further analysis.  The pre-challenge samples collected at 0700 on d 1 were 
excluded from the composite. 
Analyses 
 Mannheimia haemolytica Antibodies.  Serum samples from d 0, 7, and 14 were 
used to determine antibodies to whole bacterial cell and leukotoxin for a formalin killed 
M. haemolytica serotype 1 by an ELISA test as described by Confer et al. (1995; 1996).  
Antibody responses were expressed as nanograms of immunoglobulin binding based on a 
set of IgG standards on each plate. The intra- and inter-assay coefficients of variation 
were below 5%. 
Serum Haptoglobin.  Haptoglobin concentrations in arterial, portal and hepatic serum 
samples were analyzed in duplicate using a Bovine Haptoglobin ELISA kit (Immunology 
Consultants Lab, Portland OR) as described previously (Burciaga-Robles et al., 2009b).  
The intra and inter assay coefficient of variation were below 7.5%.   
 Metabolites and Para-Aminohippurate.  Daily composites from d 1, 2, 3, 4, 7 and 
14 were analyzed for PAH and metabolite concentrations.  Plasma PAH concentrations 
were determined colorimetrically as previously described (Harvey and Brothers, 1962).  
Commercially available kits were used for the colorimetric determinatio  of plasma 
glucose (Liquid Glucose [hexoquinase] Reagent Set, Pointe Scientific, Canton, MI), 
lactate (Lactate Reagent Set, Pointe Scientific), urea nitrogen (Ura Nitrogen Reagent, 
Teco Diagnostic, Anaheim, CA), ammonia (Ammonia Reagent Set, Pointe Scientifi ) and 
total protein (arterial blood samples only; Total Protein [Biuret] Reagent Set, Pointe 
Scientific) concentrations.  Microplates (Beckman Coulter, Fullerton, CA) were used for 
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all analyses, and absorbance was measured according to manufacturer recommendations 
for each metabolite using a plate reader (Multiskan Spectrum; Thermo Scientific, 
Waltham, MA).  Intra- and inter-assay coefficients of variation for each metabolite were 
kept below 5 and 7.5%, respectively.  
 Free plasma AA were determined via GLC using a commercially available kit 
(EZ:FAAST #KGO-7165; Phenomenex, Torrance, CA).  The kit supplied all necessary 
reagents for solid phase extraction and derivatization as described by Waggoner et al. 
(2008).  Briefly, AA were extracted from 100 µL of plasma and eluted, the AA were 
derivatized, and the eluant was allowed to separate into 2 layers.  An aliquot of the 
organic layer was collected into glass scintillation vials and analyzed for AA n a gas 
chromatograph (Varian CP-3800, Varian, Walnut Creek, CA) using a split injection 
protocol (2 µL of sample at 250°C) with helium (1.5 mL/min) as the carrier gas.  Intra-
and inter-assay coefficients of variation for AA determination were less than 15%. 
 Plasma volatile fatty acids were measured as described by Kristensen (2000) 
using a HP 5890 Series II GLC (Agilent, Atlanta, GA) with a flame ionization detector 
and HP 7673 automatic injector (Agilent). The GLC was equipped with a 60 m × 0.25 
i.d. fused-silica capillary column chemically bonded with 0.25-um DB5-MS stationary 
phase (J&W Scientific, Folsom, CA).  The injector temperature was set at 250oC.  
Helium was used as a carrier at a flow rate of 1 mL/min through the column. The column 
was maintained at a temperature of 75°C for 0.5 min, then temperature was increased to 
135°C at a rate of 3°C min− 1 and maintained at 270°C for 10 min to the end of the run.  
Peak areas were calculated by the Agilent ChemStation (Revision B.04.01; Agilent). 
Blood and Net Nutrient Flux Calculations 
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 Calculations for blood oxygen concentrations and plasma flows through the portal 
and hepatic vein were calculated as described by Hersom et al. (2003).  Briefly, blood 
flow (L/h) = IRPAH/(CVPAH − CAPAH), where IRPAH is the infusion rate (mg/min) of 
PAH, and CVPAH and CAPAH are the concentration (mg/L) of PAH in venous and 
arterial plasma, respectively.  Portal and hepatic blood flow were calculated directly, 
whereas hepatic arterial blood flow was calculated as hepatic blood flow minus portal 
blood flow. 
 Net flux of nutrients across the portal-drained viscera (PDV), hepatic, and total 
splanchnic vascular beds were calculated as described by Krehbiel et al. (1992) using the 
following equations: PDV flux = PBF × (Cp - Ca), Hepatic flux = PBF × (Ch – Cp) + 
ABF × (Ch – Ca), and total splanchnic flux = PDV flux + hepatic flux, where ABF and 
PBF are the blood flow rates (L/h) in the artery and portal vein, and Ca, Cp, and Ch are 
the metabolite concentrations in the arterial, portal, and hepatic plasma samples, 
respectively.  A positive net flux indicates a release or absorption of a nutrient, whereas a 
negative net flux represents uptake or utilization.  The number of steers sampled during 
each period and number of catheters patent at each site are listed in Table 1.  The hepatic 
extraction ratio (HER) has been described as an empirical method to calculate the 
amount of a nutrient removed (uptake) by the liver as a fraction of the total metabolit 
present in whole blood or plasma (Delgado-Elorduy et al., 2002), and was calculated 
according to Brockman and Bergman (1975) using the formula: HER =(Fpv(Cpv – Chv) + 
Fa (Ca – Chv))/FpcCpv + FaCa, where Fpv is the portal plasma flow (L/h), Cpv, Chv and  Ca 
are the portal and hepatic vein, and arterial plasma concentrations of the metabolite, nd 
Fa is the hepatic arterial plasma flow. 
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Aromatic AA were calculated as the sum of tyrosine, tryptophan and phenylalanine; 
branched chain AA (BCAA) as the sum of leucine, isoleucine and valine; gluconeogenic 
AA as the sum of alanine, glycine, glutamine, glutamic acid, serine, and threonine; sulfur 
containing AA as the sum of cysteine and methionine; essential AA (E ) as the sum of 
histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, 
and valine; non-essential AA (NEAA) as the sum of alanine, asparagine, aspartic acid, 
cysteine, glutamine, glutamic acid, glycine, hydroxyproline, proline, serine, and tyrosine; 
and total AA as the sum of all amino acids reported. 
Statistical Analysis 
 Performance data were analyzed using the Mixed Procedure of SAS with animal
as the experimental unit.  Fixed effects included diet, disease and diet × disease; period 
was included as a random effect in the model.  Dry matter intake and blood metabolite 
concentration and net flux data were analyzed using the Mixed Procedure of SAS with a 
repeated measures analysis using a first order autoregressive covariance structure with 
heterogenous variance.  A heterogenous variance between subjects was selected due to an 
increase in variance across treatments, although the pattern of variance remained 
homogenous within treatments (SAS Institute, 2003). Animal was the experimental unit 
and the repeated measure statement was sampling time within animal.  Fixed effects were 
diet, disease, time, and all possible interactions, and period was included as a random 
effect.  Results are discussed as significant if P ≤ 0.05 and as a tendency if P > 0.05 and 




 The number of steers sampled during each period and number of catheters patent 
at each site are listed in Table 1.  Luis, we need the statement on catheter patency and the 
table. 
There were disease × d interactions (P < 0.0001) for M. haemolytica whole cell 
antibodies (Figure 1a) and M. haemolytica leukotoxin (Figure 1b).  Antibody titers for 
M. haemolytica whole cells and leukotoxin were greater on d 14 following M. 
haemolytica challenge compared with CON steers.  In addition, rectal temperatures 
were greater for CH than CON steers on d 1 and 2 following the challenge (disease × d 
interaction, P < 0.0001; Figure 2).  Dry matter intake averaged across d 0 to 4, 7 to 11 
and 14 to 18 responded with a diet × disease × time interaction (P < 0.01).  Dry matter 
intake was greater (P < 0.05) for FED/CON than FED/CH, FAST/CON, and FAST/CH 
from d 0 to 4, greater for FED/CON, FED/CH, and FAST/CON than FAST/CH from d 
7 to 11, and did not differ among treatments (P > 0.05) from d 14 to 18 (Figure 3).  
Performance data is reported in Table 2.  Across the 14-d experiment, FAST steers had 
lower (P < 0.03) DMI than FED steers.  Interestingly, diet did not affect (P = 0.75) 
ADG; however, ADG was lower (P = 0.03) for CH compared with CON steers across 
the 14-d period. In addition, G:F tended (P = 0.11) to be lower CH than CON steers.  
Feed deprivation did not affect (P > 0.41) blood gas variables, whereas CH steers had 
greater blood pH (P = 0.04) and lower O2 saturation (P = 0.02), hematocrit (P = 0.0003), 
and O2 concentration (P = 0.01) than CON steers (Table 2).  Concentration of acetate in 
arterial blood was lower (P < 0.0001) in FAST compared with FED steers.  In addition, 
arterial concentrations of acetate responded with a diet × d interaction (P < 0.0001; 
Figure 4A).  Arterial acetate concentration decreased from d 1 to 3 of feed deprivation, 
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and remained lower than FED steers through d 14.  Arterial blood concentration of 
propionate was greater in FED/CON and FED/CH steers than FAST/CH steers; FED/CH 
steers were intermediate (diet × disease, P = 0.0008; Table 2).  In addition, arterial blood 
concentrations of butyrate (P = 0.04) and β-hydroxybutyrate (P = 0.02) were greater in 
CON steers than CH steers.  β-hydroxybutyrate also responded with a diet × d interaction 
(P = 0.001; Figure 4B).  On d 2, 3, and 4, β-hydroxybutyrate concentrations increased in 
FED and decreased in FAST.  By d 4 of re-feeding, arterial concentrations returned to 
pre-feed deprivation levels and remained without changes during the remainder of the 
experiment.  Lactate concentration in arterial blood was greatest for FED/CH steers, 
intermediate for FAST/CON and FAST/CH steers, and lowest for FED/CON steers (diet 
× disease, P = 0.03; Table 2).  In addition, arterial lactate concentration was greater (P < 
0.05) for CH than CON steers on d 2 and 7 post M. haemolytica challenge (diet × d, P = 
0.001; Figure 5).  Across the 14-d experiment, feed deprivation had no effect on arterial 
glucose concentrations (P = 0.30; Table 2); however, it responded with a diet × d 
interaction (P = 0.03; Figure 4C).  On d 2 of feed deprivation, glucose concentration was 
greater for FED steers than FAST steers; however, on d 3, 7 and 14, FAST steers had 
greater glucose concentrations than FED steers. 
 There were no diet × disease × d interactions (P > 0.10) for arterial concentrations 
of nitrogenous compounds (data not shown).  Arterial concentration of haptoglobin was 
greater (P = 0.05) in CH compared with CON steers (Table 3).  In contrast, arterial 
concentrations of alanine (P = 0.02), glutamine (P = 0.006), glycine (P = 0.006), 
hydroxyproline (P = 0.0001), proline (P = 0.01), glucogenic amino acids (P = 0.002), 
non-essential amino acids (P = 0.01), and total amino acids (P = 0.03) were lower in CH 
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than CON steers.  Similarly, concentrations of asparagine (P = 0.07) and glutamic acid (P 
= 0.06) tended to be lower in CH compared with CON steers.  Proline concentration in 
arterial blood responded with a diet × disease interaction (P = 0.03).  The decrease in 
proline when steers were challenged with M. haemolytica was greater in FAST compared 
with FED steers.  Concentrations of aromatic (P = 0.06) and sulfur containing amino 
acids (P = 0.07) tended to be lower in FAST compared with FED steers.  
 Diet × d interactions for arterial concentrations of AA are presented i Figure 5.  
There were similar diet × d interactions for alanine (P = 0.01; Figure 5A ) and histidine 
(P = 0.02; Figure 5C ).  During the first 7 d of the experiment concentrations were similar 
for FED and FAST steers, but on d 14 concentrations in FED steers were grater for both 
AA.  Arterial concentrations of glutamic acid (diet × d, P = 0.0004; Figure 5B) and 
methionine (diet × d, P = 0.02; Figure 5D) were similar on d 1 of the experiment; 
however, on d 3 of the feed deprivation period glutamic acid and methionine were greater 
in FED compared with FAST.  Tyrosine concentrations were greater in FED compared 
with FAST steers on d 3 and 14 (diet × d, P = 0.03; Figure 5E), whereas arterial 
concentration of serine was greater for FAST compared with FED on d 4 (diet × d, P = 
0.05; Figure 5D).  Gluconeogenic AA (diet × d, P = 0.02; Figure 5F) and NEAA (diet × 
d, P = 0.02; Figure 5G) responded in the same fashion where arterial concentrations were 
increased in FED animals compared with FAST 11 d after re-feeding.  (Luis, plea e 
check the superscript for glucogenic AA.  I believe it’s in the wrong spot.) 
 SFor AA, disease × d interactions for are presented in Figure 7.  Glycine (disease 
× d, P = 0.0002; Figure 7C), glucogenic AA (disease × d, P = 0.001; Figure 7G), and 
NEAA (disease × d, P = 0.003; Figure 7H) were lower on d 2, 3, and 4 relative to M. 
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haemolytica challenge in CH.  Glutamine (disease × d, P = 0.01; Figure 7A), and 
hydroxyproline (disease × d, P < 0.0001; Figure 7D) responded in the same fashion than 
glycine, glucogenic and NEAA, but the decreased concentrations in CH lasted until d 7 
relative to M. haemolytica challenge.  Arterial concentrations of glutamic acid (disease × 
d, P = 0.0004; Figure 7B) and threonine (disease × d, P = 0.04; Figure 7F) were lower in 
CH animals on d2 and 3 following M. haemolytica challenge. Phenylalanine was 
increased (disease × d, P = 0.01; Figure 7E) in CH on day 2 relative to M. haemolytica 
but returned to baseline concentrations on day 3 and no further differences were detected. 
 Arterial blood flow was lower (P = 0.01) in FAST compared with FED steers 
(Table 3).  Portal and hepatic blood flow were not affected (P > 0.26) by treatment.  
Oxygen consumption across the PDV was lower (P = 0.005) in FAST compared with 
FED steers, and was greater (P = 0.02) in CH compared with CON steers.  In addition, O2 
consumption across TST was lower (P = 0.02) in FAST compared with FED steers.  Net 
PDV release (P = 0.0006) and hepatic removal (P = 0.0008) of propionate were lower in 
FAST than in FED steers.  Net PDV release of butyrate tended (P = 0.07) to be greater 
and net PDV release of β-hydroxybutyrate was lower (P = 0.05) in FAST compared with 
FED steers.  Hepatic extraction of butyrate was greater (P = 0.05) in CH compared with 
CON steers.  Similar to PDV release, TST release of β-hydroxybutyrate was lower (P = 
0.03) in FAST compared with FED steers.  Net removal of lactate by the liver (P = 0.06) 
tended to be lower and TST (P = 0.008) and HER (P = 0.001) were lower in FAST 
compared with FED steers.  In addition, TST removal (tendency, P = 0.09) and HER (P = 
0.05) were lower in CH compared with CON steers.  Net release of glucose by the liver 
(tendency, P = 0.08) and TST (P = 0.04) were lower in FAST compared with FED steers. 
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There were no effects (P > 0.44) of diet, disease, or diet × disease for net PDV, liver, or 
TST flux of haptoglobin, ammonia or urea N (Table 4).  Net flux of alanine across the 
PDV responded with a diet × disease interaction (P = 0.02).  Net flux of alanine by the 
PDV was greatest for FED/CON steers, lowest for FAST/CON steers, and intermediate 
for FED/CH and FAST/CH steers.  Removal of alanine by TST was greater (P = 0.05) 
for FAST steers than FED steers.  Removal of asparagine by the liver (P = 0.01) was 
greater for FAST than for FED steers.  Net flux of asparagine across TST was greatest for 
FED/CON steers, lowest for FAST/CON steers, and intermediate for FED/CH and 
FAST/CH steers (diet × disease interaction, P = 0.03).  Net liver removal (tendency, P = 
0.06) and TST flux (P = 0.01) of aspartic acid were lower for FAST compared with FED 
steers.  Similarly, net flux of glutamine across the liver (P = 0.01) and HER (P = 0.008) 
were lower in FAST compared with FED steers.  Net liver (P = 0.01) and TST (P = 0.02) 
removal of glutamate were greater for FAST compared with FED steers.  In addition, 
removal of glutamate by TST was greater (P = 0.01) for CH compared with CON steers.  
Net flux of glycine across TST tended to be lower for FED/CH steers compared with 
steers on the remaining treatments (diet × disease interaction, P = 0.08).  Fasting tended 
(P = 0.10) to increase removal of histidine by the liver.  Challenge with M. aemolytica 
increased (P = 0.03) removal of hydroxylproline by the liver.  Net flux of isoleucine 
across the PDV tended to respond with a diet × disease interaction (P = 0.07).  Net flux 
of isoleucine was greater for FED/CON and FAST/CH steers compared with FED/CH 
and FAST/CON steers.  Net PDV, liver or TST flux of leucine, lysine, and methionine 
were not affected (P > 0.16) by diet or disease.   Net removal of ornithine by the liver 
responded with a diet × disease interaction (P = 0.05).  Net flux of ornithine was greatest 
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for FED/CON steers, lowest for FED/CCH steers, and intermediate for FAST/CON and 
FAST/CH steers.  In addition, HER of ornithine was greater (P = 0.04) in CH compared 
with CON steers.  Net TST flux of phenylalanine tended (P = 0.10) to be lower in FAST 
than in FED steers, and HER of phenylalanine was greater (P = 0.04) in FAST compared 
with FED steers.  Net removal of serine (P = 0.01), threonine (P = 0.03), and tryptophan 
(P = 0.03) by the liver was greater in FAST than in FED steers.  In addition, HER of 
serine (tendency, P = 0.09), threonine (P = 0.003), tryptophan (P = 0.01), and tyrosine (P 
= 0.002) was greater in FAST than in FED steers.  Hepatic extraction of threonine (P = 
0.03), tryptophan (tendency, P = 0.09), and tyrosine (P = 0.03) were greater in CH than 
in CON steers.  The liver removed more tyrosine (P = 0.04) in CH compared with CON 
steers. 
Feed deprivation increased net removal of aromatic (tendency, P = 0.06), 
gluconeogenic (P = 0.003), non-essential (P = 0.003), and total amino acids (P = 0.02) 
across the liver (Table 4).  In addition, challenge with M. haemolytica increased liver 
removal of aromatic (P = 0.01), gluconeogenic (P = 0.04), and non-essential (P = 0.04) 
amino acids.  Similarly, removal of aromatic (P = 0.05) and non-essential (P = 0.02) 
amino acids by TST was greater in CH than in CON steers.  Feed deprivation increased 
the HER for aromatic (P = 0.005), gluconeogenic (P = 0.009), non-essential (P = 0.008), 
and total amino acids (P = 0.01), and challenge with M. haemolytica increased HER for 
aromatic (P = 0.04), gluconeogenic (P = 0.05), non-essential (P = 0.05), and total amino 
acids (tendency, P = 0.08).  Net PDV flux of sulfur containing amino acids was greater 




In the present experiment, peak rectal temperature was reached 24 h post M. 
haemolytica challenge, and remained elevated 48 h post challenge.  Similarly, immune 
challenges with bacterial LPS in cattle (Gilliam et al., 2008, Reuter et al., 2008; 
Waggoner et al., 2008) and pigs (Webel et al., 1997) has resulted in increased rectal 
temperature, although the increase in rectal temperature is usually for a shorter period of 
time than observed in the present experiment.  Burciaga-Robles et al. (2009c) reported 
the acute changes in cytokines, rectal temperature, portal and hepatic blood flow and net 
nutrient flux across the PDV, liver, and TST during the d of M. haemolytica challenge 
following the initial 14 h of feed deprivation.  Based on those results and results from the 
present experiment, we conclude that our challenge model was successful in developing 
clinical and physiological signs associated with BRD. 
A febrile response has been reported to be a beneficial response by the host rather 
than being a negative consequence of the pathogen (Blatteis, 2003), because pathogen 
growth is sensitive to changes in body temperature.  In addition, increased body 
temperature can have a positive effect on the host immune response (e.g., activation of 
specific proteins; Sanberg et al. 2007).  Increased body temperature during a febrile 
process in humans and rats (Dantzer, 2002) has been reported to increase metabolic rate 
by 13% for every 1oC increase in body temperature. Therefore, the magnitude and 
duration of the increase in rectal temperature might impact maintenance requirments in 
morbid animals due to the increased energy cost for this metabolic process. 
Haptoglobin is an acute phase protein produced by the liver, and increased 
concentrations have been reported by Carter et al. (2002), Berry et al. (2004), and Step et 
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al. (2008) in calves experiencing clinical signs of BRD.  In the present experiment, CH 
steers had increased haptoglobin compared with CON steers.  Melchior et al. (2004), 
using complete Freund’s adjuvant as an immune challenge in fed or fasted pigs, reported 
increased haptoglobin concentrations 10 d after the challenge.  In our study and the study 
of Melchior et al. (2004), haptoglobin concentration was not affected by feed deprivation. 
To account for potential effects that intake has on nutrient digestion and 
metabolism, pair feeding has been suggested for use in experiments comparing animals
challenged with a pathogen vs. non-challenged animals (Sandberg et al., 2007).  Because 
pathogen exposure induces anorexia in host animals, potential effects of decreased intake 
should also be accounted for when developing feeding strategies for morbid animals in 
production settings (Kyriazakis et al, 1998).  In the present experiment, we observed a 
compensatory response in intake for FED/CH, and FAST/CON steers by d 7 to 11, 
although intake in FAST/CH remained below the remaining treatment groups.  In 
addition, ADG was decreased for CH compared with CON steers.  Therefore the model 
used in the present experiment was effective at simulating a BRD event across the 14 d 
experimental period.  
Blood gas 
Blood gas components and acid base equilibrium in cattle can be altered during 
respiratory disease (Carlson, 1996).  Normal blood pH in cattle has been reported to 
range 7.35 to 7.45 (Cingi et al. 2009).  In our study, blood pH was increased in CH (7.48) 
when compared with CON (7.45) steers and could be considered as marginally alkalotic.  
Parker et al. (2007) reported no differences in blood pH due to 48 h transportation with 
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feed and water deprivation, which is in agreement with results in our study where a 72 h 
fasting did not influence blood pH.  
Hemoglobin and packed cell volume were decreased in CH steers compared with 
CON steers. This data is in agreement with data reported by Corrigan et al. (2007), where 
heifers challenged with M. haemolytica had a decrease in hemoglobin and packed cell 
volume attributed to inflammation of lung tissue.  In a previous experiment (Burciaga-
Rbles et al. 2009a) using a similar experimental model, we reported a decrease in 
hemoglobin and a tendency for lower packed cell volume, similar to the present 
experiment.  
Arterial concentrations of energy metabolites 
Loerch and Fluharty (1999) reported that periods of feed and water deprivation 
associated with marketing strategies of beef cattle could have a negative effect on the 
rumen environment. In addition, Baldwing (1967) reported that total rumen bacteria were 
decreased after a 48 h period of feed and water deprivation.  Galyean et al (1981) 
reported that rumen bacteria counts were decreased after a 32 h feed deprivation, but the 
counts returned to pre-feed levels by 72 h after re-feeding occurred.  Ruminal 
fermentative capacity (RFA) has been reported to be a measurement of the capacity of 
rumen microorganisms to ferment substrate.  Baldwin et al (1967) reported that RFA is
decreased to 0% after 48 h of feed and water deprivation, and Hutchenson and Cole 
(1981) reported that this negative effect could last as long as 5 d.   
The end products of ruminal fermentation include acetate, propionate, and 
butyrate, which are either metabolized by or absorbed across the rumen wall where they 
are transported to the liver.  These VFA are the major source of energy in the normally-
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fed ruminant (Kristensen, 2005).  However, little is known about peripheral VFA 
metabolism under conditions of environmental stress or immune challenge, when energy 
requirements are suddenly increased.  In ruminants, acetate is an important substrate for 
oxidation (Annison and Armstron, 1970) and fat synthesis (Pethick, 1981; Smith and 
Crouse, 1984).  In the present experiment, arterial concentrations of acetate were not 
affected due to M. haemolytica challenge, but were decreased due to feed deprivation.  
These results are in agreement with those reported by Lomax and Baird (1983) who 
observed a decline in acetate after 24 h of feed deprivation in fasted dairy cows.   Arterial
acetate concentrations continued to decline to d 6 to approximately 95% of pre-fasting 
levels.  The decrease in acetate concentration in fasted animals suggests that the majority 
of acetate production and absorption is related to DMI, most likely resulting in rumi al 
microbial and fermentation alterations due to lack of substrate. 
In homeostasis, propionate derived from ruminal fermentation is considered the 
major gluconeogenic precursor, and the conversion rate from propionate to glucose has 
been reported to range from 32 to 73% (Seal and Reynolds, 1993).  However, 
propionate concentration depends on the availability of substrate for fermentation in the 
rumen (Bergman, 1990; Owens et al., 2008).  In addition, during periods of increased 
energetic demands, propionate conversion to glucose has been reported to increase 
(Wiltrout and Satter, 1972; Steel and Leng, 1973; Drackley et al., 2001).  In the present 
experiment, arterial concentrations of propionate were higher in FED/CON, 
intermediate for FAST/CON and FED/CH, and lowest for FAST/CH.  Although 
propionate is a potent glucogenic compound, it is difficult to assess its precise 
contribution to glucose production in the whole animal (Bergman , 1990).  Arterial 
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concentrations of propionate can only be increased if availability of substrate is 
increased or if specific disorders of propionate metabolism exist.  The decreased arterial 
concentrations of propionate in the present study in response to M. haemolytica 
challenge without increased concentrations of glucose may indicate that propionate ca  
be used for metabolic activities in peripheral tissues when energy demands are 
increased, as suggested by Bell et al. (1974).  Increased energy requirements in muscle 
or other peripheral tissues could lead to a repartitioning of nutrients from non-oxidative 
pathways (nutrient storage) to oxidative pathways in which circulating VFA might be 
used as energy substrate (Hocquette et al., 1998).   
Arterial concentrations of butyrate were decreased in CH steers in the present 
experiment.  Although butyrate is mainly taken up by epithelial tissues of the
gastrointestinal tract and liver, minimum amounts can enter peripheral circulation 
(Bergman, 1990), and in peripheral tissues be rapidly oxidized or used for lipogenesis or 
milk fat synthesis (Black et al., 1961; Annison et al., 1963).  Similar to butyrate, arterial 
β-hydroxybutyrate (βHB) concentration was lower in CH compared with CON in the 
present study.  Waldron et al. (2003) reported a linear decrease in βHB in lactating cows 
infused with different doses of LPS.  In addition, Steiger et al. (1999) reported a decrease 
in βHB in dairy heifers shortly after being infused with LPS. 
Burciaga-Robles et al. (2009b) reported no difference in lactate concentrations in 
steers following a M. haemolytica challenge, in contrast with the present experiment.  
However, the concentration of lactate was decreased in steers exposed to steers 
persistently infected with BVDV type 1b.  In contrast, Montgomery et al. (2008) reported 
decreased lactate concentrations in heifers treated against BRD when compared to non-
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treated heifers.  Coghe et al. (2000) suggested the use of plasma lactate as a 
diagnostic/prognosis tool in animals suffering from BRD, suggesting that during 
respiratory disease, a decrease in oxygen transferred from the lungs to arterial blood due 
to increased respiration would decrease aerobic metabolism.  However, increased plasma 
lactate was only a good prognosis tool when plasma lactate levels were incrased above 4 
mM when animals died within the following 24 h.  In the present experiment, a decrease 
in arterial blood oxygen concentration and increased plasma lactate might suggest that 
successful respiratory infection altered respiration rate and oxygen dynamics in CH 
steers.  In addition, increased lactate plasma concentrations have been associated with an 
increased glucogenolysis and a reduced capacity of peripheral tissues to utilize lac ate in 
response to an immune challenge (Harada el al., 1994; Mizock, 1995). 
Glucose concentrations in this study were not affected by M. haemolytica 
challenge, but decreased during the first three d of feed deprivation and then increased 
above pre-feeding levels after re-feeding.  Our results are in agreement with Galyean et 
al. (1981) and Cole et al. (1988) who reported a decrease in serum glucose when steers 
were fasted for 32 and 24 h, respectively. Heitman and Bergmann (1980) reported that 
during short periods of glucose deficit, AA from skeletal muscle can be released and used 
for glucogenesis.  However, during long periods of negative energy balance due to 
decreased intake or increased nutrient requirements, Thompson and Wu (1991) reported a 
combination of adaptation mechanisms to overcome the energy sparing from energy and 
protein, including increased peripheral oxidation of VFA and increased formation of 
ketone bodies (βHB and acetoacetate).  However, Robinson and Williams (1980) also 
suggested that the concentrations of these metabolites in peripheral circulation could be 
 193
decreased because they are utilized as oxidative fuels by the host.  Changes in arterial 
concentrations of energy related compounds are in general agreement with previous 
results related to periods of metabolic stress due to negative energy balance, sso iated 
disease, decreased DMI, and increased energy demands. 
Arterial concentrations of nitrogenous compounds 
Urea-N concentrations have been used as an indicator of protein balance in cattle
(Ndlovu et al., 2007).  In the present experiment, feed deprivation for 72 h had no effect 
on arterial concentration of ammonia and urea.  This data is in agreement with results of 
Lapierre et al. (2000) who reported no effect of increasing DM, energy, and CP intake on 
arterial concentrations of these metabolites.  Yambayamba et al. (1996) reported lower 
concentrations of urea N in feed restricted heifers compared to heifers deprive  of feed 
for 48 h.  In contrast, Hayden et al. (1993) and Cole et al. (1988) have reported increased 
concentrations of urea N in feed restricted animals  compared to an ad libitum-fed group.  
Discrepancies in results across experiments might be explained from previous protein 
nutrition status and the capability of N recycling in ruminant animals.  Webel et al. 
(1997) reported increased concentrations of urea N in pigs challenged with LPS 
compared to a non-challenged control group.  The increase in urea N was associated with 
an acute stage of proteolysis associated with the immune response.  In cattle, Orr et al. 
(1988) reported an increase in urea N in steers challenged with infectious bovine 
rhinotracheitis virus.  These authors restricted DMI to 1% of BW which might have 
increased the negative effect of the viral infection and resulted in a greater muscle 
catabolism and increase urea N.  We did not observe similar results with M. haemolytica 
challenge.  More recently, Montgomery et al. (2008) reported a linear increase in urea N 
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in heifers not treated up to treated three times against BRD. Therefore, an increse in 
plasma urea N could be an indicator of severity and duration of BRD other than just 
morbidity associated with the disease. 
 One of the main characteristics of the immune response is hypercatabolism, 
increased oxygen consumption and energy expenditure, activation of periphereal 
catabolism, and specially augmented metabolism in the hepatosplanchnic region (Dahn et 
al., 1987; Barton and Cerra, 1989).  This increased catabolism of periphereal tissues 
(muscle) provides substrates to the liver for glucogenesis and synthesis of acute phase 
proteins (Reid et al., 2004).  In general, AA concentrations in patients with sepsis(Druml 
et al., 2000), cattle following LPS challenge (Gilliam et al. 2008; Waggoner et al. 2008), 
and pigs after Freud’s complete adjuvant injection (Melchior et al., 2004) are decreas d 
compared to healthy individuals, and the extent of this difference has been used as a 
marker of the severity and prognosis of the disease process (Freund et al., 1979). 
Burciaga-Robles et al. (2009c) reported the changes in AA concentrations during the first 
8.5 h of the present experiment.  Interestingly, across 14 d M. haemolytica challenge 
decreased arterial plasma concentrations of alanine, glutamine, glycine, hydroxyproline, 
proline, gluconeogenic, NEAA and total AA concentrations (P < 0.05).  Although a 
decrease in AA concentrations following inflammatory disease could reflect th  decrease 
in feed intake (Melchior et al. 2004), there was no differences in DMI by d 14 of the 
present experiment.  In addition, feed deprivation had no effect on arterial plasma 
concentrations of individual AA except proline.  Therefore, differences in AA 
concentrations in the present experiment associated with M. haemolytica challenge might 
be attributed to an extended effect of the disease on AA metabolism.  A decrease in 
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peripheral concentrations of AA has been proposed by Melchior et al. (2004) to result 
from an increased utilization of AA as substrates for energy by peripheral tissues, 
utilization of the AA by cells of the immune system as precursors of energy or protein 
molecule synthesis, or from entering specific pathways related to body defense.  Gilliam 
et al. (2008) and Waggoner et al. (2008) reported a decrease in methionine, lysine, 
leucine, isoleucine, phenylalanine, tryptophan, glycine, serine, aspartate, glutamine and 
ornithine in response to an LPS challenge; however, the length of their experiment was 
only 12 h suggesting that changes in this AA were more related to changes occurring in 
the acute phase of the immune response as described previously for this experiment 
(Burciaga-Robles et al. 2009c).  In pigs (Melchior et al. 2004), plasma concentrations of 
AA after Freud’s adjuvant injection were lower in fed compared to fasted pigs, 
suggesting that when AA are supplied during the immune response, they are more rapidly 
metabolized in challenged animals.  However, in our experiment and during the acute 
phase previously reported (Burciaga-Robles et al. 2009c), the interactions between feed 
deprivation and M. haemolytica challenge were minimum.  
In the present experiment, decreased arterial concentrations of glucogenic AA 
were observed in CH animals.  As described previously, during an immune challenge 
there is an increased energy substrate demand due to metabolic changes in energy 
metabolism, increased glucose utilization, and oxidation of VFA to meet the energy 
demands, but in addition an increased catabolism of glucogenic AA occurs (Druml et al., 
2001).  Increased gluconeogenic activity in the liver during an immune challenge has 
been reported previously in vitro in hepatic slices from lactating dairy cows following 
LPS challenge (Waldron et al., 2003).  
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Over the 14 d experiment, arterial concentrations of BCAA were not affected by 
M. haemolytica challenge, in contrast to our previous report indicating decreased 
concentration of this group of amino acids (Burciaga-Robles et al., 2009).  In contrast, 
arterial concentrations of NEAA were still decreased after 14 d in CH animals, which 
could indicate an increased requirement for this group of AA.  Aromatic and sulfur-
containing AA tended to be decreased in feed deprived steers.  This may be attributed o 
the long-term effects that feed deprivation has on rumen bacterial populations and altered 
ruminal fermentation that has been previously described (Galyean et al., 1981; 
Hutchenson and Cole, 1996).  Increasing peripheral availability of these AA may be 
beneficial during the first 14 d after arrival to the feedlot.  The overall decrease in arterial 
concentrations of total AA observed in this experiment has also been reported in humans 
(Druml et al., 2001), pigs (Melchoir et al., 2004), and cattle (Waggoner et al., 2006; 
2008) and the degree of change has been associated with the severity of the infectious 
process (Druml et al. 2001).  
Blood flow 
Blood flow is key to the dispersion and metabolism of absorbed nutrients through 
the PDV and liver tissues (Hersom et al., 2003).  In general, blood flows were similar to 
those previously reported for growing steers (Reynolds and Huntington, 1998; Hersom et 
al. 2003). Blood flow during the first 6 h post M. haemolytica challenge has been 
reported by Burciaga-Robles et al. (2009c).  In contrast to the acute response, only 
arterial blood flow was increased in FAST compared with FED steers averaged across the 
14 d experiment, whereas blood flow across the PDV and liver were not different.  
Lomax and Baird (1983) reported decreased arterial, portal and hepatic blood flow in 
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lactating cows after 2 d of feed deprivation.  The decrease in arterial blood flow remained 
during the 6 d feed deprivation period followed by a numeric twofold increase of arterial 
blood flow 3 d following re-feeding.  Although the increase was not statistically different, 
the increase in arterial blood flow in lactating dairy cows after re-feeding might be related 
to physiological mechanisms to increase the flow of nutrients to peripheral tissues in 
order to meet the demands associated with production, whereas in non- lactating cows 
with steady-state nutrient requirements those changes were not observed.  On the d of M. 
haemolytica challenge, we observed increased hepatic and arterial blood flow due to the 
bacterial challenge (Burciaga-Robles et al., 2009c). The possible effects of immune 
related proteins on changes in blood blow were discussed in that paper.  Interestingly, the 
acute effect of M. haemolytica challenge is in agreement with the results provided by 
Lyngso et al. (2002) when changes in TST blood flow were studied in relationship to IL-
6 infusion. 
Oxygen consumption and net flux of energy related metabolites 
Several authors (Huntington et al., 1988; Burrin et al., 1989; Freetly and Ferrell, 
1991; Reynolds et al., 1992) have reported increased O2 consumption by splanchnic 
tissues with increases in energy (or DMI) intake, which is in agreement with the present 
experiment when steers were deprived of feed for 74 h.  In contrast, CH animals had 
greater PDV O2 consumption that CON.  These data are difficult to explain, and show the 
degree of complexity in metabolic changes that can occur after an immune challenge.  
Rokyta et al. (2004) observed that total hepatosplanchnic blood flow and oxygen delivery 
increased significantly in critically ill human subjects and returned to baseline after 
cessation of the illness.  Vasoconstrictor-mediated alterations could modulate splanchnic 
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response to nutrient intake and immune challenge and explain the increased hepatic blood 
flow we reported during the acute response to this challenge (Burciaga-Robles et a ., 
2009).  Marla et al. (2004) reported an increase in TST oxygen consumption when enteral 
or parenteral nutrition was provided to septic patients when compared to healthy patients.  
However, no previous reports were available on the possible effects of an immune 
challenge on increased PDV O2 consumption. Reynolds et al. (1992) reported a greater 
variation in TST O2 consumption in dairy cattle attributed to higher DMI, but also due to 
differences in productive state.  During an immune challenge the relationship between 
DMI and O2 consumption might be altered.  
In the present experiment, net flux of propionate across the PDV was decreased in 
FAST compared with FED steers.  Because the availability of propionate in portal blood 
is related to the amount produced by rumen microorganisms during fermentation of 
carbohydrates (Bergman 1990; Owens et al. 2008), the decrease in propionate flux is 
most likely explained by the alteration of RFA described previously (Hutchenson and 
Cole, 1981).  Although rumen production of propionate was not measured in the present 
experiment, decreased production or increased utilization by ruminal epithelia most likely 
resulted in decreased net PDV flux.  In addition, net propionate removal by the liver was 
decreased in FAST animals.  Propionate is the major glucose precursor in the liver of 
ruminant animals (Aiello et al., 1989).  In lactating dairy cows, Reynolds et al. (1987) 
estimated that 90% of portal propionate was removed by the liver and accounted for 55%
of glucose output.  In the present experiment, decreased portal flux of propionate was 
associated with a tendency for a decreased output of glucose by the liver. 
Net flux of nitrogenous compounds 
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Feed deprivation followed by M. haemolytica challenge had no effect on PDV, 
liver or TST flux of ammonia or urea-N.  However, net liver removal of hydroxyproline, 
tyrosine, aromatic, glucogenic, NEAA, and TAA were increased in response t  M. 
haemolytica challenge. Reid et al. (2004) reported that acute phase proteins found in 
humans have a much higher content of aromatic AA compared to muscle or dietary 
sources.  Therefore, in order for the liver to synthesize acute phase proteins, muscle 
catabolism may need to occur in order to achieve the requirements for acute phase protein 
synthesis.  Reeds et al. (1994) proposed that the amount of muscle protein that needs to 
be mobilized for the synthesis of acute phase proteins is 2:1 (Luis, relative to what, i.e., 
what is the ratio “endogenous:???”).  Interestingly, CH steers had lower ADG compared 
with CON.  Although we didn’t measure AA turnover in muscle, the combination of 
increased net removal of aromatic AA, increased haptoglobin concentrations, and lower 
ADG may support the hypothesis of Le’Floch, et al. (2004), who proposed that the 
increased requirements of aromatic AA due to an immune challenge might be the limiting 
step for animals to achieve an adequate immune response and maintain growth.  
Increased net removal of aromatic AA was also observed during the acute phase of the 
experiment (Burciaga-Robles et al., 2009), and might suggest that aromatic AA are
limiting in calves suffering from BRD. 
In humans, glucose and free fatty acids have been reported as the preferred 
sources of energy substrate in healthy individuals, and AA can act as a functional energy 
source in cases of increased demand or increased muscle catabolism (Kaesleret al., 
2003).  In healthy beef cattle, glucogenic AA can supply between 15 to 36% of the 
glucogenic substrates removed by the liver (Matras and Preston, 1989).  In the present 
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study, no differences in arterial concentrations of glucogenic AA were detected due to 
feed deprivation or bacterial challenge during the acute response to the immune 
challenge.  However, across 14 d arterial concentrations of glucogenic AA were 
decreased in CH animals, similar to data reported in pigs (Melchior et al., 2004) and 
humans (Druml et al., 2001).  Pigs suffering chronic lung inflammation (Melchior et al., 
2004) or humans with septicemia (Druml et al., 2001) had decreased plasma 
concentrations of glucogenic AA.  In the present experiment, net removal of glucogeni  
AA by the liver was detected in CH steers, even though glucose concentration and net
glucose flux across TST were not affected feed deprivation or bacterial challenge.  This 
increased liver uptake of glucogenic AA without changes in glucose concentratio  could 
reflect increased energy demand by the liver of the host animal, although hepatic O2 
consumption was not affected by the immune challenge.  Iwashita et al. (2005) reported 
that during increased energy demand in dogs due to exercise, net removal of glutamine 
and glucogenic AA by the liver was increased.  In addition, increased gluconeogenic 
activity in the liver during an immune challenge has been reported in vitro in hepatic 
slices from lactating dairy cows following LPS challenge (Waldron et al., 2003).  
Increased net removal of glucogenic AA could limit the supply needed by the host animal 
for other anabolic purposes. This increase in liver uptake and decrease in arterial 
concentrations of glucogenic AA, in addition to decreased portal propionate flux, 
decreased propionate removal, tendency for decreased liver release of glucose and 
decreased ADG provides insight into changes in metabolic demands due to BRD.  These 
effects remain across 14 d after an immune challenge and without animals showing 
further clinical (visual appearance) or physiological (rectal temperatur  back to normal) 
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signs of disease. 
Hepatic extraction of non-essential AA (NEAA) provides substrates for synthesis 
of other metabolites (Bergman, 1973).  Substantial or complete removal of NEAA can 
result in insufficient quantities entering the systemic circulation to support protein 
synthesis needs by the rest of the body (Lobley et al., 1996).  In septicemic patients, 
NEAA plasma concentrations were lower and total hepatic clearance of these AA w re 
increased compared with healthy patients (Druml et al., 2001).  These data are in 
agreement with results of the present experiment, where CH steers had greater net liver 
removal of NEAA and decreased arterial concentrations.  A decrease of NEAAduring 
disease might imply a change in NEAA metabolism in morbid compared with healthy 
cattle.  The increased liver removal of NEAA was observed during the acute respons  of 
the immune challenge and remained 14 d after the immune challenge occurred.  Increased 
removal of NEAA by the liver during disease challenge most likely supports synthesis of 
EAA and proteins required for the immune response. 
In addition to the M. haemolytica challenge, feed deprivation resulted in increased 
liver removal of aspartic acid, glutamic acid, serine, threonine, tryptophan, tyrosine, 
gluconeogenic and TAA, and a decreased liver output of glutamine.  Glutamine is the 
most abundant free AA and serves as an energy source for rapidly proliferating cells, 
especially enterocytes and immune cells (Castell, 2003).  Feed deprivation has been 
described as a stressful condition in cattle (Warriss et al., 1995) and also has been 
associated with increased corticosteroid levels (Werniki et al., 2006).  In dogs (Humbert 
et al., 2001), rats (De Blaauw et al., 2004) and humans (Darmaun et al., 1988), 
corticosteroids have been reported to enhance de novo synthesis of glutamine, most likely 
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in skeletal muscle (Karinch et al.., 2001).  Karinch et al. (2001) suggested that an 
increased period of stress resulting in de novo synthesis of glutamine could lead to 
glutamine depletion, which might ultimately lead to decreased growth rates and 
immunosupression.  In addition, Ziegler et al. (1992) suggested that the requirement of 
glutamine might be higher during disease due to a prolonged muscle catabolic state 
attempting to meet the body demands for glutamine. 
Conclusion 
Similar to non-ruminant species, feed deprivation, inflammation and immune 
system activation appear to be associated with alterations in short and long-term (14 d) 
nutrient utilization by splanchnic tissues.  Amino acids may be released from peipheral 
tissues and shifted to the liver for promotion of hepatic protein synthesis and 
gluconeogenesis.  In addition to decreased plasma concentrations, liver uptake of AA 
may also be increased suggesting enhanced metabolic clearance and turnover of 
endogenously released AA.  These changes in AA metabolism induced by BRD might 
suggest that AA requirements are different for ruminants undergoing an acute immune 
challenge and can remain increased even 14 d after the immune challenge occurs even 
though clinical or physiological manifestations of disease are no longer detectable. 
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Table 6.1. Effects of feed deprivation and M. haemolytica (MH) challenge on performance of fed or fasted 
beef steers. 
 





MH MH SEM Diet Disease Diet × Disease 
BW, kg         
d 0 317 324 326 310 10.2 0.82 0.66 0.26 
d 14 338 339 355 314 13.2 0.74 0.15 0.74 
DMI, d 0 – 14         
kg/d 7.12 6.93 6.44 4.86 0.62 0.03 0.08 0.27 
% of BW 2.17 2.00 1.83 1.55 0.16 0.02 0.11 0.62 
ADG, kg         
d 0 – 14 1.25 0.89 1.67 0.22 0.39 0.75 0.03 0.17 
G:F, kg/kg         





Table 6.2.  Effects of intratracheal M. haemolytica (MH) challenge on arterial blood gas components and concentrations of 
energy metabolites in fed or fasted beef steers. 
 Fed Fasted  P – value 
Item No MH MH No MH MH SEM Diet Disease Diet × Disease 
pH 7.45 7.47 7.45 7.48 0.007 0.70 0.04 0.36 
pCO2, mm Hg 36.8 38.0 37.0 35.5 1.47 0.41 0.91 0.31 
Bicarbonate, mM1 26.4 27.1 26.8 26.8 0.39 0.94 0.35 0.33 
O2 saturation, % 98.4 98.1 98.4 98.3 0.36 0.89 0.02 0.86 
Hemoglobin, g/100 mL 8.84 8.52 9.01 8.45 0.26 0.85 0.10 0.65 
Packed cell volume, % 26.4 23.8 26.0 23.1 0.65 0.42 0.0003 0.82 
Blood base, mM 3.58 4.19 3.67 4.17 0.39 0.92 0.16 0.89 
CO2, mM
1 26.6 28.0 26.9 26.8 0.86 0.56 0.37 0.28 
O2, mM 2.61 2.50 2.64 2.44 0.05 0.75 0.01 0.41 
Acetate, mM2 1.31 1.11 0.79 0.80 0.07 <0.0001 0.22 0.19 
Propionate, mM 0.026a 0.016b,c 0.017c 0.015b 0.0001 0.004 0.0008 0.01 
Butyrate, mM 0.033 0.019 0.020 0.015 0.004 0.09 0.04 0.35 
β-hydroxybutyrate, mM2 0.60 0.51 0.57 0.40 0.05 0.21 0.02 0.41 
 219
Lactate, mM3 0.307 0.682 0.589 0.613 0.073 0.17 0.01 0.03 
Glucose, mM2 4.44 4.40 4.56 4.56 0.19 0.30 0.97 0.92 
 1Disease × d interaction (P < 0.05). 
 2Diet × d interaction (P < 0.01). 
 3Disease × d interaction (P < 0.01). 
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Table 6.3.  Effects of intratracheal M. haemolytica (MH) challenge on arterial concentrations of nitrogenous 
metabolites in fed or fasted beef steers. 
 Fed Fasted  P – value 
Item No MH MH No MH MH SEM Diet Disease Diet × Disease 
Haptoglobin, mg/L 0.021 0.123 0.042 0.425 0.127 0.19 0.05 0.25 
Ammonia, mM1 0.065 0.089 0.095 0.090 0.009 0.12 0.35 0.14 
Urea, mM 4.33 4.50 3.60 4.79 0.53 0.67 0.19 0.33 
Alanine, µM2 157 154 161 132 7.23 0.21 0.02 0.08 
Asparagine, µM 16.6 14.3 20.8 12.9 2.71 0.60 0.07 0.30 
Aspartic acid, µM 5.12 6.56 6.04 6.01 0.94 0.83 0.45 0.43 
Cysteine, µM 4.37 3.59 3.66 5.20 0.90 0.61 0.67 0.20 
Glutamine, µM3 171 139 171 122 13.9 0.55 0.006 0.55 
Glutamic acid, µM2,3 214 185 207 185 13.2 0.80 0.06 0.80 
Glycine, µM3 251 203 223 185 14.8 0.11 0.006 0.73 
Histidine, µM4 40.0 41.4 37.7 39.8 4.25 0.64 0.68 0.93 
Hydroxyproline, µM3 19.3 15.3 21.2 13.4 1.30 0.98 0.0001 0.14 
Isoleucine, µM 108 108 110 90 8.08 0.27 0.21 0.21 
 221
Leucine, µM 138 144 135 126 10.5 0.33 0.85 0.47 
Lysine, µM 127 118 137 113 11.0 0.82 0.13 0.50 
Methionine, µM4 7.23 7.17 6.80 5.74 0.69 0.18 0.42 0.46 
Ornithine, µM 119 125 110 73.8 18.3 0.11 0.40 0.27 
Phenylalanine, µM3 43.2 47.9 41.4 43.6 2.84 0.27 0.22 0.65 
Proline, µM 64.6a 63.3b 64.5a 51.6b 2.70 0.03 0.01 0.03 
Serine, µM4 96.1 88.4 95.3 94.6 5.69 0.63 0.45 0.52 
Threonine, µM1 56.6 52.1 61.5 44.7 7.71 0.86 0.17 0.42 
Tryptophan, µM 30.5 29.8 32.7 26.8 2.78 0.87 0.22 0.35 
Tyrosine, µM4 34.5 33.3 36.3 29.8 4.19 0.83 0.35 0.52 
Valine, µM 258 253 250 215 18.9 0.21 0.27 0.40 
Aromatic amino acids, 
µM 
111 117 104 96.6 7.88 0.06 0.74 0.28 
Branched amino acids, 
µM 
502 523 483 424 41.1 0.15 0.64 0.33 
Gluconeogenic, µM3,4 949 823 920 765 42.8 0.31 0.002 0.72 
Sulfur containing 
amino acids, µM 
12.3 11.4 10.2 9.83 0.98 0.07 0.51 0.80 
Essential amino acids, 
µM 




1115 968 1091 889 50.3 0.30 0.01 0.57 
Total amino acids, µM 1965 1813 1949 1630 110 0.36 0.03 0.44 
 1Disease × d interaction (P < 0.05). 
 2Diet × d interaction (P < 0.01). 
 3Disease × d interaction (P < 0.01). 
 4Diet × d interaction (P < 0.05).
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Table 6.4.  Effects of intratracheal M. haemolytica (MH) challenge on blood flow and energy metabolite flux across 
the PDV, liver and TST fed or fasted beef steers. 
 Fed Fasted  P – value 
Item No MH MH No MH MH SEM Diet Disease Diet × Disease 
Arterial blood flow, L/h 164 145 110 111 16.6 0.01 0.59 0.52 
Portal blood flow, L/h 503 566 473 493 48.1 0.29 0.39 0.65 
Hepatic blood flow, L/h 621 695 583 572 71.0 0.26 0.65 0.54 
Oxygen consumption, 
mmol/h 
        
PDV -131 -233 -103 -117 25.3 0.005 0.02 0.07 
Liver -215 -215 -133 -201 53.4 0.36 0.51 0.51 
TST -355 -459 -233 -291 59.7 0.02 0.17 0.69 
HER         
Acetate, mmol/h         
PDV 196 135 124 129 38.3 0.13 0.27 0.21 
Liver 97.6 46.6 51.4 38.5 87.9 0.57 0.51 0.69 
TST1 227 175 160 165 110 0.52 0.69 0.63 
HER 0.165 0.041 0.043 0.413 0.242 0.57 0.57 0.26 
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Propionate, mmol/h         
PDV1 77.2 64.7 29.5 37.8 12.9 0.0006 0.81 0.25 
Liver2 -69.7 -58.1 -16.5 -32.3 14.8 0.0008 0.81 0.19 
TST3 4.67 7.98 10.7 5.49 2.61 0.48 0.70 0.10 
HER -0.546 -0.656 -0.438 -0.666 0.110 0.45 0.14 0.39 
Butyrate, mmol/h         
PDV 16.6 21.0 35.1 50.7 14.0 0.07 0.45 0.67 
Liver -14.8 -25.8 -27.9 -55.3 18.3 0.23 0.28 0.64 
TST 0.02 -7.29 9.04 -1.81 8.88 0.21 0..31 0.99 
HER3 0.116 -0.425 0.637 -0.264 0.496 0.35 0.05 0.62 
β-hydroxybutyrate, 
mmol/h 
        
PDV 0.055 0.077 0.036 0.034 0.015 0.05 0.51 0.44 
Liver 0.089 0.069 0.037 0.054 0.016 0.14 0.47 0.60 
TST 0.151 0.126 0.095 0.089 0.02 0.03 0.44 0.64 
HER -0.153 -0.108 -0.090 -0.137 0.041 0.67 0.98 0.25 
Lactate, mmol/h         
 225
PDV2 65.9 94.1 63.4 43.5 22.2 0.22 0.84 0.26 
Liver -138 -157 -122 -91.8 34.9 0.06 0.79 0.49 
TST3 -85.4 -37.0 -19.8 -13.7 28.8 0.008 0.09 0.33 
HER3 1.38 0.30 0.16 0.45 0.20 0.001 0.05 0.15 
Glucose, mmol/h         
PDV -60.7 -20.1 -69.4 -43.5 15.9 0.83 0.73 0.89 
Liver 270 172 102 33 103 0.08 0.33 0.86 
TST 258 223 30.5 -46.5 211 0.04 0.54 0.78 
HER -0.153 -0.108 -0.090 -0.137 0.041 0.67 0.98 0.25 
 1Diet × d interaction (P < 0.05). 
 2Diet × d interaction (P < 0.01). 
 3Disease × d interaction (P < 0.05).
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Table 6.5.  Effects of intratracheal M. haemolytica (MH) challenge on nitrogenous metabolite flux across the PDV, 
liver and TST in fed or fasted beef steers. 
 Fed Fasted  P – value 
Item No MH MH No MH MH SEM Diet Disease Diet × Disease 
Haptoglobin         
PDV -0.42 14.6 3.33 2.97 14.7 0.77 0.60 0.58 
Liver -4.91 -3.37 -5.78 -4.94 18.5 0.94 0.94 0.98 
TST -5.15 15.3 9.58 -8.47 31.0 0.87 0.96 0.51 
Ammonia, mmol/h         
PDV 7.19 8.17 3.14 7.78 3.24 0.47 0.37 0.55 
Liver -10.4 -9.73 -3.05 -6.42 7.58 0.44 0.85 0.76 
TST -1.91 -2.27 -1.58 0.67 3.22 0.55 0.72 0.63 
HER 0.251 0.246 0.246 0.197 0.098 0.78 0.78 0.82 
Urea N, mmol/h         
PDV -168 -118 -114 -265 103 0.77 0.97 0.71 
Liver 284 496 368 402 208 0.80 0.61 0.95 
TST 318 264 111 269 130 0.46 0.88 0.60 
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HER1 0.053 0.016 0.029 0.004 0.087 0.81 0.69 0.94 
Alanine, mmol/h         
PDV 22.1a 15.3b 10.3c 16.7b 2.99 0.08 0.95 0.02 
Liver -11.9 -15.6 -12.4 -19.2 5.78 0.71 0.34 0.77 
TST 9.84 0.20 -2.05 -2.34 3.81 0.05 0.17 0.20 
HER 0.109 0.157 0.162 0.289 0.074 0.20 0.23 0.58 
Asparagine, mmol/h         
PDV 3.97 2.84 4.10 4.20 1.12 0.49 0.63 0.57 
Liver -0.65 -1.31 -7.11 -3.03 1.69 0.01 0.29 0.15 
TST 3.84 1.34 -3.04 1.44 1.56 0.03 0.51 0.03 
HER 0.126 0.262 2.41 0.39 0.82 0.14 0.25 0.19 
Aspartic acid, mmol/h         
PDV 2.46 1.92 2.60 1.80 0.53 0.98 0.19 0.79 
Liver -0.82 -0.52 -1.76 -2.31 0.77 0.06 0.85 0.55 
TST 1.81 1.30 0.85 -0.13 0.51 0.01 0.12 0.62 
HER 0.26 0.45 0.48 1.05 0.27 0.12 0.15 0.47 
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Cysteine, mmol/h         
PDV -0.989 0.242 -0.474 -0.395 0.927 0.94 0.47 0.53 
Liver 3.27 3.46 2.11 2.11 0.94 0.18 0.92 0.91 
TST 2.69 3.89 1.64 1.87 0.98 0.12 0.46 0.61 
HER -0.497 -0.453 -0.540 -0.409 0.111 0.99 0.41 0.68 
Glutamine, mmol/h         
PDV -27.3 -8.88 -6.80 -3.06 13.5 0.33 0.41 0.58 
Liver 60.3 30.0 13.3 2.31 14.5 0.01 0.14 0.48 
TST 22.4 8.52 8.95 1.51 12.2 0.40 0.38 0.74 
HER -0.305 -0.199 -0.028 0.030 0.093 0.008 0.36 0.79 
Glutamic acid, mmol/h         
PDV 12.6 4.66 12.2 -1.58 14.6 0.81 0.45 0.83 
Liver 22.7 -5.89 -22.7 -25.8 13.4 0.01 0.21 0.31 
TST 30.1 -5.06 -10.5 -25.8 11.8 0.02 0.08 0.66 
HER -0.104 1.67 0.40 0.38 0.57 0.46    0.11 0.10 
Glycine, mmol/h         
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PDV 13.8 10.1 19.3 13.2 4.99 0.37 0.30 0.79 
Liver -7.60 -23.4 -10.2 -7.85 9.00 0.45 0.43 0.29 
TST 7.63 -15.0 7.55 7.44 6.76 0.09 0.08 0.08 
HER 0.074 0.308 0.144 0.097 0.101 0.45 0.32 0.14 
Histidine, mmol/h         
PDV -2.23 1.09 3.82 2.79 2.88 0.16 0.67 0.43 
Liver -4.97 -10.1 -9.81 -15.0 3.17 0.12 0.10 0.99 
TST -8.13 -9.53 -6.60 -10.6 3.52 0.95 0.42 0.69 
HER 0.485 1.75 1.34 1.90 0.64 0.43 0.16 0.58 
Hydroxyproline, 
mmol/h 
        
PDV 0.80 1.44 1.45 0.92 1.06 0.95 0.95 0.57 
Liver 1.24 -0.22 -1.97 -1.64 -1.09 0.03 0.56 0.40 
TST 1.41 0.04 -0.46 -0.50 0.98 0.22 0.43 0.45 
HER 0.307 0.104 0.221 0.301 0.249 0.81 0.80 0.56 
Isoleucine, mmol/h         
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PDV 11.4 4.34 7.19 9.23 2.65 0.90 0.31 0.07 
Liver -5.24 -3.95 -7.45 -9.86 5.22 0.42 0.91 0.71 
TST 7.20 1.19 -0.25 1.20 5.64 0.43 0.67 0.49 
HER 0.100 0.105 0.172 0.228 0.082 0.25 0.71 0.76 
Leucine, mmol/h         
PDV 9.55 7.94 9.08 13.5 4.39 0.55 0.74 0.48 
Liver -1.41 -3.51 -6.12 -10.4 6.99 0.39 0.63 0.86 
TST 8.76 1.09 2.88 5.51 9.94 0.93 0.70 0.59 
HER 0.072 0.082 0.114 0.154 0.078 0.44 0.73 0.83 
Lysine, mmol/h         
PDV 3.12 17.2 14.8 12.8 5.99 0.52 0.29 0.16 
Liver -2.23 -23.8 -19.7 -20.1 9.94 0.48 0.25 0.27 
TST 2.25 -3.74 -6.25 -5.97 10.2 0.58 0.77 0.75 
HER 0.177 0.994 0.542 0.487 0.325 0.88 0.28 0.21 
Methionine, mmol/h         
PDV 1.64 1.47 1.67 1.31 0.31 0.81 0.39 0.75 
 231
Liver -0.385 -0.402 -0.952 -0.870 0.564 0.34 0.95 0.92 
TST 1.35 0.91 0.78 0.43 0.44 0.22 0.36 0.91 
HER 0.127 0.109 0.270 -0.401 0.156 0.15 0.70 0.62 
Ornithine, mmol/h         
PDV1 -5.04 -4.81 4.91 8.57 7.59 0.13 0.79 0.82 
Liver 10.3a -16.1b -9.90c -9.85c 7.10 0.29 0.05 0.05 
TST 1.80 -23.0 -5.22 -0.40 9.82 0.41 0.29 0.12 
HER -0.095 0.781 0.295 0.697 0.316 0.62 0.04 0.45 
Phenylalanine, mmol/h         
PDV 5.29 5.11 5.12 4.52 1.52 0.79 0.79 0.88 
Liver1 -2.46 -3.82 -5.13 -8.12 2.30 0.11 0.32 0.70 
TST 3.20 0.31 0.06 -3.00 2.02 0.10 0.13 0.96 
HER1 0.103 0.148 0.271 0.370 0.090 0.04 0.44 0.76 
Proline, mmol/h         
PDV 4.89 2.65 4.43 6.00 1.28 0.25 0.78 0.13 
Liver -1.68 -0.86 -3.93 -4.64 2.53 0.21 0.98 0.74 
 232
TST 3.71 0.53 0.60 2.18 2.28 0.73 0.71 0.27 
HER 0.047 0.045 0.114 0.179 0.065 0.11 0.61 0.59 
Serine, mmol/h         
PDV 10.4 10.2 13.2 12.1 4.66 0.60 0.88 0.92 
Liver -1.17 -8.26 -17.5 -16.3 5.08 0.01 0.54 0.40 
TST 5.75 3.06 -3.79 -3.27 5.30 0.34 0.41 0.36 
HER 0.077 0.249 0.398 0.258 0.099 0.09 0.86 0.11 
Threonine, mmol/h         
PDV -0.18 4.08 5.39 6.10 6.21 0.53 0.68 0.77 
Liver 6.62 -6.64 -9.39 -12.0 5.86 0.03 0.29 0.55 
TST 4.31 -3.56 -3.09 -4.48 4.48 0.40 0.34 0.53 
HER 0.0007 0.331 0.483 0.863 0.167 0.003 0.03 0.87 
Tryptophan, mmol/h         
PDV -0.94 1.70 1.60 1.67 1.18 0.26 0.23 0.25 
Liver 0.32 -2.66 -3.57 -4.86 1.47 0.03 0.13 0.54 
TST -0.753 -1.20 -2.15 -2.59 1.78 0.41 0.79 0.99 
 233
HER 0.021 0.196 0.286 0.451 0.104 0.01 0.09 0.95 
Tyrosine, mmol/h         
PDV 2.50 4.01 2.94 4.08 1.86 0.88 0.46 0.91 
Liver -1.20 -7.41 -6.10 -8.32 2.16 0.16 0.04 0.33 
TST 0.95 -2.92 -2.82 3.77 2.07 0.25 0.23 0.46 
HER 0.068 0.413 0.536 0.717 0.122 0.002 0.03 0.48 
Valine, mmol/h         
PDV 12.2 4.64 6.17 18.6 7.24 0.57 0.72 0.15 
Liver -16.2 -15.0 -12.0 -11.2 15.6 0.77 0.93 0.97 
TST -6.00 -12.3 -6.8 10.7 17.1 0.75 0.98 0.27 
HER 0.140 0.133 0.185 0.121 0.102 0.85 0.70 0.76 
Aromatic amino acids, 
mmol/h 
        
PDV 1.32 3.74 5.59 7.95 3.73 0.35 0.51 0.99 
Liver 2.57 -9.65 -6.86 -14.7 3.98 0.06 0.01 0.57 
TST 3.23 -8.02 -1.37 -6.74 4.16 0.76 0.05 0.53 
HER1 -0.023 0.150 0.258 0.555 0.120 0.005 0.04 0.59 
 234
Branched amino acids, 
mmol/h 
        
PDV 28.0 6.97 22.0 39.2 19.5 0.49 0.91 0.32 
Liver -21.0 -25.7 -25.4 -41.6 24.3 0.66 0.65 0.80 
TST 11.5 -27.3 -3.01 -4.96 36.9 0.80 0.66 0.51 
HER 0.109 0.122 0.143 0.167 0.08 0.62 0.81 0.94 
Gluconeogenic amino 
acids, mmol/h 
        
PDV 27.1 35.6 54.8 44.5 33.5 0.56 0.97 0.77 
Liver 83.1 -25.7 -61.5 -83.5 33.6 0.003 0.04 0.18 
TST 105 10.7 -20.7 -34.2 -27.6 27.5 0.11 0.02 
HER -0.071 0.102 0.147 0.212 0.062 0.009 0.05 0.36 
Sulfur containing 
amino acids, mmol/h 
        
PDV -0.14 1.38 1.05 5.88 2.89 0.03 0.25 0.54 
Liver 2.43 3.02 1.08 -4.96 3.26 0.14 0.38 0.29 
TST 3.50 4.28 2.26 2.43 1.46 0.29 0.74 0.83 
HER -0.138 -0.189 -0.100 0.687 0.345 0.17 0.26 0.20 
Essential amino acids, 
mmol/h 
        
 235
PDV 38.9 50.7 58.4 71.2 19.1 0.28 0.50 0.97 
Liver -26.9 -66.4 -75.6 -96.3 38.0 0.28 0.41 0.79 
TST 26.5 -23.3 -21.9 -7.82 43.0 0.69 0.65 0.44 
HER 0.070 0.179 0.242 0.262 0.080 0.11 0.41 0.57 
Non-essential amino 
acids, mmol/h 
        
PDV 31.5 50.5 67.8 54.1 31.3 0.50 0.92 0.58 
Liver 88.7 -36.8 -72.2 -90.8 36.5 0.003 0.04 0.12 
TST 91.1 14.7 -3.55 -24.9 29.1 0.06 0.02 0.14 
HER -0.068 0.110 0.155 0.204 0.058 0.008 0.05 0.26 
Total amino acids, 
mmol/h 
        
PDV 64.4 101 131 127 47.2 0.31 0.70 0.65 
Liver 59.8 -107 -156 -195 69.4 0.02 0.12 0.33 
TST 105 -38.7 -28.6 -35.1 108 0.32 0.26 0.30 
HER -0.024 0.138 0.186 0.231 0.060 0.01 0.08 0.31 




Figure 6.1.  Changes in M. haemolytica whole cell (A; disease, P < 0.0001, SEM = 0.10; 
disease*d, P < 0.0001, SEM 0.30) and M. haemolytica leukotoxin (B; disease, P = 
0.0003, SEM = 0.031; disease*d, P < 0.0001; SEM 0.074) serum antibody concentrations 
in fed or fasted beef steers following a M. haemolytica challenge.  aWithin d, means with 
a superscript letters are different (P < 0.05). 
Figure 6.2.  Effect of M. haemolytica challenge on rectal temperature during the first 7 d 
post challenge in fed or fasted beef steers (P = 0.0006; SEM = 0.10; disease*d, P < 
0.0001, SEM = 0.031).  aWithin d, means with different superscript letters are different (P 
< 0.05).  bWithin , means with different superscript letters are different (P = 0.07) 
Figure 6.3.  Effect of M. haemolytica challenge on DMI in fed or fasted beef steers 
during a 14 d period (diet*w, P = 0.21, SEM = 0.61; disease*w, P = 0.27 SEM = 0.61 ; 
diet*disease*w P = 0.01; SEM = 0.86).  aWithin w, means with a superscript letters are 
different (P < 0.05). 
Figure 6.4. Changes in arterial plasma concentrations of acetate (A; diet*d, P = <0.0001; 
disease*d, P = 0.67, SEM = 0.09), β-hydroxybutyrate (B; diet*d, P = 0.01; disease*d, P
= 0.24, SEM = 0.07), and glucose (C; diet*d, P = 00.03; disease*d, P = 0.89, SEM = 
0.40) in fed or fasted beef steers following a M. haemolytica challenge.  aWithin d, means 
with superscript letters are different (P < 0.05). 
Figure 6.5. Changes in arterial plasma concentrations of alanine (A; diet*d, P = 0.01; 
disease*d, P = 0.60, SEM = 9.11), glutamic acid (b; diet*d, P = 0.0004; disease*d, P = 
0.0001, SEM = 16.3), histidine (C; diet*d, P = 0.02; disease*d, P = 0.55, SEM = 5.68), 
methionine (D; diet*d, P = 0.02; disease*d, P = 0.31, SEM = 1.01), Serine, (E; diet*d, P 
= 0.05; disease*d, P = 0.16, SEM = 7.00), tyrosine (F; diet*d, P = 0.03; disease*d, P = 
0.24, SEM = 5.43), glucogenic AA (G; diet*d, P = 0.02; disease*d, P = 0.03, SEM = 
51.1), and NEAA (H; diet*d, P = 0.02; disease*2, P = 0.002, SEM = 64.1) in fed or 
fasted beef steers following a M. haemolytica challenge.  aWithin d, means with 
superscript letters are different (P < 0.05). 
Figure 6.6. Changes in arterial plasma concentrations of lactate (A; disease*d, P = 
<0.001; day*d, P = 0.18, SEM = 0.08) in response to a M. haemolytica challenge in fed 
or fasted beef steers.  aWithin d, means with superscript letters are different (P < 0.05). 
Figure 6.7. Changes in arterial plasma concentrations of glutamine (A; disease*d, P = 
<0.001; diet*d, P = 0.14, SEM = 16.4), glutamic acid (b; disease*d, P = 0.0004; diet*d, P 
= 0.007, SEM = 16.3), glycine (C; disease*d, P = 0.0002; diet*d, P = 0.16, SEM = 21.3), 
hydroxyproline (D; disease*d, P = <0.0001; diet*d, P = 0.25, SEM = 1.25), 
phenylalanine, (E; disease*d, P = 0.01; diet*d, P = 0.12, SEM = 3.45), threonine (F; 
disease*d, P = 0.04; diet*d, P = 0.56, SEM = 9.57), glucogenic AA (G; disease*d, P =
0.001; diet*d, P = 0.02, SEM = 51.1), and NEAA (H; disease*d, P = 0.003; diet*d, P = 
0.0.02, SEM = 64.1) in response to a M. haemolytica challenge in fed or fasted beef 
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